<SEC-DOCUMENT>0001104659-23-092677.txt : 20230816
<SEC-HEADER>0001104659-23-092677.hdr.sgml : 20230816
<ACCEPTANCE-DATETIME>20230816172426
ACCESSION NUMBER:		0001104659-23-092677
CONFORMED SUBMISSION TYPE:	DEFR14A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20230816
DATE AS OF CHANGE:		20230816

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Theriva Biologics, Inc.
		CENTRAL INDEX KEY:			0000894158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133808303
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFR14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12584
		FILM NUMBER:		231179131

	BUSINESS ADDRESS:	
		STREET 1:		9605 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 270
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		(734) 332-7800

	MAIL ADDRESS:	
		STREET 1:		9605 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 270
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Synthetic Biologics, Inc.
		DATE OF NAME CHANGE:	20120305

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADEONA PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PIPEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20061214
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFR14A
<SEQUENCE>1
<FILENAME>tm2323985d1_defr14a.htm
<DESCRIPTION>DEFR14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDMENT NO. 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proxy Statement Pursuant to Section 14(a) of<BR>
the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by the Registrant <FONT STYLE="font-family: Wingdings">&#120;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by a Party other than the Registrant <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 95%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential, for
    Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Proxy Statement</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Additional
    Materials</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting Material
    Pursuant to Section&nbsp;240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2323985d1_def14aimg001.jpg" ALT=""></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THERIVA BIOLOGICS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name of Registrant as Specified in Its Charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name of Person(s)&nbsp;Filing Proxy Statement,
if Other Than the Registrant)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment of Filing Fee (check the appropriate box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.5in"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 95%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No fee required.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee paid previously with
    preliminary materials.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee computed on table in
    exhibit required by Item 25(b)&nbsp;per Exchange Act Rules&nbsp;14a6(i)(1)&nbsp;and 0-11.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Explanatory Note</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are filing this revised definitive proxy statement
to correct an inadvertent error in the section entitled &ldquo;Information About Voting&rdquo; on page 3 of the original definitive proxy
statement we filed with the Securities and Exchange Commission on August 14, 2023, which incorrectly referred to the web address www.voteproxy.com/tovx
to submit a proxy by Internet when the correct web address is www.proxypush.com/tovx. We will print and distribute to our stockholders
this revised definitive proxy statement in lieu of the original definitive proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2323985d1_def14aimg001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>9605 Medical Center Drive, Suite&nbsp;270</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Rockville, Maryland 20850</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(301) 417-4364</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>October&nbsp;2, 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE OF ANNUAL MEETING
OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the Stockholders of Theriva Biologics,&nbsp;Inc.:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby notify you that the 2023 Annual Meeting
of Stockholders (the &ldquo;2023 Annual Meeting of Stockholders&rdquo;) of Theriva Biologics,&nbsp;Inc., a Nevada corporation (the &ldquo;Company&rdquo;),
will be held on October&nbsp;2, 2023 at 9:30 a.m.&nbsp;(Eastern Time), at the offices of the Company, located at 9605 Medical Center
Drive, Suite&nbsp;270, Rockville, Maryland 20850, for the following purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to elect the four (4)&nbsp;nominees
    for director named in the accompanying proxy statement to our Board of Directors until such director&rsquo;s successor is duly elected
    and qualified;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to ratify the appointment
    of BDO USA, P.A. as our independent registered public accounting firm for our fiscal year ending on December&nbsp;31, 2023; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to transact such other
    business as may properly come before the 2023 Annual Meeting of Stockholders or any adjournments or postponements of the 2023 Annual
    Meeting of Stockholders.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The matters listed in this notice of meeting
are described in detail in the accompanying Proxy Statement. Our Board of Directors has fixed the close of business on August&nbsp;11,
2023 as the record date for determining those stockholders who are entitled to notice of and to vote at the meeting or any adjournment
or postponement of our 2023 Annual Meeting of Stockholders. The list of the stockholders of record as of the close of business on August&nbsp;11,
2023 will be made available for inspection at the meeting and during the ten days preceding the meeting at the Company&rsquo;s offices
located at 9605 Medical Center Drive, Suite&nbsp;270, Rockville, Maryland 20850.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY
OF PROXY MATERIALS FOR THE 2023 <FONT STYLE="text-transform: uppercase">Annual Meeting</FONT> OF STOCKHOLDERS TO BE HELD ON October&nbsp;2,
2023:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE NOTICE OF ANNUAL MEETING OF STOCKHOLDERS,
THE PROXY STATEMENT AND OUR ANNUAL REPORT ON FORM&nbsp;10-K FOR THE YEAR ENDED DECEMBER 31, 2022 ARE AVAILABLE ELECTRONICALLY AT <I>WWW.THERIVABIO.COM</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Along with the attached Proxy Statement, we are sending to you our
Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2022. Such annual report, which includes our audited financial statements,
is not to be regarded as proxy solicitation material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>YOUR VOTE IS IMPORTANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Even if you plan to attend the meeting, please submit a proxy to have
your shares voted as promptly as possible by using the internet or kindly sign, date, and return the enclosed proxy card in the envelope
provided so that your vote will be counted if you later decide not to attend the meeting. No postage is required if the proxy card is
mailed in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By Order of the Board of Directors,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Steven A. Shallcross</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer,<BR>
    Chief Financial Officer and Director<BR>
    Rockville, Maryland</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August&nbsp;14, 2023</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 95%"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROXY STATEMENT</FONT></A></TD>
    <TD STYLE="width: 5%; text-align: right"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION ABOUT VOTING</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_002">2</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPOSAL 1: ELECTION OF DIRECTORS</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_003">7</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE NOMINEES</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_004">7</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIRECTOR INDEPENDENCE</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_005">7</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION ABOUT THE NOMINEES</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_006">7</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION REGARDING THE BOARD OF
    DIRECTORS AND CORPORATE GOVERNANCE</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_007">8</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION REGARDING THE COMMITTEES
    OF THE BOARD OF DIRECTORS</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_008">10</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIRECTOR COMPENSATION</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_009">12</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIMITS ON LIABILITY AND INDEMNIFICATION</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_010">13</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPENSATION COMMITTEE INTERLOCKS</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_011">13</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPOSAL 2: RATIFICATION OF APPOINTMENT
    OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_012">14</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPORT OF THE AUDIT COMMITTEE OF THE
    BOARD OF DIRECTORS</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_013">15</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUDIT FEES AND ALL OTHER FEES</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_014">15</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE COMPENSATION</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_015">17</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
    OWNERS AND MANAGEMENT</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_016">28</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_017"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTAIN RELATIONSHIPS AND RELATED
    TRANSACTIONS</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_017">29</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_018"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AVAILABILITY OF REPORT ON FORM&nbsp;10-K</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_018">30</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_019"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE REGARDING DELIVERY OF STOCKHOLDER
    DOCUMENTS (&ldquo;HOUSEHOLDING&rdquo; INFORMATION)</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_019">30</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_020"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STOCKHOLDER PROPOSALS FOR THE 2024
    ANNUAL MEETING</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_020">30</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_021"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AVAILABLE INFORMATION ON CORPORATE
    GOVERNANCE AND SEC FILINGS</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_021">30</A></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_022"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_022">31</A></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="tm2323985d1_def14aimg001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>9605 Medical Center Drive, Suite&nbsp;270</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Rockville, Maryland 20850</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the 2023 Annual Meeting of Stockholders
to be held on October&nbsp;2, 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GENERAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Proxy Statement is being furnished to holders
of shares of common stock, $0.001 par value per share (the &ldquo;Common Stock&rdquo;) of Theriva Biologics,&nbsp;Inc., a Nevada corporation
(&ldquo;we,&rdquo; us,&rdquo; &ldquo;Theriva&rdquo; or the &ldquo;Company&rdquo;), in connection with the solicitation of proxies on
behalf of our Board of Directors (the &ldquo;Board of Directors&rdquo;) for use at our 2023 Annual Meeting of Stockholders to be held
on October&nbsp;2, 2023 at 9:30 a.m.&nbsp;(Eastern Time), at the offices of the Company, 9605 Medical Center Drive, Suite&nbsp;270, Rockville,
Maryland 20850, and at any adjournment or postponement of our 2023 Annual Meeting of Stockholders (the &ldquo;2023 Annual Meeting of
Stockholders&rdquo;). The purpose of the 2023 Annual Meeting of Stockholders and the matters to be acted on are stated in the accompanying
Notice of 2023 Annual Meeting of Stockholders. The Board of Directors knows of no other business that will come before the 2023 Annual
Meeting of Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Notice of our 2023 Annual Meeting of Stockholders,
this Proxy Statement, and a proxy card, together with our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2022,
are being mailed to our stockholders on or about August&nbsp;22<B>, </B>2023. Such annual report, which includes our audited financial
statements, is not to be regarded as proxy solicitation material. We will bear the cost of our solicitation of proxies. The original
solicitation of proxies by mail may be supplemented by personal interview, telephone, or facsimile by our directors, officers, or employees,
who will receive no additional compensation for such services. Arrangements will be made with brokerage houses and other custodians,
nominees, and fiduciaries for the forwarding of solicitation material to the beneficial owners of stock held by any such persons, and
we will reimburse those custodians, nominees, and fiduciaries for the reasonable out-of-pocket expenses incurred by them in doing so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors is soliciting votes (i)&nbsp;<B>FOR
</B>each of the four (4)&nbsp;nominees named herein for election to the Board of Directors; and (ii)&nbsp;<B>FOR</B> the ratification
of the appointment of BDO USA, P.A. as our independent registered public accounting firm for the year ending December&nbsp;31, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>2023 <FONT STYLE="text-transform: uppercase">Annual
Meeting</FONT> ADMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All stockholders who own shares of Common Stock
as of the record date are welcome to attend the 2023 Annual Meeting of Stockholders. If you attend, please note that you will be asked
to present government-issued identification (such as a driver&rsquo;s license or passport) and evidence of your share ownership of our
Common Stock on the record date. This can be your proxy card if you are a stockholder of record. If your shares are held beneficially
in the name of a bank, broker or other holder of record and you plan to attend the 2023 Annual Meeting of Stockholders, you will be required
to present proof of your ownership of our Common Stock on the record date, such as a bank or brokerage account statement or voting instruction
card, to be admitted to the 2023 Annual Meeting of Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>No cameras, recording equipment or electronic devices will be permitted
in the 2023 Annual Meeting of Stockholders.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>INFORMATION ABOUT VOTING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>Why am I receiving these materials?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A: Our Board of Directors is providing these
proxy materials to you in connection with our 2023 Annual Meeting of Stockholders, which is scheduled to take place on October&nbsp;2,
2023.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>What information is contained in these
materials?</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A: The information included in this Proxy Statement
relates to the proposals to be voted on at the 2023 Annual Meeting of Stockholders, the voting process, the compensation of our directors
and executive officers, and other required information.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>What items of business will be voted
on at the 2023 Annual Meeting of Stockholders?</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A: The two (2)&nbsp;items of business scheduled
to be voted on at the 2023 Annual Meeting of Stockholders are: (i)&nbsp;the election of our directors named herein; and (ii)&nbsp;the
ratification of the appointment of BDO USA, P.A. as our independent registered public accounting firm for the year ending December&nbsp;31,
2023.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>How does the Board of Directors recommend
that I vote?</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A: The Board of Directors recommends that you
vote your shares: (i)&nbsp;<B>FOR</B> each of the four (4)&nbsp;nominees named herein for election to the Board of Directors; and (ii)&nbsp;<B>FOR
</B>the ratification of the appointment of BDO USA, P.A. as our independent registered public accounting firm for the year ending December&nbsp;31,
2023.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>Shareholders Entitled to Vote?</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A: Only stockholders who own our Common Stock,
as of the close of business on August&nbsp;11, 2023, the record date for the 2023 Annual Meeting (the &ldquo;Record Date&rdquo;), will
be entitled to vote at the 2023 Annual Meeting of Stockholders.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>How many shares are outstanding and
how many votes is each share entitled?</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: On the record date, (i)&nbsp;17,042,765 shares
of Common Stock were issued and outstanding, (ii)&nbsp;275,000 shares of Series&nbsp;C Convertible Preferred Stock, convertible into
1,803,279 shares of Common Stock, were issued and outstanding, and (iii)&nbsp;100,000 shares of Series&nbsp;D Convertible Preferred Stock,
convertible into 655,738 shares of Common Stock, were issued and outstanding.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Only holders of record of our Common Stock as
of the close of business on the Record Date will be entitled to notice of and to vote at the 2023 Annual Meeting of Stockholders and
at any adjournments or postponements thereof.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each share of our Common Stock that is issued
and outstanding as of the close of business on August&nbsp;11, 2023, the Record Date, is entitled to be voted on all items being voted
on at the 2023 Annual Meeting of Stockholders, with each share being entitled to one vote on each matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>What is the difference between holding shares as a stockholder
of record and as a beneficial owner?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: Most of our stockholders hold their shares
through a broker or other nominee rather than directly in their own name. As summarized below, there are some distinctions between shares
held of record and those owned beneficially. If your shares are registered directly in your name with our transfer agent, Equiniti Group
plc (formerly Corporate Stock Transfer,&nbsp;Inc.), you are considered, with respect to those shares, the stockholder of record and these
proxy materials are being sent directly to you by us. As the stockholder of record, you have the right to grant your voting proxy directly
to Mr.&nbsp;Steven Shallcross, our Chief Executive Officer, Chief Financial Officer and a Director, or to vote in person at the meeting.
The Board of Directors has enclosed a proxy card for stockholders of record to use to grant a voting proxy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">I</FONT>f
your shares are held in a brokerage account or by another nominee, you are considered the beneficial owner of shares held in &ldquo;street
name,&rdquo; and these proxy materials are being forwarded to you by your broker or nominee together with a voting instruction card.
As the beneficial owner, you have the right to direct your broker or nominee how to vote. Since you are not the stockholder of record,
however, you may not vote these shares in person at the meeting unless you obtain from the broker or nominee that holds your shares a
valid proxy giving you the right to vote the shares. Your broker or nominee should have enclosed or provided voting instructions for
you to use in directing the broker or nominee how to vote your shares. If you hold your shares through a broker and you do not give instructions
to the record holder on how to vote, the record holder will be entitled to vote your shares in its discretion on certain matters considered
routine, such as the ratification of the appointment of our independent registered public accounting firm. Proposal1is not considered
a routine matter. If you hold your shares in street name and you do not instruct your broker how to vote for Proposal 1, no votes will
be cast on your behalf for these non-routine matters for which you have not provided voting instructions. These &ldquo;broker non-votes&rdquo;
will be treated as shares that are present and entitled to vote for purposes of determining the presence of a quorum, but not as shares
entitled to vote on these non-routine proposals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>May&nbsp;I attend the 2023 Annual Meeting of Stockholders?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: You are entitled to attend the 2023 Annual
Meeting of Stockholders only if you own Common Stock as of the close of business on the Record Date, August&nbsp;11, 2023, or you hold
a valid proxy for the 2023 Annual Meeting of Stockholders. You should be prepared to present photo identification for admittance. If
you are not a record holder but hold shares beneficially through a broker or nominee (that is, in &ldquo;street name&rdquo;), you should
provide proof of beneficial ownership on the record date, such as your most recent account statement, a copy of the voting instruction
card provided by your broker or nominee, or other similar evidence of ownership. If you do not provide photo identification or comply
with the other procedures outlined above upon request, you may not be admitted to the 2023 Annual Meeting of Stockholders. The 2023 Annual
Meeting of Stockholders will begin promptly at 9:30 a.m.&nbsp;(Eastern Time). Check-in will begin at 9:00 a.m., and you should allow
ample time for the check-in procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>How can I vote my shares in person at the 2023 Annual Meeting
of Stockholders?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: You may vote by ballot in person at the 2023
Annual Meeting of Stockholders any shares that you hold as the stockholder of record. You may only vote in person shares held in street
name if you obtain from the broker or nominee that holds your shares a valid proxy giving you the right to vote the shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: <I>How can I vote my shares without attending
the 2023 Annual Meeting of Stockholders?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: Whether you hold shares directly as the stockholder
of record or beneficially in street name, you may, without attending the meeting, direct how your shares are to be voted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Stockholder of Record&thinsp;&mdash;&thinsp;Shares
Registered in Your Name:</I> If you are a stockholder of record, in addition to voting in person at the 2023 Annual Meeting of Stockholders,
you may vote by submitting a proxy through the internet, or vote by proxy using a proxy card. Whether or not you plan to attend the 2023
Annual Meeting of Stockholders, we urge you to submit a proxy to ensure your vote is counted. You may still attend the meeting and vote
in person even if you have already voted by proxy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; <B>Submit a proxy by Internet</B>, by going
to the web address <I>www.proxypush.com/tovx</I> and following the instructions for internet voting shown on your proxy card. Your Internet
vote must be received by 11:59 p.m., Eastern Time, on October&nbsp;1, 2023 to be counted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; <B>Submit a proxy by mail</B>, by completing,
signing, dating and mailing the enclosed proxy card in the envelope provided. If you return your signed proxy card to us before the 2023
Annual Meeting of Stockholders, we will vote your shares as you direct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Beneficial Owner&thinsp;&mdash;&thinsp;Shares
Registered in the Name of a Broker or Bank:</I> If you are a beneficial owner of shares registered in the name of your broker, bank,
or other agent, you should have received an instruction card containing voting instructions from that organization rather than from us.
You will be provided with instructions to vote by internet or to vote by mailing in your instruction card. Simply follow the voting instructions
in the voting instruction card to ensure that your vote is counted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We provide internet proxy voting
    to allow record holders to vote your shares online, with procedures designed to ensure authenticity and correctness of your proxy
    vote instructions. Please be aware, however, that you must bear any costs associated with your internet access, such as usage charges
    from internet access providers and telephone companies.</B></FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>Can I change my vote?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: You may change your vote at any time prior
to the final vote at the 2023 Annual Meeting of Stockholders. For shares held directly in your name, you may accomplish this by: (1)&nbsp;sending
a written notice of revocation to our Corporate Secretary at Theriva Biologics,&nbsp;Inc., 9605 Medical Center Drive, Suite&nbsp;270,
Rockville, Maryland 20850; (2)&nbsp;submitting a new proxy bearing a later date (which automatically revokes the earlier proxy) subject
to the voting deadlines that are described on the proxy card or voting instruction form, as applicable; (3)&nbsp;granting a subsequent
proxy through the internet; subject to the voting deadlines that are described on the proxy card or voting instruction form, as applicable;
or (4)&nbsp;by attending the 2023 Annual Meeting of Stockholders and voting in person. Attendance at the meeting will not cause your
previously granted proxy to be revoked unless you specifically so request. <B><I>Even if you plan to attend the 2023 Annual Meeting of
Stockholders, we recommend that you also submit your proxy or voting instructions or vote through the internet so that your vote will
be counted if you later decide not to attend the 2023 Annual Meeting of Stockholders.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If your shares are held by your broker or bank as nominee or agent,
you should follow the instructions provided by your broker or bank.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>Can I revoke my proxy?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: You may revoke your proxy before it is voted
at the 2023 Annual Meeting of Stockholders. To revoke your proxy if you are a holder of record, notify our Corporate Secretary in writing
at Theriva Biologics,&nbsp;Inc., 9605 Medical Center Drive, Suite&nbsp;270, Rockville, Maryland 20850, or deliver to our Corporate Secretary
a duly executed proxy bearing a later date subject to the voting deadlines that are described on the proxy card or voting instruction
form, as applicable. You may also revoke your proxy by appearing at the 2023 Annual Meeting of Stockholders in person and voting your
shares. If you vote by internet as a holder of record, you may also revoke your proxy by granting a subsequent proxy by internet subject
to the voting deadlines that are described on the proxy card or voting instruction form, as applicable. Attendance at the 2023 Annual
Meeting of Stockholders will not, by itself, revoke a proxy. If your shares are held by your broker or bank as nominee or agent, you
should follow the instructions provided by your broker or bank.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: <I>Who can help answer my questions?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: If you have any questions about the 2023 Annual
Meeting of Stockholders or how to vote or revoke your proxy, or you need additional copies of this Proxy Statement or voting materials,
you should contact our Corporate Secretary at Theriva Biologics,&nbsp;Inc., 9605 Medical Center Drive, Suite&nbsp;270, Rockville, Maryland
20850 or by phone at (301) 417-4364.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>How are votes counted?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A: In the election of directors, holders of Common
Stock on the Record Date may vote <B>FOR</B> all of the four (4)&nbsp;nominees named herein or you may direct your vote to be <B>WITHHELD
</B>with respect to any one or more of the four (4)&nbsp;nominees named herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With respect to Proposal 2 holders of Common Stock may vote <B>FOR</B>,
<B>AGAINST</B>, or <B>ABSTAIN</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you provide specific instructions, your shares
will be voted as you instruct. If you are a record holder and submit your proxy card with no further instructions, your shares will be
voted in accordance with the recommendations of the Board of Directors, namely (i)&nbsp;<B>FOR</B> each of the four (4)&nbsp;nominees
named herein for election to the Board of Directors; and (ii)&nbsp;<B>FOR</B> the ratification of the appointment of BDO USA, P.A. as
our independent registered public accounting firm for the year ending December&nbsp;31, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you are a beneficial owner, please follow the instruction provided
to you by your broker, bank or other nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>What is a quorum and why is it necessary?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: Conducting business at the 2023 Annual Meeting
of Stockholders requires a quorum. The presence, either in person or by proxy, of the holders of shares of stock having one third of
the voting power of the shares of stock entitled to vote on August&nbsp;11, 2023 are necessary to constitute a quorum to conduct business
at the 2023 Annual Meeting of Stockholders. Your shares will be counted towards the quorum only if you submit a valid proxy (or, in the
case of a beneficial owner, one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the 2023
Annual Meeting of Stockholders. Abstentions and broker non-votes (which result when your shares are held in &ldquo;street name,&rdquo;
your broker does not have discretion to vote such shares and you do not tell the nominee how to vote your shares, as described in detail
below) are treated as present for purposes of determining whether a quorum exists. Broker non-votes are relevant in determining whether
a quorum is present at the meeting. If there is no quorum, the holders of a majority of shares present at the meeting in person or represented
by proxy may adjourn the meeting to another date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: <I>What are Broker Non-Votes?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: Under the rules&nbsp;of the New York Stock
Exchange, member brokers who hold shares in street name for their customers that are the beneficial owners of those shares have the authority
to only vote on certain &ldquo;routine&rdquo; items in the event that they have not received instructions from beneficial owners. Under
New York Stock Exchange rules, when a proposal is not a &ldquo;routine&rdquo; matter and a member broker, bank or nominee has not received
voting instructions from the beneficial owner of the shares with respect to that proposal, the brokerage firm, bank or nominee may not
vote the shares on that proposal since it does not have discretionary authority to vote those shares on that matter. A &ldquo;broker
non-vote&rdquo; is submitted when a broker, bank or nominee returns a proxy card and indicates that, with respect to particular matters,
it is not voting a specified number of shares on that matter, as it has not received voting instructions with respect to those shares
from the beneficial owner and does not have discretionary authority to vote those shares on such matters. If you hold your shares in
street name and you do not instruct your broker how to vote on these matters not considered routine, no votes will be cast on your behalf
with respect to these non-routine matters. &ldquo;Broker non-votes&rdquo; are not entitled to vote at the 2023 Annual Meeting of Stockholders
with respect to the matters to which they apply; however, &ldquo;broker non-votes&rdquo; will be included for purposes of determining
whether a quorum is present at the 2023 Annual Meeting of Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Proposal 1 is considered a &ldquo;non-routine&rdquo; matter. As a
result, brokers, banks or nominees that do not receive instructions with respect to Proposal 1 from their customers will not be entitled
to vote on such proposal for which instructions were not received.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Proposal 2 is considered a &ldquo;routine&rdquo; matters. As a result,
brokers that do not receive instructions with respect to Proposal 2 from their customers should be entitled to vote on such proposal
in their discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>What is the voting requirement to approve each of the proposals?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: For Proposal 1, which relates to the election
of directors, the four (4)&nbsp;nominees receiving the highest number of &ldquo;<B>FOR</B>&rdquo; votes (from the holders of votes of
shares of Common Stock present in person or represented by proxy at the 2023 Annual Meeting of Stockholders and entitled to vote on the
election of directors) will be elected. Only votes <B>FOR</B> will affect the outcome. Abstentions, withheld votes and broker non-votes
will have no effect on the outcome of the vote as long as each nominee receives at least one <B>FOR</B> vote. You do not have the right
to cumulate your votes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; To be approved, Proposal 2, which relates
to the ratification of the appointment of BDO USA, P.A., as our independent registered public accounting firm for the year ending December&nbsp;31,
2023, must receive <B>FOR</B> votes from the holders of a majority of the votes of shares of Common Stock present in person or represented
by proxy and entitled to vote on this matter at the 2023 Annual Meeting of Stockholders. Abstentions will have the same effect as an
<B>AGAINST</B> vote. Because this is a routine matter for which brokers have discretion, broker non-votes are not expected to exist for
this matter. This vote is advisory, and therefore is not binding on us, the Audit Committee or our Board of Directors. If our stockholders
fail to ratify the appointment, the Audit Committee will reconsider whether or not to retain that firm. Even if the appointment is ratified,
the Audit Committee in its discretion may direct the appointment of different independent auditors at any time during the year if it
determines that such a change would be in the best interests of our company and its stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recommend that you vote <B>FOR</B> each of
the nominees for director and <B>FOR</B> proposal 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your shares are held in &ldquo;street name&rdquo;
and you do not indicate how you wish to vote, your broker is permitted to exercise its discretion to vote your shares on certain &ldquo;routine&rdquo;
matters. The only matter expected to be a routine matter to be submitted to our stockholders at the 2023 Annual Meeting of Stockholders
is Proposal 2. Proposal 1 is not a routine matter. Accordingly, if you do not direct your broker how to vote for a director in Proposals
1 your broker may not exercise discretion and may not vote your shares on that proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of Proposal 1, broker non-votes
will be counted toward a quorum but are not &ldquo;entitled to vote&rdquo; at the meeting. As such, a broker non-vote will not be counted
as a vote <B>FOR</B> or <B>WITHHELD</B> with respect to a director in Proposal 1 and, therefore, will have no effect on the outcome of
the vote on such proposal as long as each nominee receives at least one <B>FOR</B> vote. Abstentions will be counted in determining the
total number of shares present in person or represented by proxy and entitled to vote on each of the proposals and will therefore have
the effect of a vote <B>AGAINST</B> on each proposal, except for Proposal 1, where the abstention will have no effect on the outcome
of the vote as long as each nominee receives at least one <B>FOR</B> vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: <I>What should I do if I receive more than
one set of voting materials?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: You may receive more than one set of voting
materials, including multiple copies of this Proxy Statement and multiple proxy cards or voting instruction cards. For example, if you
hold your shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in
which you hold shares. If you are a stockholder of record and your shares are registered in more than one name, you will receive more
than one proxy card. Please complete, sign, date, and return each proxy card and voting instruction card that you receive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: <I>Where can I find the voting results
of the 2023 Annual Meeting of Stockholders?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: We intend to announce preliminary voting results
at the 2023 Annual Meeting of Stockholders and publish final results in a Current Report on Form&nbsp;8-K that will be filed with the
U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) within four (4)&nbsp;business days after the meeting. If final voting
results are not available to us in time to file a Current Report on Form&nbsp;8-K within four (4)&nbsp;business days after the meeting,
we intend to file a Current Report on Form&nbsp;8-K to publish preliminary results and, within four (4)&nbsp;business days after the
final results are known to us, file an additional Current Report on Form&nbsp;8-K to publish the final results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Q: <I>What happens if additional matters are
presented at the 2023 Annual Meeting of Stockholders?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: Other than the two (2)&nbsp;items of business
described in this Proxy Statement, we are not aware of any other business to be acted upon at the 2023 Annual Meeting of Stockholders.
If you grant a proxy, the person named as proxy holder, Mr.&nbsp;Steven Shallcross, our Chief Executive Officer, Chief Financial Officer
and Director, will have the discretion to vote your shares on any additional matters properly presented for a vote at the meeting. If
for any unforeseen reason any of our nominees are not available as a candidate for director, the persons named as proxy holders will
vote your proxy for any one or more other candidates nominated by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>Who will count the votes?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A: One or more inspectors of election will tabulate the votes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>Is my vote confidential?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A: Proxy instructions, ballots, and voting tabulations
that identify individual stockholders are handled in a manner that protects your voting privacy. Your vote will not be disclosed, either
within our business or to anyone else, except: (1)&nbsp;as necessary to meet applicable legal requirements; (2)&nbsp;to allow for the
tabulation of votes and certification of the vote; or (3)&nbsp;to facilitate a successful proxy solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>Who will bear the cost of soliciting votes for the 2023 Annual
Meeting of Stockholders?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A: The Board of Directors is making this solicitation
on our behalf, and we will pay the entire cost of preparing, assembling, printing, mailing, and distributing these proxy materials. Certain
of our directors, officers, and employees, without any additional compensation, may also solicit your vote in person, by telephone, or
by electronic communication. On request, we will reimburse brokerage houses and other custodians, nominees, and fiduciaries for their
reasonable out-of-pocket expenses for forwarding proxy and solicitation materials to stockholders. In addition to the use of the mail,
proxies may be solicited by personal interview, telephone, telegram, facsimile and advertisement in periodicals and postings, in each
case by our directors, officers and employees without additional compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q: <I>When are stockholder proposals and director nominations due
for next year&rsquo;s (2024) Annual Meeting of Stockholders?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A: To be considered for inclusion in next year&rsquo;s proxy materials
(the 2024 Annual Meeting of Stockholders), your proposal must be submitted in writing by April&nbsp;16, 2024, to the attention of our
Corporate Secretary at Theriva Biologics,&nbsp;Inc., 9605 Medical Center Drive, Suite&nbsp;270, Rockville, Maryland 20850, and you must
comply with all applicable requirements of Rule&nbsp;14a-8 promulgated under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you wish to nominate a director at the 2024
Annual Meeting of Stockholders, or to bring any other proposal before the 2024 Annual Meeting of Stockholders, that is not to be included
in next year&rsquo;s proxy materials pursuant to Rule&nbsp;14a-8, you must currently do so in accordance with our Second Amended and
Restated Bylaws, which has been approved by the Board of Directors and will become effective on October&nbsp;3, 2023. A copy of the Second
Amended and Restated Bylaws (the &ldquo;Second A&amp;R Bylaws&rdquo;) is available on our website at <I>www.therivabio.com</I> in the
Investors section. Our Second A&amp;R Bylaws requires notice of not less than 120 days prior to the anniversary of the preceding year&rsquo;s
annual meeting to be timely, which in this case means June&nbsp;4, 2024, and contains additional requirements about advance notice required
of stockholder proposals and director nominations. The stockholder&rsquo;s notice must set forth the information required by our Second
A&amp;R Bylaws with respect to each stockholder making the proposal and each proposal and director nomination that such stockholder intends
to present at the 2024 Annual Meeting.. In addition to satisfying the foregoing requirements, to comply with the universal proxy rules,
stockholders who intend to solicit proxies in support of director nominees other than the Company&rsquo;s nominees must provide notice
that sets forth the information required by Rule&nbsp;14a-19 under the Exchange Act no later than August&nbsp;3, 2024. If such meeting
date is changed by more than 30 days, then notice must be provided by the later of 60 calendar days prior to the date of the annual meeting
or the 10th calendar day following the day on which public announcement of the date of the annual meeting is first made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>PROPOSAL 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ELECTION OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Board of Directors, based on the recommendation of the Nominations
Committee of the Board of Directors, has nominated for annual election as director each of the individuals identified below, all of whom
are incumbent directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>THE NOMINEES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Age</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Position</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Director<BR> Since</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey J. Kraws(1)(2)(3)</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: center">58</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 48%; font: 10pt Times New Roman, Times, Serif">Chairman</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">2006</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">John Monahan(1)(2)(3)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">75</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Director</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">2020</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Steven A. Shallcross</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">62</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Executive Officer, Chief Financial Officer and Director</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">2018</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey Wolf, J.D.(1)(2)(3)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">59</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Director</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">2006</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Member of the Audit Committee</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Member of the Compensation
                                            Committee</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Member of the Nominations
                                            Committee</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUR BOARD OF DIRECTORS RECOMMENDS THAT YOU
VOTE YOUR<BR>
SHARES FOR THE ELECTION OF EACH OF THESE NOMINEES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is the intention of the persons named in the
accompanying proxy card to vote all shares of Common Stock for which he has been granted a proxy for the election of each of the nominees,
each to serve as a director until the next annual meeting of stockholders and until his successor shall have been duly elected and qualified.
All of the nominees have consented to being named in this Proxy Statement and to serve as a director if elected. At the time of the 2023
Annual Meeting of Stockholders, if any of the nominees named above is not available to serve as director (an event that the Board of
Directors does not currently have any reason to anticipate), all proxies will be voted for any one or more other persons that the Board
of Directors designates. The Board of Directors believes that it is in the best interests of the Company to elect the above-described
nominees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>DIRECTOR INDEPENDENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No director or executive officer of the Company
is related by blood, marriage or adoption to any other director or executive officer. A majority of the members of our Board of Directors
are independent in compliance with the applicable listing standards of the NYSE American, LLC (&ldquo;NYSE American&rdquo;). The Board
of Directors has affirmatively determined that the independent directors and nominees are Jeffrey J. Kraws, John Monahan and Jeffrey
Wolf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_006"></A>INFORMATION ABOUT THE NOMINEES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Below is certain information regarding our directors and executive
officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Jeffrey J. Kraws.</I></B> Mr.&nbsp;Kraws
has been a member of the Company&rsquo;s Board of Directors since January&nbsp;of 2006, and was appointed independent, non-executive
Chairman of the Board in May&nbsp;2012. Since 2003, Mr.&nbsp;Kraws has served as Chief Executive Officer and co-founder of Crystal Research
Associates and CRA Advisors, and since February&nbsp;2012, he has served as partner and co-founder of TopHat Capital, LLC. Since November&nbsp;9,
2021, Mr.&nbsp;Kraws has served as the Chief Executive Officer of GridIron Bionutrients,&nbsp;Inc. From August&nbsp;2016 through January&nbsp;2021,
Mr.&nbsp;Kraws served as the Co-President of Ra Medical Systems Inc., a medical device company. Mr.&nbsp;Kraws is a partner at Grannus
Securities Pty Ltd. (an Australian based private equity fund) since November&nbsp;2015. Mr.&nbsp;Kraws is a partner of PDK Healthcare
Innovations LLC. He also consults and assists in management of private companies through his private practice. Mr.&nbsp;Kraws has received
some of the most prestigious awards in the industry. Among other awards, he was given a &ldquo;5-Star Rating&rdquo; in 2001 by Zacks
and was ranked the number one analyst among all pharmaceutical analysts for stock performance in 2001 by Starmine.com. Prior to founding
Crystal Research Associates, Mr.&nbsp;Kraws served as co-president of The Investor Relations Group (IRG), a firm representing primarily
under-followed, small-capitalization companies. Previously, Mr.&nbsp;Kraws served as a managing director of healthcare research for Ryan
Beck&nbsp;&amp; Co. and as director of research/senior pharmaceutical analyst and managing director at Gruntal&nbsp;&amp; Co., LLC (prior
to its merger with Ryan Beck&nbsp;&amp; Company). Mr.&nbsp;Kraws served as managing director of the healthcare research group and senior
pharmaceutical analyst at First Union Securities (formerly EVEREN Securities); as senior U.S. pharmaceutical analyst for the Swedish-Swiss
conglomerate Asea Brown Boveri; and as managing director and president of the Brokerage/Investment Banking operation of ABB Aros Securities,&nbsp;Inc.
He also served as senior pharmaceutical analyst at Nationsbanc Montgomery Securities, BT Alex Brown&nbsp;&amp; Sons, and Buckingham Research.
Mr.&nbsp;Kraws also has industry experience, having been responsible for competitive analysis within the treasury group at Bristol-Myers-Squibb
Company. During 2006 through February&nbsp;of 2007, Mr.&nbsp;Kraws served as our Vice President of Business Development, on a part-time
basis. Since December&nbsp;2013, Mr.&nbsp;Kraws serves on the board of directors of Avivagen Inc. and from 2013 until 2020 served on
the board of directors of Saleen Automotive,&nbsp;Inc. He holds an M.B.A. from Cornell University and a B.S. degree from State University
of New York&thinsp;&mdash;&thinsp;Buffalo. Mr.&nbsp;Kraws brings a strong business background to us, having worked as a pharmaceutical
analyst for over 22 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Kraws brings to the Board of Directors
significant strategic, business and financial experience related to the business and financial issues facing pharmaceutical companies.
Mr.&nbsp;Kraws has a broad understanding of the operational, financial and strategic issues facing pharmaceutical companies. His healthcare
experience, executive and leadership experience further qualify him as a member of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>John Monahan.</I></B> Dr.&nbsp;Monahan
has been a member of the Company's Board of Directors since November&nbsp;11, 2020. Dr.&nbsp;Monahan has served on the board of directors
of NightHawk Biosciences,&nbsp;Inc. (formerly known as Heat Biologics,&nbsp;Inc.), a biopharmaceutical company primarily engaged in the
development of immune therapies and vaccines, since November&nbsp;2009, and from August&nbsp;2016 until May&nbsp;2021 also served on
the board of directors of the biotech company Anixa Biosciences,&nbsp;Inc. (formerly known as ITUS Corporation), a biotechnology company
focused on using the body's immune system to diagnose, treat and prevent cancer. He is also a board member of Cellix Ltd. (Ireland) and
has served on a number of other public and private boards over the years. Dr.&nbsp;Monahan co-founded Avigen Inc. in 1992, a company
which has become a leader in its sector for the development of novel pharmaceutical products for the treatment of serious human diseases.
Over a 12-year period as Chief Executive Officer of Avigen he raised over $235 million in several private and public financings including
its initial public offering. From 1989-1992, he was Vice President of Research&nbsp;&amp; Development at Somatix Therapy Corp., Alameda,
CA and from 1985-1989 he was Director of Molecular&nbsp;&amp; Cell Biology at Triton Biosciences Inc., Alameda, CA. Prior to that from
1982-1985, he was Research Group Chief, Department of Molecular Genetics, Hoffmann-LaRoche,&nbsp;Inc. Nutley, NJ, and from 1975 to 1977
he was an Instructor at Baylor College of Medicine, Houston TX. Dr.&nbsp;Monahan served as a scientific advisory consultant to the Company
from 2015 to November&nbsp;10, 2020 and from 2010 through 2015 he was the Company's Senior Executive Vice President of Research&nbsp;&amp;
Development. Dr.&nbsp;Monahan was also a Scientific Advisory Board member of Agilis Biotherapeutics (recently merged into PTC Therapeutics),
from 2014 to 2019. Dr.&nbsp;Monahan received his Ph.D. in Biochemistry from McMaster University, Canada and his B.Sc. from University
College Dublin,&nbsp;Ireland.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr.&nbsp;Monahan brings to our Board of Directors
significant knowledge of and experience in the pharmaceutical and medical industries. He has extensive business, managerial, executive
and leadership experience that further qualify him to serve as a member of the Board of Directors and a valuable understanding of biochemistry
and our product candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Jeffrey Wolf, J.D.</I></B> Mr.&nbsp;Wolf,
who has been a member of the Company&rsquo;s Board of Directors since 2006, has substantial experience in creating, financing, nurturing
and biomedical ventures based upon breakthrough research and technology. In August&nbsp;2008, Mr.&nbsp;Wolf founded NightHawk Biosciences,&nbsp;Inc.
(&ldquo;NightHawk&rdquo;), a publicly traded company engaged in research and development of drugs focused on modulating the immune system.
Since April&nbsp;2010, Mr.&nbsp;Wolf has served as the Chief Executive Officer and Chairman of the Board of NightHawk. Prior to founding
NightHawk, from June&nbsp;1997 to March&nbsp;2011, Mr.&nbsp;Wolf has served as managing director at Seed-One Ventures, LLC a venture
firm focused on launching and growing exceptional healthcare companies from the ground up. Mr.&nbsp;Wolf has also founded and run several
biomedical companies. Mr.&nbsp;Wolf&rsquo;s start-ups include Avigen, a San Francisco-based gene therapy company where he was a co-founder
and director; TyRx Pharma, a company focused on the development of bio-compatible polymers where he was a co-founder and Chairman; and
Elusys Therapeutics, a company focused on the development of ANTHIM, an FDA approved antitoxin against anthrax, which is currently a
subsidiary of NightHawk. Mr.&nbsp;Wolf received his MBA. from Stanford Business School, his J.D. from New York University School of Law
and his B.A. from the University of Chicago, where he graduated with honors in Economics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr.&nbsp;Wolf has extensive knowledge of the
industry and in particular research and development. His legal and business background provide him with a broad understanding of the
legal, operational, financial and strategic issues facing our company. Having served as a board member on other public company boards,
Mr.&nbsp;Wolf has an extensive understanding of the operational, financial and strategic issues facing public companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Steven A. Shallcross.</I></B> Mr.&nbsp;Shallcross
has been a member of our Board of Directors since December&nbsp;6, 2018 and currently serves as our Chief Executive Officer, a position
he was appointed to on December&nbsp;6, 2018, and our Chief Financial Officer. Mr.&nbsp;Shallcross was appointed as our Interim Chief
Executive Officer on December&nbsp;5, 2017 and has served as our Chief Financial Officer since joining us in June&nbsp;2015. Mr.&nbsp;Shallcross
brings to our company operational, financial and international biotech industry experience, as well as an established track record at
leading the financial development and strategy for several publicly traded biotech companies. From May&nbsp;2013 through May&nbsp;2015,
Mr.&nbsp;Shallcross served as Executive Vice President and Chief Financial Officer of Nuo Therapeutics,&nbsp;Inc. (formerly Cytomedix,&nbsp;Inc.).
In January&nbsp;2016, Nuo Therapeutics,&nbsp;Inc. filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code
in the United States Bankruptcy Court for the District of Delaware and on April&nbsp;25, 2016, the Bankruptcy Court entered an order
granting approval of Nuo&rsquo;s plan of reorganization. From July&nbsp;2012 to May&nbsp;2013, Mr.&nbsp;Shallcross held the offices of
Executive Vice President, Chief Financial Officer and Treasurer of Empire Petroleum Partners, LLC, a motor fuel distribution company.
From July&nbsp;2011 to March&nbsp;2012, Mr.&nbsp;Shallcross was Acting Chief Financial Officer of Senseonics, a privately-held medical
device company located in Germantown, MD. From January&nbsp;2009 to March&nbsp;2011, he served as Executive Vice President and Chief
Financial Officer of Innocoll AG (formerly privately held Innocoll Holdings,&nbsp;Inc.), a global, commercial-stage biopharmaceutical
company specializing in the development and commercialization of collagen-based products. He also served for four years as the Chief
Financial Officer and Treasurer of Vanda Pharmaceuticals,&nbsp;Inc., leading the company through its successful IPO and follow-on offering
and previously served as the Senior Vice President and Chief Financial Officer of Middlebrook Pharmaceuticals,&nbsp;Inc. (formerly Advancis
Pharmaceutical Corporation). In addition, Mr.&nbsp;Shallcross also served as the Chief Financial Officer of Bering Truck Corporation.
Since June&nbsp;2019, Mr.&nbsp;Shallcross has served on the board of directors of Elys Game Technology,&nbsp;Corp., an international,
vertically integrated commercial-stage company engaged in various aspects of the leisure gaming industry and from April&nbsp;2021 until
June&nbsp;2022, he served on the board of directors of TwinVee Powercats,&nbsp;Co., a designer, manufacturer and marketer of recreational
and commercial power catamaran boats. He holds an MBA from the University of Chicago&rsquo;s Booth School of Business, a Bachelor of
Science degree in Accounting from the University of Illinois, Chicago, and is a Certified Public Accountant in the State of Illinois.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Shallcross brings to the Board of Directors
significant strategic, business and financial experience related to the business and financial issues facing biotechnology companies.
Mr.&nbsp;Shallcross has a broad understanding of the financial markets, financial statements as well as generally accepted accounting
principles. Through his services as our Chief Executive Officer and Chief Financial Officer, he has developed extensive knowledge of
our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A>INFORMATION REGARDING THE
BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Independence of the Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Common Stock is listed on the NYSE American.
Under the NYSE American listing standards, independent directors must comprise a majority of a listed company&rsquo;s board of directors
and all members of the Audit Committee, Compensation Committee and Nominations Committee must be independent. Audit Committee members
must also satisfy the independence criteria set forth in Rule&nbsp;10A-3 under the Exchange Act and Compensation Committee members must
also satisfy the independence criteria set forth in Rule&nbsp;10C-1 under the Exchange Act. Under the NYSE American listing standards,
a director will only qualify as an &ldquo;independent director&rdquo; if, in the opinion of that company&rsquo;s Board of Directors,
that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities
of a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In order to be considered to be independent for
purposes of Rule&nbsp;10A-3, a member of an Audit Committee of a listed company may not, other than in his or her capacity as a member
of the Audit Committee, the board of directors, or any other board committee: (i)&nbsp;accept, directly or indirectly, any consulting,
advisory or other compensatory fee from the listed company or any of its subsidiaries, or (ii)&nbsp;be an affiliated person of the listed
company or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board of Directors undertook a review of
the independence of the members of the Board of Directors and considered whether any director has a material relationship with our company
that could compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities. Based upon information
requested from and provided by each director concerning their background, employment and affiliations, including family relationships,
the Board of Directors has determined that all of our current directors, except Mr.&nbsp;Shallcross, due to his current position as Chief
Executive Officer and Chief Financial Officer of our company, is &ldquo;independent&rdquo; as that term is defined under the rules&nbsp;of
the NYSE American. As a result, Mr.&nbsp;Kraws, Dr.&nbsp;Monahan and Mr.&nbsp;Wolf are deemed to be &ldquo;independent&rdquo; as that
term is defined under the rules&nbsp;of the NYSE American.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In making these determinations, the Board of
Directors considered the current and prior relationships that each non-employee director has with our company and all other facts and
circumstances the Board of Directors deemed relevant in determining their independence, including the beneficial ownership of capital
stock by each non-employee director, and the transactions involving them described in the section of this proxy statement entitled &ldquo;Certain
Relationships and Related Party Transactions.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board Leadership Structure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors has an independent Chairman,
Mr.&nbsp;Kraws, who has authority, among other things, to call and preside over meetings of the Board of Directors, including meetings
of the independent directors, to set meeting agendas and to determine materials to be distributed to the Board of Directors. Accordingly,
the Chairman of the Board has substantial ability to shape the work of the Board of Directors. We believe that separation of the positions
of Chairman of the Board and Chief Executive Officer reinforces the independence of the Board of Directors in its oversight of our business
and affairs. In addition, we believe that having an independent Chairman of the Board creates an environment that is more conducive to
objective evaluation and oversight of management&rsquo;s performance, increasing management accountability and improving the ability
of the Board of Directors to monitor whether management&rsquo;s actions are in our best interests and the best interests of our stockholders.
As a result, we believe that having an independent Chairman of the Board can enhance the effectiveness of the Board of Directors as a
whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risk Oversight</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">One of the Board of Directors&rsquo; key functions
is informed oversight of our risk management process. The Board of Directors does not have a standing risk management committee, but
rather administers this oversight function directly through the Board of Directors as a whole, as well as through various standing committees
of the Board of Directors that address risks inherent in their respective areas of oversight. In particular, the Board of Directors is
responsible for monitoring and assessing strategic risk exposure, including a determination of the nature and level of risk appropriate
for us. Our Audit Committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management
has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and
management is undertaken. The Audit Committee also monitors compliance with legal and regulatory requirements, in addition to oversight
of the performance of our internal audit function at the time of its establishment. Our Nominations Committee monitors the effectiveness
of our corporate governance guidelines, including whether they are successful in preventing illegal or improper liability-creating conduct.
Our Compensation Committee assesses and monitors whether any of our compensation policies and programs has the potential to encourage
excessive risk-taking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board and Committee Meetings and Attendance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December&nbsp;31, 2022,
the Board of Directors held thirteen (13) meetings. During the year ended December&nbsp;31, 2022, our Audit, Compensation and Nominations
Committees met four (4)&nbsp;times, two (2)&nbsp;times, and one (1)&nbsp;time, respectively. Each director attended at least seventy
five percent (75%) of the aggregate of all meetings of the Board of Directors and all of the Committee meetings, for the Committees on
which he serves.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board Attendance at Annual Stockholders&rsquo;
Meeting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our policy is to invite and encourage each member
of the Board of Directors to be present at our annual meetings of stockholders (assuming that we hold in-person annual meetings). Only
one director, Steven Shallcross, attended our 2022 Annual Meeting in person and our other three directors attended our 2022 Annual Meeting
of Stockholders via telephone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Review of Transactions with Related Persons</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to our charter, our Audit Committee
reviews on an on-going basis for potential conflicts of interest, and approves if appropriate, all our &ldquo;Related Party Transactions.&rdquo;
For purposes of the Audit Committee Charter, &ldquo;Related Party Transactions&rdquo; means those transactions required to be disclosed
pursuant to Item 404 of SEC Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A discussion of our current related person transactions
appears in this Proxy Statement under &ldquo;Certain Relationships and Related Party Transactions.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Communication with Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders may direct any communications intended
for the Board of Directors to our Corporate Secretary by telephone at (301) 417-4364, by facsimile at (301) 417-4367, or by mail to Theriva
Biologics,&nbsp;Inc., 9605 Medical Center Drive, Suite&nbsp;270, Rockville, Maryland 20850.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This centralized process assists the Board of
Directors in reviewing and responding to stockholder communications in an appropriate manner. If a stockholder wishes to direct any communication
to a specific member of the Board of Directors, the name of that member of the Board of Directors should be noted in the communication.
The Board of Directors has instructed the Corporate Secretary to forward stockholder correspondence only to the intended recipients,
and has also instructed the Corporate Secretary to review all stockholder correspondence and, in the Corporate Secretary&rsquo;s discretion,
refrain from forwarding any items deemed to be of a commercial or frivolous nature or otherwise inappropriate for the Board of Directors&rsquo;
consideration. Any such items may be forwarded elsewhere in the Company for review and possible response.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Code of Conduct</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have adopted a code of conduct that applies
to all officers, directors and employees. The Code of Conduct is intended to promote honest and ethical conduct, full, accurate and timely
disclosure, and compliance with all applicable laws and government regulations. The full text of the code of conduct is posted on our
website at <I>www.therivabio.com</I> and a copy will be made available to stockholders without charge, upon request, in writing to the
Corporate Secretary at 9605 Medical Center, Suite&nbsp;270, Rockville, Maryland 20850. If we make any substantive amendments to the code
of conduct or grant any waiver from a provision of the code of conduct to any executive officer or director, we will promptly disclose
the nature of the amendment or waiver on our website or by filing with the SEC a Current Report on Form&nbsp;8-K, in each case if such
disclosure is required by SEC or the NYSE American rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Code of Ethics for Financial Management</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We adopted a Code of Ethics for Financial Management
that applies to all persons responsible for our financial management. The Code of Ethics for Financial Management is intended to promote
professional conduct in our financial management. A copy of our Code of Ethics for Financial Management is available on our website at
<I>www.therivabio.com</I> and a copy will be made available to stockholders without charge, upon request, in writing to the Corporate
Secretary at 9605 Medical Center, Suite&nbsp;270, Rockville, Maryland 20850. Violations of the Code of Ethics for Financial Management
may result in disciplinary action. If we make any substantive amendments to the Code of Ethics for Financial Management or grant any
waiver from a provision of the Code of Ethics for Financial Management to any director or officer, we will promptly disclose the nature
of the amendment or waiver on our website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Anti-Hedging/Anti-Pledging Policy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has adopted an insider trading policy
which incorporates anti-hedging and anti-pledging provisions. Consequently, no employee, executive officer or director may enter into
a hedge or pledge of the Company&rsquo;s Common Stock, including short sales, derivatives, put options, swaps and collars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_008"></A>INFORMATION REGARDING COMMITTEES
OF THE BOARD OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors has the authority to appoint
committees to perform certain management and administration functions. As disclosed above, the Board of Directors has established an
Audit Committee, a Compensation Committee and Nominations Committee. The Board of Directors may establish other committees to facilitate
the management of our company&rsquo;s business. The composition and functions of each committee are described below. Members serve on
these committees until their resignation or until otherwise determined by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All of the committees comply with all applicable
requirements of the Sarbanes-Oxley Act of 2002, NYSE American, and SEC, rules&nbsp;and regulations as further described below. The charters
for each of these committees are available on our website at <I>www.therivabio.com</I>. Information contained on or accessible through
our website is not a part of this `Proxy Statement and the inclusion of such website address in this proxy statement is an inactive textual
reference only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Committees of the Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The table set forth below shows the directors who are currently members
or Chairman of each of the Audit Committee, Compensation Committee and Nominations Committee. From time to time, the Board of Directors
may also establish <I>ad hoc</I> committees to address particular matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="border-bottom: white 1pt solid; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 23%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit</B></FONT></TD>
    <TD STYLE="border-bottom: white 1pt solid; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 23%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation</B></FONT></TD>
    <TD STYLE="border-bottom: white 1pt solid; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 24%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nominations</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven Shallcross*</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey Kraws**</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John Monahan</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey Wolf</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*Mr.&nbsp;Shallcross is not a member of any of the committees of the
Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">**Mr.&nbsp;Kraws serves as the Chairman of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Below is a description of each committee of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Audit Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Wolf (Chairman), Mr.&nbsp;Kraws and
Dr.&nbsp;Monahan currently serve as members of the Audit Committee. The Board of Directors has determined that Mr.&nbsp;Kraws, Dr.&nbsp;Monahan
and Mr.&nbsp;Wolf are each &ldquo;independent&rdquo; in accordance with the NYSE American definition of independence. The Board of Directors
has determined that each of Messrs.&nbsp;Kraws, Monahan and Wolf has the related financial management expertise within the meaning of
the NYSE American rules, that Messrs.&nbsp;Kraws and Wolf is each an &ldquo;audit committee financial expert&rdquo; as defined by SEC
regulations and that each member of the Audit Committee is &ldquo;financially literate&rdquo; under the applicable rules&nbsp;and regulations
of the SEC and NYSE American.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The primary purpose of the Audit Committee is
to assist the Board of Directors in its oversight of the integrity of our financial statements, of our compliance with legal and regulatory
requirements, of the independence and qualifications of the registered public accounting firm or firms engaged as our independent outside
auditors and the performance of our internal audit function and independent auditors. Specific responsibilities of the Audit Committee
include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; overseeing the work and compensation of
the independent auditor in connection with the preparation by the independent auditor of the audit report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&bull; reviewing and approving the internal corporate audit staff
functions;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; approving the retention or replacement
of the independent auditors;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; reviewing the scope of the independent
auditor&rsquo;s audit examination and approving the retention of the independent auditors to perform any proposed permissible non-audit
services;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; overseeing the rotation of partners of
the independent auditors on our audit engagement team as required by law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; reviewing and approving transactions between
us and any related persons;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; conferring with management and the independent
auditors regarding the adequacy of internal controls over financial reporting; establishing procedures, as required under applicable
law, for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or auditing
matters and the confidential and anonymous submission by employees of concerns regarding questionable accounting or auditing matters;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; reviewing and discussing our annual audited
financial statements and quarterly financial statements with management and the independent auditor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee operates pursuant to a written
charter adopted by the Board of Directors, which is available on our website at <I>www.therivabio.com</I>. The charter describes in more
detail the nature and scope of responsibilities of the Audit Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Compensation Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Kraws (Chairman), Dr.&nbsp;Monahan and
Mr.&nbsp;Wolf currently serve as members of the Compensation Committee, each of whom the Board of Directors has determined is independent
in accordance Rule&nbsp;10C-1 under the Exchange Act and the NYSE American definition of independence and that each is a &ldquo;non-employee
director&rdquo; as defined in Rule&nbsp;16b-3 promulgated under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The primary purpose of the Compensation Committee
is to assist the Board of Directors in fulfilling its oversight responsibilities relating to compensation of our Chief Executive Officer
and other senior executive officers, including evaluating and approving officer&rsquo;s benefits, bonus, incentive compensation, severance,
equity base-compensation and other compensation. Specific responsibilities of the Compensation Committee include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; establishing on an annual basis the performance
goals and objectives for purposes of determining the compensation of our Chief Executive Officer and other senior executive officers,
and evaluating performance in light of such goals and objectives and based upon these evaluations setting the compensation level for
those officers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; recommending to the Board of Directors
the compensation of the directors;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; overseeing the administration of equity
incentive plans, including making recommendations to the Board of Directors regarding granting of options and other awards;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; overseeing the administration of other
equity incentive plans and making recommendations to the Board of Directors regarding participation in those plans;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; reviewing and making recommendations to
the Board of Directors Chief Executive Officer and other senior executive officers regarding employment agreement, severance agreements
and, change in control agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee operates pursuant
to a written charter adopted by the Board of Directors, which is available on our website at <I>www.therivabio.com</I>. The charter describes
in more detail the nature and scope of responsibilities of the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nominations Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr.&nbsp;Monahan (Chairman), Mr.&nbsp;Kraws,
and Mr.&nbsp;Wolf currently serve as members of the Nominations Committee, each of whom the Board of Directors has determined is independent
in accordance with the NYSE American definition of independence. Specific responsibilities of the Nominations Committee include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; considering and recommending to the Board
of Directors, candidates for appointment or election as directors, and making recommendations regarding re-election of incumbent directors;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; considering and recommending to the Board
of Directors changes to the size of the Board of Directors or any Committee; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&bull; recommending to the Board of Directors,
candidates to vacancies on any committees of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nominations Committee believes that candidates
for director should have certain minimum qualifications, including the ability to read and understand basic financial statements, being
over 21 years of age and having the highest personal integrity and ethics. The Nominations Committee also intends to consider such factors
as possessing relevant expertise upon which to be able to offer advice and guidance to management, having sufficient time to devote to
our affairs, demonstrated excellence in his or her field, having the ability to exercise sound business judgment and having the commitment
to rigorously represent the long-term interests of our stockholders. However, the Nominations Committee retains the right to modify these
qualifications from time to time. The Nominations Committee does not have a set policy or process for considering diversity in identifying
nominees, but endeavors to establish a diversity of background and experience in a number of areas of core competency, including business
judgment, management, accounting, finance, knowledge of our industry, strategic vision, research and development and other areas relevant
to our business. Candidates for director nominees are reviewed in the context of the current composition of the Board of Directors, our
operating requirements and the long-term interests of its stockholders. In conducting this assessment, the Nominations Committee typically
considers diversity, age, skills and such other factors as it deems appropriate, given the current needs of the Company and the Board
of Directors, to maintain a balance of knowledge, experience and capability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the case of incumbent directors whose terms
of office are set to expire, the Nominations Committee reviews these directors&rsquo; overall service to us during their terms, including
the number of meetings attended, level of participation, quality of performance and any other relationships and transactions that might
impair the directors&rsquo; independence. The Nominations Committee also takes into account the results of the Board of Directors&rsquo;
self-evaluation, conducted annually on a group and individual basis. In the case of new director candidates, the Nominations Committee
also determines whether the nominee is independent for NYSE American purposes, which determination is based upon applicable NYSE American
listing standards, applicable SEC rules&nbsp;and regulations and the advice of counsel, if necessary. The Nominations Committee then
uses its network of contacts to compile a list of potential candidates, but may also engage, if it deems appropriate, a professional
search firm. The Nominations Committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible
candidates after considering the function and needs of the Board of Directors. The Nominations Committee meets to discuss and consider
the candidates&rsquo; qualifications and then selects a nominee for recommendation to the Board of Directors by majority vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nominations Committee operates pursuant to
a written charter adopted by the Board of Directors, which is available on our website at <I>www.therivabio.com</I>. The charter describes
in more detail the nature and scope of responsibilities of the Nominations Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nominations Committee will consider director
candidates recommended by stockholders. The Nominations Committee does not intend to alter the manner in which it evaluates candidates,
including the minimum criteria set forth above, based on whether or not the candidate was recommended by a stockholder. Under our current
governing documents, stockholders wishing to directly recommend candidates for election to the Board of Directors at our next annual
meeting to be included in our Proxy Statement must do so by giving written notice to: Chairman of the Nominations Committee, Theriva
Biologics,&nbsp;Inc., 9605 Medical Center Drive, Suite&nbsp;270, Rockville, Maryland 20850. Any such notice must be delivered to the
Chairman not less than 120 days prior to the anniversary of the preceding year&rsquo;s annual meeting. The notice must state: (1)&nbsp;the
name and address of the stockholder making the recommendations; (2)&nbsp;the name, age, business address, and residential address of
each person recommended; (3)&nbsp;the principal occupation or employment of each person recommended; (4)&nbsp;the class and number of
shares of the Company&rsquo;s stock that are beneficially owned by each person recommended and by the recommending stockholder; (5)&nbsp;any
other information concerning the persons recommended that must be disclosed in nominee and proxy solicitations in accordance with Regulation
14A of the Exchange Act; and (6)&nbsp;a signed consent of each person recommended stating that he or she consents to serve as a director
of the Company if elected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Changes to Procedures for Recommending Nominees to the Board of
Directors.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_009"></A>DIRECTOR COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information for
the fiscal&nbsp;year ended December&nbsp;31, 2022 regarding the compensation of our directors who at December&nbsp;31, 2022 were not
also our Named Executive Officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fees&nbsp;Earned</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">or</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Other</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Paid&nbsp;in&nbsp;Cash</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Awards(1)(2)</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Compensation</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey J. Kraws(3)</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">176,250</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">40,629</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">216,879</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">John Monahan (5)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">66,750</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">40,629</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">107,379</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey Wolf</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">73,750</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">40,629</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">114,379</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts in the &ldquo;Option
    Awards&rdquo; column reflect the dollar amounts of the grant date fair value for the financial statement reporting purposes for stock
    options for the fiscal&nbsp;year ended December&nbsp;31, 2022 in accordance with ASC 718. The fair value of the options was determined
    using the Black-Scholes model. For a discussion of the assumptions used in computing this valuation, see &ldquo;Management&rsquo;s
    Discussion and Analysis of Financial Conditions and Results of Operations&rdquo; and Note&nbsp;6 of the Notes&nbsp;to Consolidated
    Financial Statements in our Annual Report for the fiscal&nbsp;year ended December&nbsp;31, 2022.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December&nbsp;31,
    2022, the following are the outstanding aggregate number of option awards held by each of our directors who were not also Named Executive
    Officers:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Awards</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(#)</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey J. Kraws</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; font: 10pt Times New Roman, Times, Serif; text-align: right">163,377</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">John Monahan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">137,508</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey Wolf</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">169,377</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2022, our independent, non-executive Chairman
of the Board of Directors received an annual cash retainer of $150,000, each other non-employee member of the Board of Directors received
an annual cash retainer of $43,000, all non-employee directors receive an annual cash fee of $7,500, $5,000 and $3,750 for service as
a member of the Audit, Compensation and Nominations Committees, respectively, or an additional annual cash fee of $15,000, $10,000 and
$7,500 for service as Chairman of the Audit, Compensation and Nominations Committees, respectively. In addition, each non-employee member
of the Board of Directors was issued an option exercisable for 100,000 shares of our common stock, for a term of seven years, vesting
monthly over one year of the date of grant. In setting 2022 and 2021 compensation for directors, the Compensation Committee relied on
a report from Meridian Compensation Partners, LLC. Based on an analysis of director compensation set forth in the report, our financial
performance, general market conditions and the interests of stockholders, it was determined that the annual cash retainer for serving
on the board and the committee retainers would remain for 2023 the same as they were in 2022 and 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.&nbsp;Kraws
                                            was appointed as our independent, non-executive Chairman of the Board of Directors in May&nbsp;2012.
                                            Mr.&nbsp;Kraws receives an annual retainer of $150,000 for serving as our Chairman.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_010"></A>LIMITS ON LIABILITY AND
INDEMNIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Articles of Incorporation and Amended and
Restated By-Laws provide that we will indemnify and hold harmless each person who serves at any time as a director or officer from and
against any and all claims, judgments and liabilities to which such person shall become subject by reason of the fact that he or she
is or was a director or officer of the Company, and shall reimburse such person for all legal and other expenses reasonably incurred
by him or her in connection with any such claim or liability. We believe that this indemnification covers at least negligence and gross
negligence on the part of the indemnified parties. Insofar as indemnification for liabilities under the Securities Act of 1933, as amended
(the &ldquo;Securities Act&rdquo;) may be permitted to directors, officers, and controlling persons of the Company under the foregoing
provisions or otherwise, we have been advised that in the opinion of the SEC that indemnification is against public policy as expressed
in the Securities Act, and is therefore unenforceable. We entered into an indemnification agreement with our directors and officers.
The agreement confirms our obligation to indemnify the directors and officers to the fullest extent authorized by our Articles of Incorporation
and Amended and Restated By-Laws and supplements the indemnification otherwise available to the covered person under our Articles of
Incorporation and Amended and Restated By-Laws. The form of indemnification agreement was described and filed as an exhibit to the Form&nbsp;8-K
we filed with the SEC on January&nbsp;6, 2009.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_011"></A>COMPENSATION COMMITTEE
INTERLOCKS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the last fiscal year ended December&nbsp;31, 2022, none of
our executive officers served on the Board of Directors or Compensation Committee of any other entity whose officers served either on
our Board of Directors or Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>PROPOSAL 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RATIFICATION OF APPOINTMENT OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee has selected BDO USA, P.A.,
an independent registered accounting firm, to audit the books and financial records of the Company for the year ending December&nbsp;31,
2023. Theriva is asking its stockholders to ratify the appointment of BDO USA, P.A. as Theriva&rsquo;s independent registered public
accounting firm for fiscal 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A representative of BDO USA, P.A. is expected
to be present either in person or via teleconference at the 2023 Annual Meeting of Stockholders and available to respond to appropriate
questions, and will have the opportunity to make a statement if he or she desires to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The affirmative vote of the holders of a majority
of the shares present in person or represented by proxy and entitled to vote on this matter at the 2023 Annual Meeting of Stockholders
will be required to approve the ratification of the appointment of Theriva&rsquo;s independent registered public accounting firm. Abstentions
will be counted and will have the same effect as a vote against the proposal. Ratification of the appointment of BDO USA, P.A. by our
stockholders is not required by law, our bylaws or other governing documents. As a matter of policy, however, the appointment is being
submitted to our stockholders for ratification at the 2023 Annual Meeting of Stockholders. If our stockholders fail to ratify the appointment,
the Audit Committee will reconsider whether or not to retain that firm. Even if the appointment is ratified, the Audit Committee, in
its discretion, may direct the appointment of different independent auditors at any time during the year if they determine that such
a change would be in our best interest and the best interests of our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS
THAT YOU VOTE FOR RATIFICATION OF THE SELECTION OF BDO USA, P.A. AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL
YEAR ENDING ON<BR>
DECEMBER 31, 2023.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_013"></A>REPORT OF THE AUDIT COMMITTEE
OF THE BOARD OF DIRECTORS<SUP>1</SUP></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee reviews our financial reporting
process on behalf of the Board of Directors. In January&nbsp;2007, the Board of Directors adopted a written charter for the Audit Committee,
which it re-evaluates annually. In fulfilling its responsibilities, the Audit Committee has reviewed and discussed the audited financial
statements contained in the Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2022 with our management and our independent
registered public accounting firm for such year, BDO USA, P.A. Our management is responsible for the financial statements and the reporting
process, including the system of internal controls. The independent registered public accounting firm is responsible for expressing an
opinion on the conformity of those audited financial statements with accounting principles generally accepted in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee (1)&nbsp;discussed with BDO
USA, P.A. the matters required by the applicable requirements of the Public Company Accounting Oversight Board (&ldquo;PCAOB&rdquo;)
and the SEC; (2)&nbsp;received and reviewed the written disclosures and the letter from BDO USA, P.A. required by PCAOB Ethics and Independence
Rule&nbsp;3526, <I>Communication with Audit Committees Concerning Independence</I>; and (3)&nbsp;discussed with BDO USA, P.A. its independence.
The Audit Committee also considered whether, and determined that, the independent registered public accounting firm&rsquo;s provision
of other non-audit services to us was compatible with maintaining BDO USA, P.A.&rsquo;s independence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2022, management evaluated our system
of internal control over financial reporting in accordance with the requirements set forth in Section&nbsp;404 of the Sarbanes-Oxley
Act of 2002 and related regulations. The Audit Committee was kept apprised of the progress of the evaluation and provided oversight and
advice to management during the process. In connection with this oversight, the Audit Committee received periodic updates provided by
management and the independent registered public accounting firm at each regularly scheduled Audit Committee meeting. At the conclusion
of the process, management provided the Audit Committee with a report on the effectiveness of our internal control over financial reporting.
The Audit Committee also reviewed the report of management contained in our 2022 Annual Report on Form&nbsp;10-K, as well as the Report
of Independent Registered Public Accounting Firm and the Consolidated Financial Statements (included in the 2022 Annual Report on Form&nbsp;10-K).
These reports related to its audit of the consolidated financial statements. The Audit Committee continues to oversee our efforts related
to our internal control over financial reporting and management&rsquo;s preparations for the evaluations in 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It should be noted that the members of our Audit
Committee are not our employees and are not performing the functions of auditors or accountants. Accordingly, it is not the duty or responsibility
of the Audit Committee or its members to conduct &ldquo;field work&rdquo; or other types of auditing or accounting reviews or procedures
or to set auditor independence standards. Members of the Audit Committee necessarily rely on the information provided to them by management
and the independent auditors. Accordingly, the Audit Committee&rsquo;s considerations and discussions referred to above do not constitute
assurance that the audit of our financial statements has been carried out in accordance with generally accepted auditing standards or
that our auditors are in fact independent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the review and discussions referred
to above, the Audit Committee recommended to the Board of Directors (and the Board of Directors approved) that the audited financial
statements be included in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2022, for filing with the SEC. In
addition, the Audit Committee recommended to the Board of Directors and the Board of Directors approved that BDO USA, P.A. be appointed
as our independent registered public accounting firm for the year ended December&nbsp;31, 2023 and that this appointment be presented
to stockholders for ratification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Members of the Audit Committee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Jeffrey Wolf (Chairman)<BR>
Jeffrey J. Kraws<BR>
John Monahan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_014"></A>AUDIT FEES AND ALL OTHER
FEES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Independent Registered Public Accounting Firm
Fees and Services</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the aggregate
fees including expenses billed to us for the years ended December&nbsp;31, 2022 and 2021 by BDO USA, P.A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">December&nbsp;31,</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2022</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 65%; font: 10pt Times New Roman, Times, Serif; text-align: left">Audit Fees</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 14%; font: 10pt Times New Roman, Times, Serif; text-align: right">673,500</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 14%; font: 10pt Times New Roman, Times, Serif; text-align: right">324,500</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Audit-Related fees</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Tax Fees</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">37,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">19,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">All Other Fees</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Fees (1)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">711,000</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">344,000</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit fees and expenses
    were for professional services rendered for the audit and reviews of the consolidated financial statements of the Company, professional
    services rendered for issuance of consents and assistance with review of documents filed with the SEC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify">The material
                                            in this report is not &ldquo;soliciting material,&rdquo; is not deemed &ldquo;filed&rdquo;
                                            with the SEC and is not incorporated by reference in any filing of the Company under the
                                            Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the
                                            date hereof and irrespective of any general incorporation language in any such filing.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Audit Committee Pre-Approval Policy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee has adopted procedures for
pre-approving all audit and non-audit services provided by the independent registered public accounting firm, including the fees and
terms of such services. These procedures include reviewing detailed back-up documentation for audit and permitted non-audit services.
The documentation includes a description of, and a budgeted amount for, particular categories of non-audit services that are recurring
in nature and therefore anticipated at the time that the budget is submitted. Audit Committee approval is required to exceed the pre-approved
amount for a particular category of non-audit services and to engage the independent registered public accounting firm for any non-audit
services not included in those pre-approved amounts. For both types of pre-approval, the Audit Committee considers whether such services
are consistent with the rules&nbsp;on auditor independence promulgated by the SEC and the Public Company Accounting Oversight Board (PCAOB).
The Audit Committee also considers whether the independent registered public accounting firm is best positioned to provide the most effective
and efficient service, based on such reasons as the auditor&rsquo;s familiarity with our business, people, culture, accounting systems,
risk profile, and whether the services enhance our ability to manage or control risks and improve audit quality. The Audit Committee
may form and delegate pre-approval authority to subcommittees consisting of one or more members of the Audit Committee, and such subcommittees
must report any pre-approval decisions to the Audit Committee at its next scheduled meeting. All of the services provided by the independent
registered public accounting firm were pre-approved by the Audit Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Vote Required</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The proposal to ratify the appointment of BDO
USA, P.A. as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2023, requires an affirmative
vote from the holders of a majority of the votes of shares of Common Stock present in person or represented by proxy and entitled to
vote on this matter at the 2023 Annual Meeting of Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>OUR BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS
THAT YOU VOTE FOR RATIFICATION OF THE SELECTION OF BDO USA, P.A. AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING
DECEMBER 31, 2023.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_015"></A>EXECUTIVE COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a &ldquo;smaller reporting company&rdquo;
and the following compensation disclosure is intended to comply with the requirements applicable to smaller reporting companies. Although
the rules&nbsp;allow us to provide less detail about our executive compensation program, the Compensation Committee is committed to providing
the information necessary to help stockholders understand its executive compensation-related decisions. Accordingly, this section includes
supplemental narratives that describe the 2022 executive compensation program for our Named Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Summary Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes all compensation
awarded to, earned by or paid to our Named Executive Officers, Steven A. Shallcross and Frank Tufaro, during the fiscal years presented
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">All Other</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">Name and Principal</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Compensation</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Position</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Year</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Salary
    ($)(1)</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Bonus
    ($)(2)</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Awards
    ($)(3)</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">($)(4)</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Total
    ($)</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 21%; font: 10pt Times New Roman, Times, Serif; text-align: left">Steven Shallcross</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">2022</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">585,000</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">385,000</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">192,989</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">27,674</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">1,190,663</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">(5)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Executive Officer</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2021</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">585,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">365,625</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">144,216</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">26,508</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,121,124</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">and Chief Financial Officer</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Frank Tufaro</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2022</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">291,667</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">85,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">40,629</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">23,963</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">441,259</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Former Chief Operating Officer(6)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&nbsp;Shallcross was appointed as our
    Chief Executive Officer on December&nbsp;6, 2018. Mr.&nbsp;Shallcross' annual salary was $585,000 for the years ended December&nbsp;31,
    2021 and 2022. Dr.&nbsp;Tufaro was appointed our Chief Operating Officer on March&nbsp;22, 2022. Dr.&nbsp;Tufaro annual salary was
    $375,000 commencing March&nbsp;22, 2022.</P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts represent annual
    cash bonuses earned for the applicable fiscal year. The annual cash bonuses are paid in the first quarter of the calendar year following
    the year to which the cash bonus relates.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount reflects the grant
    date fair value of the Named Executive Officer&rsquo;s stock options, calculated in accordance with FASB ASC Topic 718. For a discussion
    of the assumptions used in calculating these values, see Note 6 to Consolidated Financial Statements in our Annual Report for the
    fiscal&nbsp;year ended December&nbsp;31, 2022. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The all other compensation
    column is comprised of vacation accrual paid, and the portion of medical, dental and vision premiums paid by us on behalf of our
    Named Executive Officers. These benefits are offered to all Theriva&nbsp;&nbsp;employees who work at least 17.5 hours per week.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount excludes compensation paid to the wife of Mr.&nbsp;Shallcross
    disclosed under the heading &quot;Certain Relationships and Related Party Transactions&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.&nbsp;Tufaro was appointed as our Chief Operating
    officer on March&nbsp;22, 2022 and resigned from the Company effective May&nbsp;10, 2023.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Narrative Disclosure to Summary Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview of Our Compensation Program</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A. Philosophy and Objectives</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee seeks to attract and
retain superior executive talent by offering competitive base salaries, bonuses and long-term incentives. The Compensation Committee&rsquo;s
philosophy is to deliver higher rewards for superior performance and consequences for underperformance. It is also the Compensation Committee&rsquo;s
practice to provide a balanced mix of cash and equity-based compensation that aligns both the short and long-term interests of our executives
with that of our stockholders. Our executive compensation program is based on the following philosophies and objectives:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Compensation Should
    Align with Stockholders&rsquo; Interests</I> &mdash; The Compensation Committee believes that executives&rsquo; interests should
    be aligned with those of the stockholders. Executives are granted stock options so that their total compensation is tied directly
    to value realized by our stockholders. Executive bonuses are tied directly to the achievement of performance goals that the Compensation
    Committee believes will ultimately drive stockholder value creation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Compensation is Competitive
    &mdash;</I> The Compensation Committee seeks to provide a total compensation package that attracts, motivates and retains the executive
    talent that we need in order to maximize our return to stockholders. To accomplish this objective, executive compensation is reviewed
    annually to ensure that compensation levels are competitive and reasonable relative to our level of performance and to the compensation
    opportunities provided by comparable companies with which we compete for talent.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Compensation Motivates
    and Rewards the Achievement of Goals</I> &mdash; Our executive compensation program is designed to appropriately reward both individual
    and collective performance that meets and exceeds our annual, long-term and strategic goals. To accomplish this objective, a substantial
    percentage of total compensation is variable and &ldquo;at risk&rdquo;, both through annual incentive compensation in the form of
    cash bonuses and the granting of long-term incentive awards.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>B. Oversight of Executive Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Role of the Compensation Committee</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the terms of its charter, the Compensation
Committee is responsible for the review of all aspects of our executive compensation program and makes decisions regarding the compensation
of the Named Executive Officers. Our Named Executive Officers for the year ended December&nbsp;31, 2022 were Steven Shallcross, our Chief
Executive Officer who also serves as our Chief Financial Officer and Frank Tufaro, who served as our Chief Operating Officer for the
year ended December&nbsp;31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee&rsquo;s responsibilities
include but are not limited to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establishing on an annual
    basis the performance goals and objectives for purposes of determining the compensation of our Chief Executive Officer and other
    senior executive officers.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluating the Chief Executive
    Officer&rsquo;s and other senior executive officers&rsquo; performance at least annually in light of those goals and objectives,
    and based upon these evaluations setting the compensation level for those officers.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing the competitive
    position of, and making recommendations to, the Board of Directors with respect to the cash-based and equity-based compensation plans
    and our programs relating to compensation and benefits.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overseeing administration
    of our stock option plan and incentive compensation plans, making recommendations to the Board of Directors regarding the granting
    of options and incentives and otherwise assisting the Board of Directors in administering awards under these plans.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing the financial
    performance and operations of our major benefit plans.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additional information regarding the Compensation
Committee&rsquo;s responsibilities is set forth in its charter, which is posted on our website at <I><U>www.therivabio.com</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Role of the Chief Executive Officer</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Chief Executive Officer makes recommendations
to the Compensation Committee regarding the compensation of our other Named Executive Officers. The Chief Executive Officer does not
participate in any discussions or processes concerning his own compensation and participates in a non-voting capacity in discussions
or processes concerning the compensation of our other members of management. In addition to our Chief Executive Officer, other members
of our management and consultants also attend Compensation Committee meetings from time to time and may take part in discussions of executive
compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>C. Program Design</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee uses a simple and
straightforward approach in compensating our Named Executive Officers in which base salary, annual incentives and stock options are the
principal components. In addition, executive officers generally participate in the same benefit programs as other full-time employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our executive compensation program is designed
to provide executives with a reasonable level of fixed compensation through base salary and benefits, and an opportunity to earn incentive
compensation through the annual and long-term incentive programs based on a mix of individual and corporate performance, individual performance
and the value of our stock. We do not currently have formal policies for allocating compensation among base salary, performance-based
bonus and equity awards. Instead our Compensation Committee uses its judgment to establish a total direct compensation opportunity for
each Named Executive Officer that is a mix of current, short-term and long-term incentive compensation and cash and non-cash compensation
that it believes appropriate to achieve the goals of our executive compensation program and corporate objectives. Our target pay mix
places a significant emphasis on performance based variable compensation. The incentive plans are designed to pay well when performance
meets or exceeds expectations and pay little or no incentive if performance is below expectations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In designing and implementing our executive compensation
program, our Compensation Committee considers our company&rsquo;s operating and financial objectives, including our risk profile, and
the effect that its executive compensation decisions will have on encouraging our executive officers to take an appropriate level of
business risk consistent with our overall goal of enhancing long-term stockholder value. In particular, the Compensation Committee considers
those business risks identified in our risk factors and the known trends and uncertainties identified in our management discussion and
analysis contained in our annual report on Form&nbsp;10-K and subsequent reports and considers how our executive compensation program
serves to achieve our operating and financial objectives while at the same time mitigating any incentives for our executive officers
to engage in excessive risk-taking to achieve short-term results that may not be sustainable in the long-term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Target compensation comprises base salary and
performance based variable compensation, including targeted cash bonus amounts and equity-based compensation. As an executive&rsquo;s
level of responsibility increases, the Compensation Committee generally targets a greater portion of the executive&rsquo;s compensation
to be contingent upon performance in the form of variable compensation. For example, historically our Named Executive Officers have a
higher percentage of compensation at risk (and thus greater upside and downside potential) relative to our other employees. The Compensation
Committee believes this is appropriate because our Named Executive Officers have the greatest influence on our performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2022, the salary for our Chief Executive
Officer who also serves as our Chief Financial Officer was 55% of his target compensation package and performance based variable compensation
comprised 45% of his target compensation. Of the performance based variable compensation 60% was equity-based compensation and 40% was
his target cash bonus. During 2022, the salary for our Chief Operating Officer was 66% of his annualized target compensation package
and performance based variable compensation comprised 34% of his target compensation. Of the performance based variable compensation
21% was equity-based compensation and 79% was his target cash bonus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>D. Compensation Review Process</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee annually reviews compensation
for our Named Executive Officers. The Compensation Committee considers the executive&rsquo;s role and responsibilities, corporate and
individual performance, and industry-wide compensation practices and trends for other companies of similar size. This approach is used
to set base salaries, bonuses, stock option award levels and the mix of compensation elements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We strive to attract and retain the most highly
qualified executive officers in an extremely competitive market. Our Compensation Committee believes that it is important when making
its compensation decisions to be informed as to the competitive market for executive talent, including the current practices of comparable
public companies with which we compete for such talent. Consequently, our Compensation Committee reviewed an executive compensation report
prepared by Meridian Compensation Partners, LLC (&ldquo;Meridian&rdquo;) at the Compensation Committee&rsquo;s request. With respect
to its analysis of the compensation of the Chief Executive Officer, the Compensation Committee took into account that our Chief Executive
Officer also serves as our Chief Financial Officer, which is not typical for most companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While the Compensation Committee does take into
consideration the data it reviewed, the Committee does not attempt to benchmark our executive compensation against any specific level,
range, or percentile of compensation paid at any other companies, does not apply any specific measures of internal or external pay equity
in reaching its conclusions, and does not employ tally sheets, wealth accumulation, or similar tools in its analysis. Rather, the Compensation
Committee reviews compensation data from the survey and report mentioned above, as reference points in making executive compensation
decisions especially in light of the fact that our Chief Executive Officer is also performing the role of Chief Financial Officer. The
Compensation Committee&rsquo;s general aim is for our compensation to remain competitive with the market, falling above or below the
median of the market data as appropriate based on corporate and individual executive performance, and other factors deemed to be appropriate.
Competitive market positioning is only one of several factors, as described below, that the Compensation Committee considers in making
compensation decisions, and therefore individual Named Executive Officer compensation may fall at varying levels as compared to the market
data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Compensation Committee values the opinion
of our stockholders. At our 2022 Annual Meeting of Stockholders approximately 71% of the shares voted (excluding broker non-votes) were
cast in support of our fiscal 2021 executive compensation and related disclosures. At that time, our Compensation Committee viewed those
voting results as broad stockholder support for our executive compensation program and consequently made no material changes to the program
or to our compensation policies. Our Compensation Committee will continue to consider input from stockholders, including through advisory
votes on executive compensation, in making compensation decisions and reviewing executive compensation programs and policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently hold our advisory vote to approve
the compensation of our named executive officers (&ldquo;Say-on-Pay vote&rdquo;) every three years. Stockholders have an opportunity
to cast an advisory vote on the frequency of the Say-on-Pay vote at least every six years, and the next advisory vote on the frequency
of the Say-on-Pay vote will be at our 2025 Annual Meeting of Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>E. Components of Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We provide four compensation components to Named
Executive Officers:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">base salary;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bonuses based on the achievement
    of specified goals and objectives;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">long-term incentives; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benefits</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>1. Base Salaries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We provide our Named Executive Officers a base
salary commensurate with their position, responsibilities and experience. In setting the base salary, the Compensation Committee considers
the scope and accountability associated with each Named Executive Officer&rsquo;s position and such factors as performance and experience
of each Named Executive Officer. We design base pay to provide the essential reward for an employee&rsquo;s work that is required to
be competitive in attracting talent. Once base pay levels are initially determined, increases in base pay may be provided to recognize
an employee&rsquo;s specific performance achievements or expansion of responsibilities. The base salaries are targeted to be competitive
with other similar biotechnology companies. Base salaries for the Named Executive Officers are set by their respective employment contracts
and are reviewed annually by the Compensation Committee. Based on the analysis of the executive compensation report provided by Meridian
peer group and other comparative research performed by the Committee, the Committee was able to compare the base salary for the Chief
Executive Officer who also serves as our Chief Financial Officer, including base salary, long-term incentives and bonuses. Upon the appointment
of Mr.&nbsp;Shallcross to serve as our Chief Executive Officer in December&nbsp;2018 and in light of the fact that he also serves as
our Chief Financial Officer, it was determined that his overall compensation levels were not competitive with the peer group and therefore
his annual base salary was increased to $550,000, which was the same annual base salary as that of our prior Chief Executive Officer.
Mr.&nbsp;Shallcross&rsquo; employment agreement, dated December&nbsp;6, 2018, was amended on December&nbsp;5, 2019 to reflect a 3% merit
adjustment to Mr.&nbsp;Shallcross&rsquo; base salary, increasing his annual base salary to $565,000 and further amended on December&nbsp;31,
2020 to reflect a 3.5% merit adjustment to Mr.&nbsp;Shallcross&rsquo; base salary, increasing his annual base salary to $585,000 and
further amended on December&nbsp;15, 2022 to increase his base salary to $614,250. On December&nbsp;15, 2022, the Company entered into
an Amendment to Dr.&nbsp;Tufaro&rsquo;s Employment Agreement to increase his base salary to $393,750.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below shows the 2022 base salary level
for each of our Named Executive Officers, including a comparison with our 2021 for our Chief Executive Officer who also serves as our
Chief Financial Officer. Our Chief Operating Officer was hired in 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Named Executive Officer</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Base Salary</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Base Salary</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 69%; font: 10pt Times New Roman, Times, Serif; text-align: left">Steven A. Shallcross, Chief Executive Officer
    and Chief Financial Officer</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">585,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 12%; font-size: 10pt; text-align: right">585,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Frank Tufaro, Chief Operating Officer</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">375,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>2. Bonuses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee believes that the
granting of a bonus is appropriate to motivate the Named Executive Officers. The bonuses are to be rewarded in the discretion of the
Compensation Committee and the Board of Directors, based on a review of achievements for the year. The Compensation Committee focuses
on individual performance, which enables the Compensation Committee to differentiate among executives and emphasize the link between
personal performance and compensation. The Compensation Committee also used information from the Meridian executive compensation report
in determining bonus amounts. Although the Compensation Committee does not use any fixed formula in determining bonuses, it does link
bonuses to objectives the Compensation Committee deems important such as for 2022, effective M&amp;A strategy and implementation, financings,
and achievement of clinical milestones.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.&nbsp;Shallcross&rsquo;
    employment agreement provided that he was eligible for a target bonus of up to fifty percent (50%) of his base salary in cash. After
    considering Mr.&nbsp;Shallcross&rsquo; achievement relative to performance goals in 2022, the Compensation Committee approved a $385,000
    cash bonus, or 132% of target.&nbsp;&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.&nbsp;Tufaro&rsquo;s
    employment agreement provided that he was eligible for a target bonus of up to forty percent (40%) of his base salary in cash. After
    considering Dr.&nbsp;Tufaro&rsquo;s achievement relative to performance goals in 2022, the Compensation Committee approved a $85,000
    cash bonus, or 72% of his target, pro-rated for the number of days he provided service to us in 2022.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Compensation Committee
    also approved an option grant to purchase 475,000 shares of our common stock for Mr.&nbsp;Shallcross and an option grant to purchase
    100,000 shares of our common stock for Dr.&nbsp;Tufaro.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>3. Long-Term Incentives</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee believes that a substantial
portion of the Named Executive Officer&rsquo;s compensation should be awarded in equity-based compensation since equity-based compensation
is directly linked to the interests of stockholders. The Compensation Committee has elected to grant stock options to the Named Executive
Officers and other key employees as the primary long-term incentive vehicle. In making this determination, the Compensation Committee
considered a number of factors including: the accounting impact, potential value of stock option grants versus other equity instruments
and cash incentives, and the alignment of equity participants with stockholders. The Compensation Committee determined to grant stock
options to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enhance the link between
    the creation of stockholder value and executive compensation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide an opportunity
    for equity ownership;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">act as a retention tool; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide competitive levels of total compensation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2022, the Compensation Committee approved
grants of options exercisable for 475,000 and 100,000 shares to Mr.&nbsp;Shallcross and Dr.&nbsp;Tufaro, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee reviews the performance,
potential burn rates and dilution levels to create an option pool that may be awarded to employee participants. Grants to the Named Executive
Officers are determined by the Compensation Committee after reviewing market data, including the reports and analysis discussed above
and after considering each executive&rsquo;s performance, role and responsibilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee does not seek to time
equity grants to take advantage of information, either positive or negative, about our company that has not been publicly disclosed and
typically makes awards at the same time each year, at the end of the year when performance for the year is reviewed. Option grants are
effective on the date the award determination is made by the Compensation Committee and the exercise price of options is the closing
market price of our common stock on the business day of the grant or, if the grant is made on a weekend or holiday, on the prior business
day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>4. Benefits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Named Executive Officers are eligible to participate
in our standard medical, dental, vision, disability insurance, life insurance plans and other health and welfare plans provided to other
full-time employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each of our Named Executive Officers are entitled
to participate in our 401(k)&nbsp;contributory defined contribution plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Pension Benefits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not currently provide pension arrangements
or post-retirement health coverage for our employees, although we may consider such benefits in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Retirement Benefits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each of our Named Executive Officers are eligible
to participate in our 401(k)&nbsp;contributory defined contribution plan. Pursuant to our 401(k)&nbsp;plan, all eligible employees, including
our Named Executive Officers, are provided with a means of saving for their retirement. We currently match all participating employee
contributions up to maximum of 4 percent of compensation which vest immediately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Nonqualified Deferred Compensation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not provide any nonqualified deferred compensation
plans to our employees, although we may consider such benefits in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Conclusion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attracting and retaining talented and motivated
management and key employees is essential to creating long-term stockholder value. Offering a competitive, performance-based compensation
program with a substantial equity component helps to achieve this objective by aligning the interests of the executive officers and other
key employees with those of stockholders. We believe that our compensation program met these objectives and that our 2022 compensation
program was appropriate in light of the challenges we and our employees face.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risk Analysis of Our Compensation Program</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Compensation Committee has reviewed our compensation
policies as generally applicable to our employees and believes that our policies do not encourage excessive or inappropriate risk taking
and that the level of risk that they do encourage is not reasonably likely to have a material adverse effect on us. As part of its assessment,
the Compensation Committee considered, among other factors, the allocation of compensation among base salary and short- and long-term
compensation, and our approach to establishing company-wide and individual financial, operational and other performance goals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below reflects all outstanding equity
awards made to each of the Named Executive Officers that are outstanding at December&nbsp;31, 2022. We currently grant stock-based awards
pursuant to our 2020 Stock Incentive Plan (the &ldquo;2020 Stock Plan&rdquo;) and have outstanding awards under our 2001 Stock Incentive
Plan (the &ldquo;2001 Stock Plan&rdquo;), 2007 Stock Incentive Plan (the &ldquo;2007 Stock Plan&rdquo;) and 2010 Stock Incentive Plan
(the &ldquo;2010 Stock Plan&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Securities</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Securities</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Underlying</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Underlying</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Unexercised</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Unexercised</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Grant Date(1)</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Exercisable</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Unexercisable</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Price ($)</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Expiration Date</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 15%; font: 10pt Times New Roman, Times, Serif; text-align: left">Steven Shallcross</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/15/22</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font: 10pt Times New Roman, Times, Serif; text-align: right">475,000</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 14%; font: 10pt Times New Roman, Times, Serif; text-align: right">0.58</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 15%; font: 10pt Times New Roman, Times, Serif; text-align: right">12/15/29</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/23/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">21,667</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">43,334</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3.31</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12/23/28</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/20</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">30,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">15,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4.17</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12/30/27</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/06/19</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">45,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4.18</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12/04/26</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/20/18</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6.89</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12/06/25</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/20/17</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,572</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">182.00</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12/20/24</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/30/16</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1429</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">280.00</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11/30/23</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/01/15</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,573</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">756.00</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">06/01/25</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Frank Tufaro</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/15/22</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.58</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12/15/29</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Options will vest pro
                                            rata, on a monthly basis, over 36 months.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PAY VERSUS PERFORMANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As required by Item 402(v)&nbsp;of Regulation
S-K, we are providing the following information about the relationship between executive compensation actually paid and certain financial
performance of the Company. For the most recently completed fiscal year, the Company did not use any &ldquo;financial performance measures&rdquo;
as defined in Item 402(v)&nbsp;of Regulation S-K to link compensation paid to our Named Executive Officers, or NEOs, to the Company&rsquo;s
performance. We are also permitted to report as a &ldquo;smaller reporting company&rdquo; as defined under the U.S. federal securities
laws. Accordingly, we have not included a tabular list of financial performance measures, and the table below does not include a column
for a &ldquo;Company-Selected Measure&rdquo; as defined in Item 402(v)&nbsp;of Regulation S-K. For further information regarding our
compensation philosophy and how we seek to align executive compensation with the Company&rsquo;s performance, refer to &ldquo;Executive
Compensation&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCT
    Total<BR>
    Compensation For <BR>
    PEO<SUP>(1)</SUP></B></FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation<BR>
    Actually Paid to<BR>
    PEO<SUP>(2)</SUP></B></FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Average
    SCT Total<BR>
    Compensation for <BR>
    Other Non-PEOs<SUP>(3)</SUP></B></FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Average<BR>
    Compensation<BR>
    Actually Paid to<BR>
    Other Non-PEOs<SUP>(4)</SUP></B></FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Value
    of Initial<BR>
    Fixed<BR> $100 Investment<BR>
    Based on<BR>
    Cumulative TSR<SUP>(5)</SUP></B></FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Net
    Loss</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt">2022</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">1,190,663</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">(904,217</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">441,259</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">430,432</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">8.97</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">(20,025,000</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt">2021</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,121,124</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">349,848</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;N/A
                                            </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;N/A
                                            </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">53.70</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(23,189,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt">2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,062,519</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,432</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;N/A
                                            </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;N/A
                                            </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">75.56</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(12,557,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dollar amounts reported are the amounts of total compensation reported for Steven A. Shallcross (our Chief Exeutive Officer and principal
    executive officer, or PEO) for each corresponding year in the &ldquo;Total&rdquo;&nbsp;column of the Summary Compensation Table.
    Refer to &ldquo;Executive Compensation&mdash;Summary Compensation Table.&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dollar amounts reported in column (c)&nbsp;represent the amount of &ldquo;compensation actually paid&rdquo;&nbsp;to Mr.&nbsp;Shallcross,
    as computed in accordance with Item 402(v)&nbsp;of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation
    earned by or paid to Mr.&nbsp;Shallcross during the applicable year. In accordance with the requirements of Item 402(v)&nbsp;of Regulation
    S-K, the adjustments below were made to Mr.&nbsp;Shallcross' total compensation for each year to determine the compensation actually
    paid.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dollar amounts reported represent the average of the amounts reported for the non-PEOs as a group (excluding our PEO) in the &ldquo;Total&rdquo;&nbsp;column
    of the Summary Compensation Table in each applicable year. Frank Tufaro was our only non-PEO (excluding our PEO) included for purposes
    of calculating the average amounts in 2022. For the years 2021 and 2020, we did not have any named executive officers other than
    our PEO.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    dollar amounts reported represent the average amount of &ldquo;compensation actually paid&rdquo;&nbsp;to the NEOs as a group (excluding
    our PEO), as computed in accordance with Item 402(v)&nbsp;of Regulation S-K. The dollar amounts do not reflect the actual average
    amount of compensation earned by or paid to the NEOs as a group (excluding our PEO) during the applicable year. In accordance with
    the requirements of Item 402(v)&nbsp;of Regulation S-K, the adjustments below were made to average total compensation for the NEOs
    as a group (excluding our PEO) for each year to determine the compensation actually paid, using the same methodology described above
    in Note (2).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment,
    and the difference between the Company&rsquo;s share price at the end and the beginning of the measurement period by the Company&rsquo;s
    share price at the beginning of the measurement period.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The amounts deducted or added in calculating the equity award adjustments
with regard to our PEO are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 15%; font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left">Total Compensation as reported SCT</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">1,190,663</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">1,121,124</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">1,062,519</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Subtract</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Pension values reported in SCT for covered fiscal year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Subtract</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fair value of equity awards granted during covered fiscal
    year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(192,989</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(144,216</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(120,257</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Add</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Pension value attributable to covered fiscal year&rsquo;s
    service and any change in pension value attributable to plan amendments made in the covered year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Add</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fair value of equity awards granted in covered fiscal year
    and that are unvested at end of such covered fiscal year &ndash; valued at year-end</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">141,562</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">114,916</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">104,850</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Add</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fair value of equity awards granted in covered fiscal year
    that vested during such covered fiscal year - valued on date of vesting</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Add</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Dividends or other earnings paid on stock or option awards
    in the covered fiscal year prior to the vesting date that are not otherwise included in the total compensation for the covered fiscal
    year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Add/(Subtract)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in fair value from end of prior fiscal year to end
    of covered fiscal year for awards made in prior fiscal years that were unvested at end of current fiscal year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,009,600</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(791,158</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,022,839</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Add/Subtract</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in fair value from end of prior fiscal year to vesting
    date for awards made in prior fiscal years that vested during covered fiscal year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(33,852</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">49,182</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(16,841</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Subtract</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fair value of awards forfeited in current fiscal year determined
    at end of prior fiscal year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Equals</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Compensation Actually Paid to CEO</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(904,217</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">349,848</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,432</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The amounts deducted or added in calculating the equity award adjustments
with regard to our non-PEO are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 15%; font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: left">Total Compensation as reported SCT</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">441,259</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Subtract</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Pension values reported in SCT for covered fiscal year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Subtract</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fair value of equity awards granted during covered fiscal
    year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(40,629</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Add</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Pension value attributable to covered fiscal year&rsquo;s
    service and any change in pension value attributable to plan amendments made in the covered year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Add</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fair value of equity awards granted in covered fiscal year
    and that are unvested at end of such covered fiscal year &ndash; valued at year-end</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">29,802</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Add</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fair value of equity awards granted in covered fiscal year
    that vested during such covered fiscal year - valued on date of vesting</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Add</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Dividends or other earnings paid on stock or option awards
    in the covered fiscal year prior to the vesting date that are not otherwise included in the total compensation for the covered fiscal
    year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Add/(Subtract)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in fair value from end of prior fiscal year to end
    of covered fiscal year for awards made in prior fiscal years that were unvested at end of current fiscal year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Add/Subtract</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in fair value from end of prior fiscal year to vesting
    date for awards made in prior fiscal years that vested during covered fiscal year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Subtract</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Fair value of awards forfeited in current fiscal year determined
    at end of prior fiscal year</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Equals</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Compensation Actually Paid to CEO</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">430,432</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Analysis of the Information Presented in the
Pay Versus Performance Table</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As described in more detail above in &ldquo;Executive
Compensation&ndash;Narrative Disclosure to Summary Compensation Table,&rdquo; the Company&rsquo;s executive compensation program reflects
a performance-driven compensation philosophy. While the Company utilizes several performance measures to align executive compensation
with Company performance, those Company measures are not financial performance measures and are therefore not presented in the Pay Versus
Performance table. Moreover, the Company generally seeks to incentivize long-term performance, and therefore does not specifically align
the Company&rsquo;s performance measures with &ldquo;compensation actually paid&rdquo; (as computed in accordance with Item 402(v)&nbsp;of
Regulation S-K) for a particular year. In accordance with Item 402(v)&nbsp;of Regulation S-K, we are providing the following descriptions
of the relationships between information presented in the Pay Versus Performance table above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Compensation Actually Paid and Cumulative
TSR</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The chart below shows the relationship between
the compensation actually paid to our PEO and the average compensation actually paid to our non-PEO NEOs, on the one hand, to the Company&rsquo;s
cumulative TSR over the three years presented in the table, on the other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2323985d1_def14aimg002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Compensation Actually Paid and Net Income</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The chart below shows the relationship between
the compensation actually paid to our PEO and the average compensation actually paid to our non-PEO NEOs, on the one hand, to the Company&rsquo;s
net income, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2323985d1_def14aimg003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>All information provided above under the heading
 &ldquo;Pay Versus Performance&rdquo; will not be deemed to be incorporated by reference into any filing of the Company under the Securities
Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective
of any general incorporation language in any such filing, except to the extent the Company specifically incorporates such information
by reference.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Employment Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Steven A. Shallcross, Chief Executive Officer, Chief Financial
Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January&nbsp;3, 2022, we entered into a three-year
employment agreement with Mr.&nbsp;Shallcross (the &ldquo;2022 Shallcross Employment Agreement&rdquo;), to serve as the Chief Executive
Officer and to continue to serve as our Chief Financial Officer. Mr.&nbsp;Shallcross has served as our Chief Financial Officer since
June&nbsp;1, 2015, initially pursuant to the terms of a two year employment agreement that we entered with him on April&nbsp;28, 2015
(the &ldquo;Initial Shallcross Employment Agreement&rdquo;) and then pursuant an employment agreement we entered into with him on December&nbsp;6,
2018, which replaced the Initial Shallcross Agreement (the &ldquo;Amended Shallcross Employment Agreement&rdquo;) Mr.&nbsp;Shallcross
was appointed as a director of the Company. Mr.&nbsp;Shallcross does not receive additional compensation for service as our director.
The material terms of the 2022 Shallcross Employment Agreement and Amended Shallcross Agreement are set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Amended Shallcross Employment
Agreement, as amended, Mr.&nbsp;Shallcross is entitled to an annual base salary of $614,250 and an annual performance bonus targeted
at fifty percent (50%) of his annual base salary. The annual bonus will be based upon the assessment of the Board of Mr.&nbsp;Shallcross&rsquo;s
performance. The Amended Shallcross Employment Agreement also includes confidentiality obligations and inventions assignments by Mr.&nbsp;Shallcross
and non-solicitation and non-competition provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Amended Shallcross Employment Agreement has
a stated term of three years but may be terminated earlier pursuant to its terms. If Mr.&nbsp;Shallcross&rsquo;s employment is terminated
for any reason, he or his estate as the case may be, will be entitled to receive the accrued base salary, vacation pay, expense reimbursement
and any other entitlements accrued by him to the extent not previously paid (the &ldquo;Accrued Obligations&rdquo;); provided, however,
that if his employment is terminated (i)&nbsp;by us without Cause or by Mr.&nbsp;Shallcross for Good Reason (as each is defined in the
Shallcross Employment Agreement) then in addition to paying the Accrued Obligations, (a)&nbsp;we will continue to pay his then current
base salary and continue to provide benefits at least equal to those that were provided at the time of termination for a period of twelve
(12) months and (b)&nbsp;he shall have the right to exercise any vested equity awards until the earlier of six (6)&nbsp;months after
termination or the remaining term of the awards; or (ii)&nbsp;by reason of his death or Disability (as defined in the Shallcross Employment
Agreement), then in addition to paying the Accrued Obligations, Mr.&nbsp;Shallcross would have the right to exercise any vested options
until the earlier of six (6)&nbsp;months after termination or the remaining term of the awards. In such event, if Mr.&nbsp;Shallcross
commenced employment with another employer and becomes eligible to receive medical or other welfare benefits under another employer-provided
plan, the medical and other welfare benefits to be provided by us as described herein would terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Amended Shallcross Employment Agreement provides
that upon the closing of a &ldquo;Change in Control&rdquo; (as defined in the Shallcross Employment Agreement), all unvested options
shall immediately vest and the time period that Mr.&nbsp;Shallcross will have to exercise all vested stock options and other awards that
Mr.&nbsp;Shallcross may have will be equal to the shorter of: (i)&nbsp;six (6)&nbsp;months after termination, or (ii)&nbsp;the remaining
term of the award(s). If within one (1)&nbsp;year after the occurrence of a Change in Control, Mr.&nbsp;Shallcross terminates his employment
for &ldquo;Good Reason&rdquo; or we terminate Mr.&nbsp;Shallcross&rsquo;s employment for any reason other than death, disability or Cause,
Mr.&nbsp;Shallcross will be entitled to receive: (i)&nbsp;the portion of his base salary for periods prior to the effective date of termination
accrued but unpaid (if any); (ii)&nbsp;all unreimbursed expenses (if any); (iii)&nbsp;an aggregate amount (the &ldquo;Change in Control
Severance Amount&rdquo;) equal to two (2)&nbsp;times the sum of his base salary plus an amount equal to the bonus that would be payable
if the &ldquo;target&rdquo; level performance were achieved under the Company&rsquo;s annual bonus plan (if any) in respect of the fiscal
year during which the termination occurs (or the prior fiscal year if bonus levels have not yet been established for the year of termination);
and (iv)&nbsp;the payment or provision of any other benefits. If within two (2)&nbsp;years after the occurrence of a Change in Control,
Mr.&nbsp;Shallcross terminates his employment for &ldquo;Good Reason&rdquo; or we terminate Mr.&nbsp;Shallcross&rsquo;s employment for
any reason other than death, disability or Cause, Mr.&nbsp;Shallcross will be entitled to also receive for the period of two (2)&nbsp;consecutive
years commencing on the date of such termination of his employment, medical, dental, life and disability insurance coverage for him and
the members of his family that are not less favorable to him than the group medical, dental, life and disability insurance coverage carried
by us for him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Change in Control Severance Amount is to
be paid in a lump sum if the Change in Control event constitutes a &ldquo;change in the ownership&rdquo; or a &ldquo;change in the effective
control&rdquo; of the Company or a &ldquo;change in the ownership of a substantial portion of a corporation&rsquo;s assets&rdquo; (each
within the meaning of Section&nbsp;409A of the Internal Revenue Code (&ldquo;Rule&nbsp;409A&rdquo;)), or in 48 substantially equal payments,
if the Change in Control event does not so comply with Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January&nbsp;3, 2022, we entered into a three-year
employment agreement with Steven A. Shallcross (the &ldquo;2022 Employment Agreement&rdquo;), The 2022 Employment Agreement replaced
the prior employment agreement with the us that Mr.&nbsp;Shallcross entered into on December&nbsp;6, 2018, as amended December&nbsp;5,
2019 (the &ldquo;Amended Employment Agreement&rsquo;). The material terms of the Employment Agreement are set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the 2022 Employment Agreement, Mr.&nbsp;Shallcross
is entitled to an annual base salary of $585,000 and an annual cash performance bonus targeted at fifty percent (50%) of his annual base
salary as well as discretionary annual equity awards pursuant to the Company&rsquo;s incentive plans. The annual bonus will be based
upon the assessment of the Board of Mr.&nbsp;Shallcross&rsquo;s performance. The 2022 Employment Agreement also includes confidentiality
obligations and inventions assignments by Mr.&nbsp;Shallcross and non-solicitation and non-competition provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2022 Shallcross Employment Agreement has
a stated term of three years but may be terminated earlier pursuant to its terms. If Mr.&nbsp;Shallcross&rsquo;s employment is terminated
for any reason, he or his estate as the case may be, will be entitled to receive the unpaid base salary through the date of termination
and accrued vacation, any unpaid annual bonus earned with respect to any calendar year ending on or preceding the date of termination,
expense reimbursement and any other entitlements accrued by him to the extent not previously paid (the &ldquo;Accrued Obligations&rdquo;);
provided, however, that if his employment is terminated (i)&nbsp;by the us without Cause or by Mr.&nbsp;Shallcross for Good Reason (as
each is defined in the Employment Agreement) then, subject to him executing a general release in form acceptable to the us that becomes
effective, in addition to paying the Accrued Obligations, (a)&nbsp;we will continue to pay his then current base salary and if he timely
elects continued coverage under COBRA, we will continue to provide benefits at least equal to those that were provided at the time of
termination for a period of twelve (12) months and (b)&nbsp;all unvested equity awards will vest and he shall have the right to exercise
any such vested equity awards until the earlier of eighteen (18) months after termination or the remaining term of the awards; or (ii)&nbsp;by
reason of his death or Disability (as defined in the 2022 Employment Agreement), then in addition to paying the Accrued Obligations,
Mr.&nbsp;Shallcross or his estate would have the right to exercise any vested options until the earlier of six (6)&nbsp;months after
termination or the remaining term of the awards. In such event, if Mr.&nbsp;Shallcross commenced employment with another employer and
becomes eligible to receive medical or other welfare benefits under another employer-provided plan, the medical and other welfare benefits
to be provided by the Company as described herein would terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2022 Shallcross Employment Agreement provides
that upon the closing of a &ldquo;Change in Control&rdquo; (as defined in the 2022 Employment Agreement), all unvested options shall
immediately vest and the time period that Mr.&nbsp;Shallcross will have to exercise all vested stock options and other awards that Mr.&nbsp;Shallcross
may have will be equal to the shorter of: (i)&nbsp;eighteen (18) months after termination, or (ii)&nbsp;the remaining term of the award(s).
If within one (1)&nbsp;year after the occurrence of a Change in Control, Mr.&nbsp;Shallcross terminates his employment for &ldquo;Good
Reason&rdquo; or we terminate Mr.&nbsp;Shallcross&rsquo;s employment for any reason other than death, disability or Cause, Mr.&nbsp;Shallcross
will be entitled to receive: (i)&nbsp;the portion of his base salary for periods prior to the effective date of termination accrued but
unpaid (if any); (ii)&nbsp;all unreimbursed expenses (if any); (iii)&nbsp;an aggregate amount (the &ldquo;Change in Control Severance
Amount&rdquo;) equal to two (2)&nbsp;times the sum of his base salary plus an amount equal to the bonus that would be payable if the
 &ldquo;target&rdquo; level performance were achieved under our annual bonus plan (if any) in respect of the fiscal year during which
the termination occurs (or the prior fiscal year if bonus levels have not yet been established for the year of termination) subject to
him executing a general release in form acceptable to us that becomes effective. If within two (2)&nbsp;years after the occurrence of
a Change in Control, Mr.&nbsp;Shallcross terminates his employment for &ldquo;Good Reason&rdquo; or we terminate Mr.&nbsp;Shallcross&rsquo;s
employment for any reason other than death, disability or Cause, Mr.&nbsp;Shallcross will be entitled to also receive for the period
of two (2)&nbsp;consecutive years commencing on the date of such termination of his employment, medical, dental, life and disability
insurance coverage for him and the members of his family that are not less favorable to him than the group medical, dental, life and
disability insurance coverage carried by us for him subject to him executing a general release in form acceptable to us that becomes
effective. The Change in Control Severance Amount is to be paid in a lump sum if the Change in Control event constitutes a &ldquo;change
in the ownership&rdquo; or a &ldquo;change in the effective control&rdquo; of the Company or a &ldquo;change in the ownership of a substantial
portion of a corporation&rsquo;s assets&rdquo; (each within the meaning of Section&nbsp;409A of the Internal Revenue Code (&ldquo;Rule&nbsp;409A&rdquo;)),
or in 48 substantially equal payments, if the Change in Control event does not so comply with Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Frank Tufaro, Chief Operating Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March&nbsp;22, 2022, we entered into an employment
agreement with Frank Tufaro, as amended on December&nbsp;15, 2022 (the &ldquo;Tufaro Employment Agreement&rdquo;) to serve as the Chief
Operating Officer of the Company. Effective May&nbsp;10, 2023, The Company entered into a Separation Agreement and Release with Frank
Tufaro (the &ldquo;Separation Agreement&rdquo;) and a consulting agreement with Dr.&nbsp;Tufaro. The material terms of the Employment
Agreement and Separation Agreement and Release are set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Tufaro Employment Agreement,
as amended Dr.&nbsp;Tufaro received an annual base salary of $393,750 and was eligible to earn an annual performance bonus targeted at
forty percent (40%) of his annual base salary. The annual bonus was based upon the assessment of the Company&rsquo;s Board of Dr.&nbsp;Tufaro&rsquo;s
performance and our attainment of targeted goals set by the Board of Directors. In addition, Dr.&nbsp;Tufaro was also eligible to receive
annual equity awards pursuant to our incentive equity plans, such awards (including the number and type of awards), if any, to be in
the sole discretion of the Board of Directors. The Tufaro Employment Agreement also included confidentiality obligations and inventions
assignments by Dr.&nbsp;Tufaro and non-solicitation and non-competition provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Tufaro Employment Agreement had a stated
term of three (3)&nbsp;years but could be terminated earlier pursuant to its terms. If Dr.&nbsp;Tufaro&rsquo;s employment was terminated
for any reason, he or his estate as the case may be, would be entitled to receive the accrued base salary, any unpaid annual bonus earned
with respect to any calendar year ending on or preceding the date of termination, vacation pay, expense reimbursement and any other entitlements
accrued by him to the extent not previously paid (the &ldquo;Accrued Obligations&rdquo;); provided, however, that if his employment is
terminated (i)&nbsp;by us without Cause or by Dr.&nbsp;Tufaro for Good Reason (as each is defined in the Tufaro Employment Agreement)
then in addition to paying the Accrued Obligations, (a)&nbsp;we would continue to pay his then current base salary and continue to provide
benefits at least equal to those that were provided at the time of termination for a period of six (6)&nbsp;months and (b)&nbsp;all unvested
stock options and other equity awards would immediately vest and he would be entitled to exercise any vested equity awards until the
earlier of six (6)&nbsp;months after termination or the remaining term of the awards; or (ii)&nbsp;by reason of his death or Disability
(as defined in the Tufaro Employment Agreement), then in addition to paying the Accrued Obligations, Dr.&nbsp;Tufaro, or his estate as
the case may be, would have the right to exercise any vested options until the earlier of six (6)&nbsp;months after termination or the
remaining term of the awards. If Dr.&nbsp;Tufaro commenced employment with another employer and became eligible to receive medical or
other welfare benefits under another employer-provided plan, the medical and other welfare benefits to be provided by us as described
herein would terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Tufaro Employment Agreement also had terms
similar to those contained in the 2022 Shallcross Employment Agreement with respect to a &ldquo;Change in Control&rdquo; (as defined
in the Employment Agreement)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Separation Agreement and Consulting Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective May&nbsp;10, 2023, we entered into
a Separation Agreement and Release with Frank Tufaro (the &ldquo;Separation Agreement&rdquo;) and a consulting agreement with Dr.&nbsp;Tufaro.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the terms of the Tufaro Employment
Agreement, the Separation Agreement provides for (i)&nbsp;the payment to Dr.&nbsp;Tufaro of a total of $196,875, paid in bi-monthly installments,
less applicable withholding, for a period of six months, (ii)&nbsp;reimbursement of COBRA coverage for himself, his spouse and other
eligible dependents for the lesser of: six months or until he commences new employment or substantial self-employment, and (iii)&nbsp;acceleration
of the vesting of his outstanding stock options (the &ldquo;Option Awards&rdquo;), and (iv)&nbsp;the extension of the period of time
for which Dr.&nbsp;Tufaro has the right to exercise any vested shares subject to options until the earlier of (i)&nbsp;the expiration
date of the Option Awards, or (ii)&nbsp;six (6)&nbsp;months from the separation date. The Separation Agreement contains mutual general
releases of claims and non-disparagement provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Consulting Agreement has a term of six months
unless sooner terminated. Either party may terminate the Consulting Agreement without cause at any time upon thirty (days&rsquo; prior
written notice or with cause immediately. Dr.&nbsp;Tufaro is compensated a set daily rate for each full day that he provides consulting
services, pro-rated for any days services are provided less than eight hours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Compensation of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information for
the fiscal year ended December&nbsp;31, 2022 regarding the compensation of our directors who at December&nbsp;31, 2022 were not also
our Named Executive Officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fees Earned</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">or</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Other</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Paid in
    Cash</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Awards(1)(2)</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Compensation</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 47%; font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey J. Kraws(3)</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">176,250</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">40,629</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">216,879</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">John Monahan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">66,750</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">40,629</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">107,379</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey Wolf</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">73,750</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">40,629</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">114,379</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts in the &ldquo;Option
    Awards&rdquo; column reflect the dollar amounts of the grant date fair value for the financial statement reporting purposes for stock
    options for the fiscal year ended December&nbsp;31, 2022 in accordance with ASC 718. The fair value of the options was determined
    using the Black-Scholes model. For a discussion of the assumptions used in computing this valuation, see &ldquo;Management&rsquo;s
    Discussion and Analysis of Financial Conditions and Results of Operations&rdquo; and Note 6 of the Notes to Consolidated Financial
    Statements in our Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2022.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December&nbsp;31,
    2022, the following are the outstanding aggregate number of option awards held by each of our directors who were not also Named Executive
    Officers:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Awards</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(#)</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 84%; font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey J. Kraws</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">163,377</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">John Monahan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">137,508</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey Wolf</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">169,377</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2022, our independent, non-executive Chairman
of the Board of Directors received an annual cash retainer of $150,000, each other non-employee member of the Board of Directors received
an annual cash retainer of $43,000, all non-employee directors receive an annual cash fee of $7,500, $5,000 and $3,750 for service as
a member of the Audit, Compensation and Nominations Committees, respectively, or an additional annual cash fee of $15,000, $10,000 and
$7,500 for service as Chairman of the Audit, Compensation and Nominations Committees, respectively. In addition, each non-employee member
of the Board of Directors was issued an option exercisable for 100,000 shares of our common stock, for a term of seven years, vesting
monthly over one year of the date of grant. In setting 2022 and 2021 compensation for directors, the Compensation Committee relied on
an executive compensation report from Meridian Compensation Partners, LLC. Based on an analysis of director compensation set forth in
the executive compensation report, our financial performance, general market conditions and the interests of stockholders, it was determined
that the annual cash retainer for serving on the board of directors and the committee retainers would remain for 2023 the same as they
were in 2022 and 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.&nbsp;Kraws was appointed
    as our independent, non-executive Chairman of the Board of Directors in May&nbsp;2012. Pursuant to his agreement Mr.&nbsp;Kraws receives
    an annual retainer of $150,000 for serving as our Chairman.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Compensation Committee Interlocks</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the last fiscal year ended December&nbsp;31,
2022, none of our executive officers served on the Board of Directors or Compensation Committee of any other entity whose officers served
either on our Board of Directors or Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_016"></A>SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information, as
of August&nbsp;11, 2023, or as otherwise set forth below, with respect to the beneficial ownership of our common stock (i)&nbsp;all persons
known to us to be the beneficial owners of more than 5% of the outstanding shares of our common stock; (ii)&nbsp;each of our directors
and our named executive officers named in the Summary Compensation Table; and (iii)&nbsp;all of our directors and our current executive
officer as a group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Shares
    Owned (1)</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percentages</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Name and Address of Beneficial Ownership
    (2)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Owned</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">of Shares
    (3)</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 69%; font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey J. Kraws (4)</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">145,031</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Steven Shallcross (5)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">532,495</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3.07</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey Wolf (6)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">144,377</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">John Monahan (7)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">112,508</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Frank Tufaro (8)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">180,645</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.05</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">All current officers and directors as a group (4 persons)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">934,411</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5.27</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">represents less than 1% of our common stock</FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify; font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The address
    for each officer and directors is 9605 Medical Center, Suite&nbsp;270, Rockville, Maryland 20850.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership is
    determined in accordance with SEC rules&nbsp;and generally includes voting or investment power with respect to securities. Except
    as indicated in the footnotes to the table, to the knowledge of the Company, the persons named in the table have sole voting and
    investment power with respect to all shares of common stock, preferred stock, options and/or warrants shown as beneficially owned
    by them, subject to community property laws, where applicable. Pursuant to the rules&nbsp;of the SEC, the number of shares of our
    common stock deemed outstanding includes shares issuable pursuant to options held by the respective person or group that are currently
    exercisable or may be exercised within 60 days of August&nbsp;11 2023. Does not include any shares of Series&nbsp;C Convertible Preferred
    Stock or Series&nbsp;D Convertible Preferred Stock. <FONT STYLE="background-color: white">We currently have outstanding 275,000 shares
    of Series&nbsp;C Preferred Stock and 100,000 shares of Series&nbsp;D Preferred Stock convertible, at a conversion price (the &ldquo;Conversion
    Price&rdquo;) of $1.22 per share (subject in certain circumstances to adjustments and to a 4.99% limit on beneficial ownership),
    into an aggregate of 2,459,016 shares of the common stock. The shares of Series&nbsp;C Preferred Stock and Series&nbsp;D Preferred
    Stock had voting rights exclusively with respect to certain corporate actions (name change, increase in authorized shares and adjournment
    with respect to such proposals), which corporate actions were approved by our stockholders and therefore the Series&nbsp;C Preferred
    Stock and Series&nbsp;D Preferred Stock no longer have voting rights with respect to such corporate matters and only have voting
    rights with certain limited actions directly impacting the Series&nbsp;C Preferred Stock and Series&nbsp;D Preferred Stock. All of
    the shares of Series&nbsp;C Preferred Stock and Series&nbsp;D Preferred Stock are owned by MSD Credit Opportunity Master Fund, L.P.
    MSD Partners, L.P. (&ldquo;MSD Partners&rdquo;) is the investment manager of MSD Credit Opportunity Master Fund, L.P. MSD Partners
    (GP), LLC (&ldquo;MSD GP&rdquo;), a Delaware limited liability company, is the general partner of MSD Partners. Each of Gregg R.
    Lemkau, Marc R. Lisker and Brendan Rogers is a manager of, and may be deemed to beneficially own securities beneficially owned by,
    MSD GP. The business address of MSD Credit Opportunity Master Fund, L.P. is One Vanderbilt Avenue, 26<SUP>th</SUP>&nbsp;Floor, New
    York, New York 10017.</FONT></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of August&nbsp;11, 2023,
    the Company had 17,042,765 shares of common stock outstanding.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes: (i)&nbsp;654
    shares of Common Stock owned by Mr.&nbsp;Kraws; and (ii)&nbsp;144,377 shares issuable upon exercise of options held by Mr.&nbsp;Kraws
    that are exercisable within the 60-day period following August&nbsp;11, 2023. Does not include an additional 25,000 shares issuable
    upon exercise of options held by Mr.&nbsp;Kraws that are not exercisable within the 60-day period following August&nbsp;11, 2023,
    2023.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Includes: (i)&nbsp;250,000 shares of Common
    Stock owned by Mr.&nbsp;Shallcross; (ii)&nbsp;268,495 shares issuable upon exercise of options held by Mr.&nbsp;Shallcross; and (iii)&nbsp;14,000
    shares of Common Stock issuable upon exercise of options held by Mrs.&nbsp;Shallcross (Mr.&nbsp;Shallcross&rsquo;s wife) that are
    exercisable within the 60-day period following August&nbsp;11, 2023. Does not include an additional 387,083 shares issuable upon
    exercise of options held by Mr.&nbsp;Shallcross and 39,000 issuable upon exercise of options held by Mrs.&nbsp;Shallcross that are
    not exercisable within the 60-day period following August&nbsp;11, 2023.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 144,377 shares
    issuable upon exercise of options held by Mr.&nbsp;Wolf that are exercisable within the 60-day period following August&nbsp;11, 2023.
    Does not include an additional 25,000 shares issuable upon exercise of options held by Mr.&nbsp;Wolf that are not exercisable within
    the 60-day period following August&nbsp;11, 2023.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 112,508 shares
    issuable upon exercise of options held by Dr.&nbsp;Monahan that are exercisable within the 60-day period following August&nbsp;11,
    2023. Does not include an additional 25,000 shares issuable upon exercise of options held by Dr.&nbsp;Monahan that are not exercisable
    within the 60-day period following August&nbsp;11, 2023.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="width: 98%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes: (i)&nbsp;80,645
    shares of Common Stock owned by Dr.&nbsp;Tufaro; and (ii)&nbsp;100,000 shares issuable upon exercise of options held by Dr.&nbsp;Tufaro
    that are exercisable within the 60-day period following August&nbsp;11, 2023. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Equity Compensation Plan Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information about
the securities authorized for issuance under our equity compensation plans for the fiscal year ended December&nbsp;31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Securities</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Remaining</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Securities</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Available for</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">to be Issued Upon</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted-Average</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Future Issuance</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise of</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price of</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Under Equity</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Outstanding</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Outstanding</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Compensation</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Plan
    Category</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Options</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Options</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Plans</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Equity compensation plans approved by stockholders:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">2001 Stock Incentive Plan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 54%; font: 10pt Times New Roman, Times, Serif; text-align: left">2007 Stock Incentive Plan</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">515</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">695.10</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">2010 Stock Incentive Plan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">202,381</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">26.74</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&mdash;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">2020 Stock Incentive Plan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,093,002</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1.12</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,906,998</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Equity compensation plans not approved
    by stockholders</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,295,898</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3.53</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,906,998</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_017"></A>CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to our charter, our Audit Committee
shall review on an on-going basis for potential conflicts of interest, and approve if appropriate, all our &ldquo;Related Party Transactions&rdquo;
as required by Section&nbsp;120 of the NYSE American Company Guide. For purposes of the Audit Committee Charter, &ldquo;Related Party
Transactions&rdquo; shall mean those transactions required to be disclosed pursuant to SEC Regulation S-K,&nbsp;Item 404.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors undertook a review of
the independence of the members of the Board of Directors and considered whether any director has a material relationship with our company
that could compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities. Based upon information
requested from and provided by each director concerning their background, employment and affiliations, including family relationships,
the Board of Directors has determined that Mr.&nbsp;Kraws, Dr.&nbsp;Monahan and Mr.&nbsp;Wolf are independent directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as disclosed under &ldquo;Executive Compensation,&rdquo;
and below there were no related party transactions during the two years ended December&nbsp;31, 2022 or the current year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December&nbsp;15, 2022, we approved the retention
of MaryAnn Shallcross, the wife of Steven Shallcross, as director of Clinical Operations, for compensation of $145,000 and the grant
of an option to purchase 50,000 shares of common stock having a value of $20,000. Ms.&nbsp;Shallcross had been performing services for
us during 2022 for total compensation of less than $120,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Review, Approval
and Ratification of Transactions with Related Persons</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The general policy of
Theriva and our Audit Committee is that all material transactions with a related-party and agreements with related parties, as well as
all material transactions in which there is an actual, or in some cases, perceived, conflict of interest, will be subject to prior review
and approval by our Audit Committee and its independent members, which will determine whether such transactions or proposals are fair
and reasonable to our company and our stockholders. In general, potential related-party transactions will be identified by our management
and discussed with our Audit Committee at our Audit Committee&rsquo;s meetings. When reviewing a related party transaction, the Audit
Committee shall take into account all of the relevant facts and circumstances available to it, including (if applicable), but not limited
to (a)&nbsp;the material terms and conditions of the transaction; (b)&nbsp;the related party&rsquo;s relationship to the Corporation;
(c)&nbsp;the related party&rsquo;s interest in the transaction; (d)&nbsp;the approximate dollar value of the transaction; (e)&nbsp;the
availability from other sources of comparable products and services; and (f)&nbsp;an assessment of whether the transaction is on terms
that are comparable to the terms available to the Corporation from an unrelated third party. Our policies and procedures regarding related-party
transactions are set forth in our Audit Committee Charter and Code of Business Conduct and Ethics, both of which are publicly available
on our website at <I>www.therivabio.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_018"></A>ANNUAL REPORT/FORM&nbsp;10-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Theriva&rsquo;s 2022 Annual Report is being mailed
to certain stockholders concurrently with this Proxy Statement. Copies of the 2022 Annual Report and any amendments thereto, as filed
with the SEC, may be obtained without charge by writing to Theriva Biologics,&nbsp;Inc., 9605 Medical Center Drive, Suite&nbsp;270, Rockville,
Maryland 20850, Attention: Corporate Secretary. A complimentary copy may also be obtained at the internet website maintained by the SEC
at <I>www.sec.gov</I>, and by visiting our internet website at <I>www.therivabio.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_019"></A>NOTICE REGARDING DELIVERY
OF STOCKHOLDER DOCUMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(</B>&ldquo;<B>HOUSEHOLDING</B>&rdquo; <B>INFORMATION)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC has adopted rules&nbsp;that permit companies
and intermediaries (e.g., brokers) to satisfy the delivery requirements for proxy statements and annual reports by delivering a single
copy of these materials to an address shared by two or more Theriva stockholders. This process, which is commonly referred to as &ldquo;householding,&rdquo;
potentially means extra convenience for stockholders and cost savings for companies and intermediaries. A number of brokers and other
intermediaries with account holders who are our stockholders may be householding our proxy materials, including this Proxy Statement.
In that event, a single proxy statement, as the case may be, will be delivered to multiple stockholders sharing an address unless contrary
instructions have been received from the affected stockholders. Once you have received notice from your broker or other intermediary
that it will be householding communications to your address, householding will continue until you are notified otherwise or until you
revoke your consent, which is deemed to be given unless you inform the broker or other intermediary otherwise when you receive or received
the original notice of householding. If, at any time, you no longer wish to participate in householding and would prefer to receive a
separate proxy statement, please notify your broker or other intermediary to discontinue householding and direct your written request
to receive a separate proxy statement and other annual meeting materials to us at: Theriva Biologics,&nbsp;Inc., Attention: Corporate
Secretary, 9605 Medical Center Drive, Suite&nbsp;270, Rockville, Maryland 20850 or by calling us at (301) 417-4364. Stockholders who
currently receive multiple copies of the proxy statement at their address and would like to request householding of their communications
should contact their broker or other intermediary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPRAISAL RIGHTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the Nevada Revised Statutes, our stockholders are not entitled
to appraisal or dissenter&rsquo;s rights with respect to any of the proposals, and we will not independently provide our stockholders
with any such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_020"></A>STOCKHOLDER PROPOSALS FOR
THE 2024 ANNUAL MEETING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders who intend to present proposals
for inclusion in next year&rsquo;s proxy materials at the 2024 Annual Meeting of Stockholders under SEC Rule&nbsp;14a-8 must ensure that
such proposals are received by the Corporate Secretary of the Company not later than April&nbsp;16, 2024. Such proposals must meet the
requirements of the SEC to be eligible for inclusion in our 2024 proxy materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you wish to nominate a director at the
2024 Annual Meeting of Stockholders, or to bring any other proposal before the 2024 Annual Meeting of Stockholders, that is not to
be included in next year&rsquo;s proxy materials pursuant to Rule&nbsp;14a-8, you must currently do so in accordance with our Second
A&amp;R Bylaws, which has been approved by the Board of Directors and will become effective on October&nbsp;3, 2023. A copy of the
Second A&amp;R Bylaws is attached as an exhibit to our Current Report on Form 8-K that was filed with the SEC on August 11, 2023,
which filing can be accessed on our website at <I>www.therivabio.com</I> in the Investors section. Our Second A&amp;R Bylaws
requires notice of not less than 120 days prior to the anniversary of the preceding year&rsquo;s annual meeting to be timely, which
in this case means June&nbsp;4, 2024, and contains additional requirements about advance notice required of stockholder proposals
and director nominations. The stockholder&rsquo;s notice must set forth the information required by our Second A&amp;R Bylaws with
respect to each stockholder making the proposal and each proposal and director nomination that such stockholder intends to present
at the 2024 Annual Meeting of Stockholders. All stockholder director nominations must be given in writing to the Chairman of the
Nominations Committee, Theriva Biologics,&nbsp;Inc., 9605 Medical Center Drive, Suite&nbsp;270, Rockville, Maryland 20850, All other
stockholder proposals must be given in writing to the Corporate Secretary, Theriva Biologics,&nbsp;Inc., 9605 Medical Center Drive,
Suite&nbsp;270, Rockville, Maryland 20850. In addition to satisfying the foregoing requirements, to comply with the universal proxy
rules, stockholders who intend to solicit proxies in support of director nominees other than the Company&rsquo;s nominees must
provide notice that sets forth the information required by Rule&nbsp;14a-19 under the Exchange Act no later than August&nbsp;3,
2024. If such meeting date is changed by more than 30 days, then notice must be provided by the later of 60 calendar days prior to
the date of the annual meeting or the 10th calendar day following the day on which public announcement of the date of the annual
meeting is first made</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_021"></A>AVAILABLE
INFORMATION ON CORPORATE GOVERNANCE AND SEC FILINGS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through our website (<I>www.therivabio.com</I>),
we make available, free of charge, our Annual Reports on Form&nbsp;10-K, Quarterly Reports on Form&nbsp;10-Q, Current Reports on Form&nbsp;8-K,
all amendments to those reports, and other filings with the SEC, as soon as reasonably practicable after they are electronically filed
with, or furnished to, the SEC. We also make the following documents available on our website: the Audit Committee Charter; the Compensation
Committee Charter; the Nominations Committee Charter; our Code of Conduct; and our Code of Ethics for Financial Management. You may also
obtain a copy of any of the foregoing documents, free of charge, if you submit a written request to the Corporate Secretary, Theriva
Biologics,&nbsp;Inc., 9605 Medical Center Drive, Suite&nbsp;270, Rockville, Maryland 20850.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No person is authorized to give any information
or make any representation other than that contained in this Proxy Statement, and if given or made, such information may not be relied
upon as having been authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_022"></A>MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board of Directors knows of no other business
to be presented at the 2023 Annual Meeting of Stockholders. If, however, other matters properly do come before the 2023 Annual Meeting
of Stockholders, it is intended that the proxies in the accompanying form will be voted thereon in accordance with the judgment of the
person or persons holding such proxies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>YOU ARE URGED TO CAST YOUR VOTE AS INDICATED
IN THE PROXY MATERIALS.<BR>
PROMPT RESPONSE WILL GREATLY FACILITATE ARRANGEMENTS FOR THE 2023 ANNUAL<BR>
MEETING OF STOCKHOLDERS, AND YOUR COOPERATION WILL BE APPRECIATED.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By order of the Board of Directors,</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Steven A.
    Shallcross</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Steven A. Shallcross</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Chief Executive Officer, Chief Financial Officer and Director</I></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rockville, Maryland</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August&nbsp;14, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Theriva Biologics,&nbsp;Inc.<BR>
9605 Medical Center, Suite&nbsp;270<BR>
Rockville, Maryland 20850&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SUBMIT A PROXY TO VOTE BY INTERNET&thinsp;&mdash;&thinsp;www.proxypush.com/tovx</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Use the Internet to transmit your voting instructions
and for electronic delivery of information up until 11:59 P.M.&nbsp;Eastern Time on October&nbsp;1, 2023. Have your proxy card in hand
when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS&thinsp;&mdash;&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you would like to reduce the costs incurred
by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically
via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and,
when prompted, indicate that you agree to receive or access proxy materials electronically in future years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SUBMIT A PROXY TO VOTE BY MAIL&thinsp;&mdash;&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mark, sign and date your proxy card and return it in the postage-paid
envelope we have provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="white-space: nowrap; padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
    Board of Directors recommends you vote FOR the<BR>
    election of each of the following:</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For<BR>
    All</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Withhold<BR>
    All</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For<BR>
    All<BR>
    Except</B></FONT></TD>
    <TD COLSPAN="4" STYLE="white-space: nowrap; padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>To
    withhold authority to vote<BR>
    for any individual nominee(s),<BR>
    mark &ldquo;For All Except&rdquo; and<BR>
    write the number(s)&nbsp;of the<BR>
    nominee(s)&nbsp;on the line below.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; width: 19%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
    of Directors</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; width: 20%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; text-align: center; width: 8%"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; text-align: center; width: 8%"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; text-align: center; width: 8%"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; width: 8%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; width: 8%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; width: 3%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; width: 8%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nominees:</B></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01 Jeffrey
    Kraws</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02 John
    Monahan</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03 Steven
    Shallcross</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04 Jeffrey
    Wolf</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="7" STYLE="padding-bottom: 2pt; padding-top: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
    Board of Directors recommends you vote FOR the proposal 2</B></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For</B></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Against</B></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Abstain</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD COLSPAN="6" STYLE="padding-bottom: 2pt; padding-top: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    ratify the appointment of BDO USA, P.A. as our independent registered public accounting firm for our fiscal year ending on December&nbsp;31,
    2023;</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; text-align: center"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6" STYLE="padding-bottom: 2pt; padding-top: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE</B>:
    To transact such other business as may properly come before the meeting or any adjournments or postponements of the meeting.</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6" STYLE="padding-bottom: 2pt; padding-top: 2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    sign exactly as your name(s)&nbsp;appear(s)&nbsp;hereon. When signing as attorney, executor, administrator, or other fiduciary, please
    give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please
    sign in full corporate or partnership name, by authorized officer.</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
    [PLEASE SIGN WITHIN BOX]</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature<BR>
    (Joint Owners)</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 2pt; padding-top: 2pt; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THERIVA BIOLOGICS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2023 Annual Meeting of Stockholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>October&nbsp;2, 2023 9:30 A.M.&nbsp;Eastern
Time</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>This proxy is solicited by the Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned stockholder hereby appoints Steven
A. Shallcross, , as proxy, each with the power to appoint his or her substitute, and hereby authorizes him to represent and to vote,
as designated on the reverse side of this ballot, all of the shares of common stock of THERIVA BIOLOGICS,&nbsp;INC. that the undersigned
is entitled to vote at the Annual Meeting of Stockholders to be held at 9:30 A.M., Eastern Time, on October&nbsp;2, 2023 at the offices
of the Company located at 9605 Medical Center Drive, Suite&nbsp;270, Rockville, Maryland 20850, or any adjournment or postponement thereof.
The purpose of the 2023 Annual Meeting of Stockholders and the matters to be acted on are stated in the accompanying Notice of Annual
Meeting of Stockholders. The Board of Directors knows of no other business that will come before the 2023 Annual Meeting of Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>This proxy, when properly executed, will be
voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors</B>&rsquo;
<B>recommendations.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Continued and to be signed on reverse side</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2323985d1_def14aimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2323985d1_def14aimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  K )H# 2(  A$! Q$!_\0
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MDQE92P8C@=*H_%"SM=%N-"M;92EO C;5SG R#_C6D:-.514XL2J/ENSVU2"
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BI1<?LO,Q]$RLDJ; % &"H(!_ UN5&H / J2I9<(<JL?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2323985d1_def14aimg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2323985d1_def14aimg002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (1 R # 2(  A$! Q$!_\0
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MK4K#3]4LM,CT^TT:X*3:++J#/_:)OWD!<:K8 '?8D<QG86(;<"PJ[]A\5_\
M0Q6'_A+G_P"7E&E_\C?XI_[!GAG_ -'>(:ZV@#DOL/BO_H8K#_PES_\ +RC[
M#XK_ .ABL/\ PES_ /+RNMHH Y+[#XK_ .ABL/\ PES_ /+RC[#XK_Z&*P_\
M)<__ "\KK:* .2^P^*_^ABL/_"7/_P O*/L/BO\ Z&*P_P#"7/\ \O*ZVB@#
MDOL/BO\ Z&*P_P#"7/\ \O*/L/BO_H8K#_PES_\ +RNMHH Y+[#XK_Z&*P_\
M)<__ "\H^P^*_P#H8K#_ ,)<_P#R\KK:* .2^P^*_P#H8K#_ ,)<_P#R\H^P
M^*_^ABL/_"7/_P O*ZVB@#DOL/BO_H8K#_PES_\ +RC[#XK_ .ABL/\ PES_
M /+RNMHH Y+[#XK_ .ABL/\ PES_ /+RC[#XK_Z&*P_\)<__ "\KK:* .2^P
M^*_^ABL/_"7/_P O*/L/BO\ Z&*P_P#"7/\ \O*ZVB@#DOL/BO\ Z&*P_P#"
M7/\ \O*/L/BO_H8K#_PES_\ +RNMHH Y+[#XK_Z&*P_\)<__ "\H^P^*_P#H
M8K#_ ,)<_P#R\KK:* .2^P^*_P#H8K#_ ,)<_P#R\H^P^*_^ABL/_"7/_P O
M*ZVB@#DOL/BO_H8K#_PES_\ +RC[#XK_ .ABL/\ PES_ /+RNMHH Y+[#XK_
M .ABL/\ PES_ /+RC[#XK_Z&*P_\)<__ "\KK:* .2^P^*_^ABL/_"7/_P O
M*/L/BO\ Z&*P_P#"7/\ \O*ZVB@#DOL/BO\ Z&*P_P#"7/\ \O*/L/BO_H8K
M#_PES_\ +RNMHH Y+[#XK_Z&*P_\)<__ "\H^P^*_P#H8K#_ ,)<_P#R\KK:
M* .2^P^*_P#H8K#_ ,)<_P#R\H^P^*_^ABL/_"7/_P O*ZVB@#DOL/BO_H8K
M#_PES_\ +RC[#XK_ .ABL/\ PES_ /+RNMHH Y+[#XK_ .ABL/\ PES_ /+R
MC[#XK_Z&*P_\)<__ "\KK:* .2^P^*_^ABL/_"7/_P O*/L/BO\ Z&*P_P#"
M7/\ \O*ZVB@#DOL/BO\ Z&*P_P#"7/\ \O*/L/BO_H8K#_PES_\ +RNMHR!U
M.* .2^P^*_\ H8K#_P )<_\ R\H^P^*_^ABL/_"7/_R\KK:,CU%+FCW71;K=
M[+?KT Y+[#XK_P"ABL/_  ES_P#+RC[#XK_Z&*P_\)<__+RNL# G /Z&EI];
M=;7MUMWMO8#DOL/BO_H8K#_PES_\O*/L/BO_ *&*P_\ "7/_ ,O*ZVD) ZGO
MC\:+JZ5]7LNK]%U^0')_8?%?_0Q6'_A+G_Y>4?8?%?\ T,5A_P"$N?\ Y>5U
M@(/0]\?C2T75VKZK==5ZKH!R7V'Q7_T,5A_X2Y_^7E'V'Q7_ -#%8?\ A+G_
M .7E=:2!R::70'!84-I:MV7=Z(%J[+5VO9;V[VWL<I]A\5_]#%8?^$N?_EY1
M]A\5_P#0Q6'_ (2Y_P#EY769!)&>1UI: 33V=_0Y+[#XK_Z&*P_\)<__ "\H
M^P^*_P#H8K#_ ,)<_P#R\KK"P!P2,D9Q[<_X&DW+Z]/8_P"%"UO;6V]M;>O;
MY@VE9-I-[)NS?IW^1RGV'Q7_ -#%8?\ A+G_ .7E'V'Q7_T,5A_X2Y_^7E=8
M"",CD&EH Y+[#XK_ .ABL/\ PES_ /+RC[#XK_Z&*P_\)<__ "\KK-P]1^=)
MO7.,]3@?6A-/5.Z[K7\KAY=3E/L/BO\ Z&*P_P#"7/\ \O*/L/BO_H8K#_PE
MS_\ +RNMHHVW Y+[#XK_ .ABL/\ PES_ /+RC[#XK_Z&*P_\)<__ "\KK::6
M5< D G) ]0,9/X9&?K0M=M?34#E/L/BO_H8K#_PES_\ +RC[#XK_ .ABL/\
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M?_ TM ')?8?%?_0Q6'_A+G_Y>4?8?%?_ $,5A_X2Y_\ EY76T4 <E]A\5_\
M0Q6'_A+G_P"7E'V'Q7_T,5A_X2Y_^7E=7O7.,\YQ^/I074=6 H34M8M/TU_*
MX+5V6K[+5G*?8?%?_0Q6'_A+G_Y>4?8?%?\ T,5A_P"$N?\ Y>5U@8'H<]Z0
MNB\E@!QSVY( 'U)(&*.MNN]NMN]M[:,3:BKR:BN[:2_&QRGV'Q7_ -#%8?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV9_VO?V>/''[!/[1'P&^&&I_'WQ!X#^+'Q ^'/Q'\-^(?@#I<3WFJ_$WP_\
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MMM15+$!5+@@$,GSKE2#7X&_MM_\ !:+XG?LA^(?B_P")-._X)N_'SQO^S?\
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M?"SQ)XBT".9(?+N_%*Z?/8^"],6.29$F-]XBN+5(XG>-II)5@ \QU2OY;_\
M@B/XX_:Y_8>_;A^"OP-_;8^-'Q#^)G@__@K'^QSIG[3GPBO?B+XD\1>);'P)
M^T3X-U+4/%OB[X0>&)-?U#5;31XX_AUK^I:CJ<-E<6FG7C3?#JSM_M.HW-K:
MIS86^+Q-6A237L*\<'[.-G4GC:F68_.*6$A""E.=>KEF5YACJ=*G"3E0P=>U
MZJC0J5BZD<-A88ERA34WB7S3]V+IX'%8+!X^=VO@PF(S#!X>M)VC"KB::YI)
M5)TO[:!/$V-A+@EAE%9E#*<,I8 A6!.-I(/7C@X0W, #$2*P5E5MGS%6=@J@
MA<D98@9Z#(S@5^+/[3/_  5PU_P+^T?X\_9*_8R_8N^+O[??QV^ _A#3?B/^
MT9HWP_\ B-\-OA-X/^#OA76;:XN=)TB]\9?$2\D3QC\1-4MK::\TKX<>'-(D
MU;4852*QNKC4(Y[&'\_?V^_^"\'Q&O\ _@G=^SK^V'_P3?\ A+J'C/P_^T!\
M=/"?P4\;^*O&_B/P#X=\6_ KQ7)XILM/U/X+:UX!U/5]0F'Q)\>1--I'A[Q5
M;?VGX<\(:9J%KXKU@B.ZTF-KI<M>-*4)1G3Q$L-&E--.-58S&XC+<)*#O[]+
M$YAA<1@J%:*="MBZ3P\*TJDJ2K:33ISG2J>Y4INJJE.32G"5#!QS"O&46[QG
M1P$XXZK!^_#!R6)E!4/WB_JG2Z@D5VBD$JH65FC!<;DFEMW0%007CFAECD49
M:-D(<"HWNK?S%3>K-DK@'G+!64=_]8,%#T88VG)%?C]XE_X*=>+?AG\??^";
M/[,WQF_90\2_#/XN_M^>&OB9J7BC1[GXR>#O&/\ PSIK_P *-+\.7EUH>LZS
MX2T;4?#/Q6DU-/$,)?4?#FNZ!!:1M$[V<MQ=3I;=AX&_X*5:'XT_X*/?M6?\
M$^6^#GBC3+C]E'X#>#/C;JGQ0T76V\6/X[L?&&G>#]2?PAH'PNT/PU+K]EJU
MDWC*"TL%L=9UF\U>XLG@ALK:26T2;)\TVO92]QX;.\1"HM(N'#U-RS>2=EIE
MLW3ABTE>#FE&-9W1S5:\804H2C)^TR2,E%J7[OB'%1PN53NG;ES&3G'"2ORU
M'%\SHJTC]41<0G:!O)&",1N5+-N^7=MVEE",'0$O'E=ZC<NZ"2ZB7)93L8E5
M.UCN8IOVK\OS,<JH )9FP "2*_G \:_\%_[[X)?$_P"#5C^U#_P3[^.W[+O[
M/7[0'Q5LOA;\*/BS\7_C!\!/#WQV:YU349](L_'WCW]A_5?$6G?M _#?X?V0
MB;5O%WB;7[!E\-^'[O2+RX@O-0\0Z#I.IV?AKX[\;W/_  7Q_P""D'@B]\:>
M,KGP1X;_ ."?OP@UK0/!DWBWQ"_A70=7U%]5DU'5M&\-R:A_9>DZQ?(J>=J=
ME9V]^KASYC;RS93E.%*$ZM*3HSRCB+'XNLDN55N'\HI9Q6P,O>O&M7PU2,>2
M2O&->$I6C)(VC:5>IAX./M(X[(,-AX=9T,\SJADL*L6K)PEBIU*,91DU.I"<
M(N\7)?T:274:.T;*<AGZH^TLDB(N#MP6.X-M'S%<.!M)JR+J !$9D#R!C'&#
M\\GE*K2[%ZML# L%!*@<U_'A_P $L?\ @IKXE_8\_P""+'_!./XO_'K0/'_Q
MR\*?&']IGXG? CXN?'#Q#\2]2N]<^$D7BK]H/XB:'X-\;>)9O$VB>(]1\;>&
MK>\MK;0/*D\0:(NC6"6$<-V\<2V%O^[7Q#_X*(:?X/\ ^"C7[.7_  3C\&_"
M;4_B5XH^,_P)\7_M&?$3XD:;XRL-'T7X$?"CPQ>:II/A_P 2:_X>/AS6+OQ(
MGC7Q)I-QX>L NMZ*8-4O='C47$6HB6'MQ%#ZMCHX6$O;QI5ZF6U*M.2G!8NC
ME.3YXZ5K1G3G4RW-Z.*A[2,(5</AYU*<WR^R>%*K4G&7M8\K>#J8FE)M6FL+
MGN<</8ZJGS-?[/FN6K 58WYX8E<O).$HUI?ID;F,-Y85RY5V'[J5MRHJ,Q&%
M*L!YBJ-N=SDQKEPRA5" KN$F4PA812[3N1GW;]NW;M!#/N"(^$)#L%/X3_\
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M@_Q+X<^)G@'P)XZ\6Z6;PZSIFH>-?!NEZ7KD]I:ZC/H6C2RS0:GK-Y(L5O\
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M2JU<3#$RQ=36,9XK%Y6LGQ51PARQC0JY=&G3C2I4U26,C/$JG"O.=:?\R?\
MP4"^$/[<_P 5?C3_ ,$A_P#@I?\ !7]COQKX@\8?LLW/Q.7XY?L9#XE_#C3_
M (M:)HWQ:TSPQIJV6G>+;[7;?X7ZH-(C\-2Q:U<Z9J;@)J=@[B5;.>.V\G^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7*:I_R-/AW_ +!'BG_T
M+0JZNN4U3_D:?#O_ &"/%/\ Z%H5 #=+_P"1O\4_]@SPS_Z.\0UUM<EI?_(W
M^*?^P9X9_P#1WB&NMH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *Y35/^1I\._\ 8(\4_P#H6A5U
M=<IJG_(T^'?^P1XI_P#0M"H ;I?_ "-_BG_L&>&?_1WB&NMKDM+_ .1O\4_]
M@SPS_P"CO$-=;0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M44Q^@^O]#2D[*^^J7WR2_4'L.W+G&Y<GH,C/8?S('XCUI-Z8SO7&,YW#&#P#
MUZ$]Z\,_:*^+NB_ 'X.?$#XU^(M$\1^)=$^&7A;6/%>H^'_"<*77B#6(M/@7
MR-/TRUGD@LYKF[NY+> />W%M:V,;R:E/.D-G(&_.3P/_ ,%#/CA8_LV?%GX_
M?'?]E/PUX03PSX\T/PO\-+WX5_M#Z-\5OA+X\U3Q[\8F^#7A_P /^*_B#?\
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M\,_^CO$-=;0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#)8>%?"6E7.K:SJUR]OI5G%+I]M)>B^UC2;6]\4\!?MZ_L>_%/7/'_A_P?\
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M_@WX*\*_&#Q3\2O#/Q#\;:9\=?A7\;_%WB7QGXOE^%/@"[^'GACQ*_P?\/\
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MI(#1E)%;!$FW<C5&TN)_LN\JYM%=()9$:2YMQ+;FWEDM+MY6N;6>1"R/*DC
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MZDDJC=-TI+W7"2G>^S4DVFFD]4SZ"$XS5XOF6W,K6OV]?E;<DHHHK0H****
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M?5<+PY@<QH0<76MS0Q56<N=*+=/EHN/LH1BOHFBBBO[_ #_/$*0G&.,Y./\
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M#2">^!W'K^-!4$ <\4ZBB48S5I*Z[?\ #6 3'.?;%+115;:=@"BBB@ HHHH
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M_BG_ +!GAG_T=XAKK:Y+2_\ D;_%/_8,\,_^CO$-=;0 4444 %%%% !1110
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M&GP[_P!@CQ3_ .A:%0 W2_\ D;_%/_8,\,_^CO$-=;7):7_R-_BG_L&>&?\
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MSQ'%X>\9:+K$6JZ7H,?A#P^]AY=PU]9"66)V^1_CO^T-\3_B7\5KK]I#XB?
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M42VUGX;Z/INH3ZSI]K<:M]G;]8_V&/B#\.OCS^UY_P %"_VA/@1XJ\.?$O\
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M"3P9^R;\1= ^%.@I\2OB])XR\%ZCH]\][X-^T/V0= ^+?Q+_ &B_V,O$NK?
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M*?\ P#\$?_,A0!U'F1_\]$_[Z7_&CS(_^>B?]]+_ (UR_P#PCVJ_]#MXI_\
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MSAEZ?\+$\(D\<Y.!G'H#P<5_$:I!5$!W20Q0K(@^=HW:-9%#J-Q1F1U=<XW
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M)QG#$04Z,XR4HUH\JDY4Y*ZE&UW=.UO1G7^9'_ST3_OI?\:/,C_YZ)_WTO\
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M*M.,'&,\)2FN9-J4'*LHSBGK'F:E'WE%W@U963?[L6A+/*S 9Q&BOL(+(FX
M-(?]:"YDD1@,!)!CDFL+5/\ D:?#O_8(\4_^A:%6_:!!NV[@VQ 5).%4-( J
M*0 $')! .<XR0!6!JG_(T^'?^P1XI_\ 0M"HA_R\_P"OU;_TY+^NW;0(_!#_
M *]T_P#TB(W2_P#D;_%/_8,\,_\ H[Q#76UR6E_\C?XI_P"P9X9_]'>(:ZVK
M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0W"AH)U*A@
MT,BE6) 8%&!4D D @X) ) Y /2IJCF ,,H/0QR ]N"I'7G'Y&HJM1IU)-V4:
M=23?91IS;>SV2;V>VSV=1^*/^*/_ *5$_G'_ ."\6E_&ZX\%^%+K0=+_ &B_
M%'P2L/A[X]$]I^S9H7Q7\2>(-)_:7MO&OPZU/X0Z_P#%#1/@O'/XSOO &G^"
M[?QY:Z7>3:5JF@:;XP.B-XH,HN+6<?<7_!+_ %'XCZ_X8_:7\6:SH?QR\-_
MKQU^TWX@\4?LE>&OVB?#_C3PC\5-'^#.H?"OX4?\)7?W?A/XCV>G^._"/@;Q
M+\?8?C+K_P +O"WBO3M-UFW\(ZG9W4.EQ>'[S3Y+;Y__ ."GWB;6G^//[*/@
M[XC^'/V]_$/[)7BKP;\79?B]H7["OPD_:4\7>)X/B#I<WA1_AW+\6/&'[-OA
MS6?&GA_P64N-?LK+PUH>NVNL:WKKVFI_9]2\/Z9?WEO0_P""5W[56I:EXP^-
M7[/_ (E\"_\ !1:+PC??'_Q-=_LG:[^U[^R-^U)X<U'0_P!GF#X/> M92S^)
MO[0GCOX7:;X-LM-U/XM6'QD/PBMOB#XQ_P"$YN/#%_X3\,ZE<W7B#4K+2+>L
M$U.AF\$TO]NS"+<U9J^,RJE)TKW3:G1FKQLHI3:DU--YXN$N?*))0DUA\"_W
M4E?W</G4DJJ37[RVD[MN2Y/=5E?\X/\ @JG^SA\+_P!G;XL^-/C'\7]1_9 U
MNY^-EU\5/C!HO@_PO_P2H_:;_:?^-.F_#3X=-X=G^)?Q2^)^L?#S]N;P#X3'
MA3X?V'BO0+3Q]\0/$/A;P;X9,^NZ3!!HDFHWEC'!^IW_  0^NO"DOP4^.&E>
M%/"6E^"V\/?&F?1O$.@6'[%_C_\ 83NK'7X_"VB7=S;ZU\'OBE\>OCWX^N-2
M2UO+24:_K.H^%;>XM+BUM=/T*:&U;4)^@_X*:>%?@?>>._@GXN^*O@K]M;Q?
M=:G\+?VH/@-XCM/V1?V5_C%^TOIGBWX"_'/PQX*TGXF_#;XMGX3^!O&Z^ !?
M>,?#WPN^(/@+7W?2?%$FM_#BZM-*:721XCA=/^"-EEX'G\"_M!>*M ^('[3/
MQ.\;ZU\4= \,_%'Q1^T_^SAKO[+WC*RUWX8_#[PYX&\/^#XOAMK6B:',E]X7
M\):=H]KXFU::V_M#4]<GFO+W!GC"Z9=43PF949)RE"7)3GOK0Q%*-:Z^RH\\
M8N3^*4DH<RNU./=ZV6U*;YHS:=5ZI156C6=&W-;FY^23M%7BE[\8-I2_9B.,
M1@JOW/X5Q]WUY[Y///2GT45!H%%%% !1130P/0&@5_Q]3-CL9TV9DB?RX3!&
M=FTB)F@9X\!3&&=HY"9HXHOE^SQO%(;<RRVHXIED5BX*@8;!RSY5E^;>C'";
M491&\8W22Y&T!7L%L=C_ )_SZ4TR8Q\IY&>H'<^N/8_B*CVD+.5](OE;L]'O
M;;_@#6LN5;VO;R3MOMOYW)**:&R<8(X!Y]\<?AG'X4ZK[>:3^3$FG>W1M/U6
M_P#6P4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH R;VQ@OQ-;7D<%S:3JT5S:7$8EBN(60AH94(V/$X;#1RK-&RD[H\
MX(\]UGX-?#;7?#.L>$=7\#>%KW0?$.GOI^NZ?'H^GZ;%JUN\8B(N3IEK;,DQ
M4;EN[8PR6[A7MTCPJCU)XV))0JI)SG;D_P QSQZT@C?&'<'W (QWZ9/YYS7'
M7R_ XJ:JXG!8+$2BE%.K0ISFTG?5RIV>MWJ]6W>[LR)4H3BY5:>&JRU48SHQ
M=XIW2DY0?J];<VK3>I^$EC>_$+_@F!\7ET35Y-7\;?LE_$OQ#->6&IJ@EN/"
M-_>E?M4A@D,4&E^+--54?46CNI;/XCZ8?MUO_9>HZ?;Z59_MKX;\3Z'XLT;2
M/$7AS5K37="UZ.VOM'U?3&^TV-_9W$1N([A)X@R)'M4HYE,9CN +60+<LL1Y
MSXC?##PO\5/!NM>!?'.GVVM>'=?LY+6\MI8%,T4O[TP:A82L6-IJEN[1R07,
M6TP/&ODB-6*U^.WP^\<^.?\ @FM\7K;X3?%"^U#Q+^S'XZUB67PAXYGCGDMO
M#EU)-YM]/"T"W*V]]HEH9+GQ;X9CBCC_ +,MI/$&DM-)YL+_ )G&IB_#_,JE
M+%UGB_#W-*])99&2J3Q/"^:5:T/:X?$UF[0X/:Y)X!QC4Q&#Q,I+%QI8-5*U
M+Y.FZW#6*JTJ]6MB<HS.O&>&Q2BYQR.3E3A'".*C.JZ->I-0A.$/9TW4O.=.
M*DW^[-%8NG:[I^L66GZGI5Q;:EIFJV\5YINI65W!<65[9SQ>?;3V\\;,)EN(
M#YT/EAU:-9&W#9@ZJR;FV[?7G<#C'J,=Z_4Z=:E5C3G3FI0JQYZ<E?EE!VY)
MJ6W+534J,F[5XM2HNI%IOZY-.,9IIQE;E<6I)WV?N\UEYO3S):***U&%%%%
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M6UK]G']N_P 2_LO>'?BO\=_B!\&=;_9'\._&J*T^/OQ]^*_[0WBG0?B/X?\
MB;?> -=U_2/'GQH\2^-?'NCV7B_0;BWGU?PU;^-4\'6NIV46I>%?"?AZ;[8\
MGR%XL\7?%F[N_C_^V!_PN;XYZ?\ $SX/_P#!3K1?V>_!_@#0OC?\2K#X&P_
M#1_%'PB^%\GPNUG]G1-;C^!6NWGCC3?%_B/Q_>_$'Q)\,M?^*UKK?B.SFTCX
MAVVFZ+X9CTWGJSE2492C*,7AJ.*=XOF]EB,VCDM).-[JH\9.,Y4W[T,'.&+;
M]G)4WSRQ5&G5]A-5/:2J3I1<8-TU.E@Z>/G>:DHI?5ZL%%M-2K<U%+GBY/\
MH6.H(S*T>R>-Q\IB;?C;_K'.PMF/:\ 0QAB))5$OE@C$\=VKR)%)&%9@6V<&
M2$'<8UGB4NT1D1'8.V(25"*[.RJ?Y>K?XO?'#X<? /\ 9 _;M\/?&[XYZQ\7
M/VF_&O[0ND_&?X?^,_C+\2?&/P6U+3KW]G[]I#XC^"]"\'?!+Q9K>K?"KX.G
MX,:]\+O"-YH=Y\)_!7@76M<L-*U#1_'=WXHO]:U#6+7ZM_8YNO'OPG_:-_8E
MT&+XR?'CXH:#^U]_P3Y^+/QV^,.E_&SXX?%#XTZ;_P +J^'6J?LN:QI?Q&\"
M:;\4?$OBM?A':ZY:?'7QWX:N_ WPMD\%?#3^S;#2$M/!=O<Z7:W V=./MIT.
M5ODJX[#SM'1U\OP%?,\0XNZ3@L)AZCI3?*JM7EHPC>49BK5'AJ4:M1W=7WJ7
M):<E'^T\)E+C)*SC)8W&T7R^]_L_M,0YJ-.5)_O-D;L?Q;<_AD=?Q_K2U1MI
M9)'4N%'R,/E! X88ZLWXU>K.+;YK])67IRPDOPFO1W737>+4H1G&]IQYM59W
MYIP=UTUIOY6?5!1115#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** *YC8Q@=PQ['H>_P#D'^M>0?&+X+>"/C?\/M=^
M'GC[3YM1TG6+>,Q7D$B0ZMI&IVC/-IVNZ/>B-GL=9L)VW0W<* O#OM9EDMI9
MHI/92N0 2W'?(S_+^E1M&-C#>X!5AG< 1D8.#C@^X_PKCQ6$PV+PE7 8W!T,
M=@:U*I2KT,0HSIU:-6G4IU:<Z<HN\9TJM2#2:;C-I-.S6=:E2KT9X>M",Z4H
MRBW))N*G%Q<DGU2?,M4[QC9II-?AY\%OBOX^_P""?_Q1'[/7Q[O)[[X%:U=7
M]]\-_B/+#)]BT:&>Z+W,YD22X:#P]&TL;ZYI4NT^%Y,W=@]SI2WCQ?MCIVH0
MZB+:YLWMYK.YM?M<-Q!<0W$5Q;3G=8W%O)"SI+;WEN1=P3HWER1.NTL1FO&_
MC[^S[X!_:)\ :G\/_'5M-);SC[=HFKVXA;4O#>OPP20:?KFF&6)XFFLXYYX)
M["5?[/U:QN+O3M3@N(+@E/S%_9O^._Q!_8W^)=M^RS^TQJ;2^!)WCMOA)\2+
MV*2/1TMIY_L]K8Q:LTX:X\/W9*[$OHI9?#NJ2_V<&@L"B0?F>!JXSPZQ]/)\
MUQ]?->$,VQO-D&98RU3%<*^U?NY'F,I24\7E5.3C'+<S=2,<KIQIT:U*JI1:
M^:P]2KP_B(X;%3G4RS%5%2PN)=ZBH2G>WUIW2HTE;2K)R47*TEU7[;45G6]V
M]P RM$R-&CJZ*^&#$E65BQ5@Z%2R@GRB0 TP;<MR-F8L&*G&W& 0><YSR1V&
M,>^:_5%5B_96C-NJE))13<(2C*4*E5*;Y*<TDH3]Y2E."LN:\?J(-5(<\&G#
M=26TEIK%]5KOH2T445H,**** "J<G3_@+_\ H-7*IR=/^ O_ .@UAB/X-3_K
MU7_]1Z@1^-_]>JA_#=_P4Y_Y/[_:>_['7PO_ .JN\"U\*5]U_P#!3G_D_O\
M:>_['7PO_P"JN\"U\*5_K7P;_P D?P?_ -D=PI_ZH\,?Q1Q+_P E)GO_ &,:
MWZA4;]1_NM_Z$E25&_4?[K?^A)7U,/X:_P"P_#?^HF(/$?QT/^PO#?\ IR)_
M>E^P/_R9?^S'_P!D9\$?^FF*OKJOD7]@?_DR_P#9C_[(SX(_]-,5?75?Y&<2
M?\E'Q#_V/<Y_]6F./[DRS_D6X#_L"PO_ *CT0HHHKQ3N"BBB@ HHHH ***:Q
M(P1[Y_(G^E ?HF_NU'451N+B:,IL52I60N2DC;=H7:05R"Q8C]V<%D\QU;,6
MUF+<W'[XLBJJ%54E'7.?XSR6\LEE_A!6,&1CDE4;35K]6H^EW:[[16[?1:D\
MRY:<NE2,Y1[VA'F=UT;6D5=N3:2LV:-%9:WD^V1F1"PPR1J$PR@C<%F-P(V\
MQ2?*;Y3\K$HQ4K33?3J'#(C2H\BE4! ;9C9R[*L8D! #2,H\P.BAE4.9OI4E
M9I4E>5U;^;2/\S7*KI;>TI?\_(E+64(*W-45XJ]NB=GVDD]G_+/7W6:U5B0H
M+'@*"2>!@ 9/)P!^)Q50WDY"[$C8M%N7=\H:8_*(B%=G!W?,2BR%4SP3@50;
M4ILLH6(%48N=KOL;S(T,9"R89HP_[SYE;[I*)NVF6[Z6::HK%NZM:E"2YD]?
MXB4E^[M=J[YM!*:7?WL13P<=+WK5ING3M_T[<DTZFRL_=;5CX%_X*G6,VM_\
M$YOVOM,M?!?BOXD-KOP+\6Z//X+\"2:A_P )OXGTC51%8ZOI'@V;1/#7C34)
MO%;Z5<7L_AF&U\,:W)-K*V=NMG(DLI'Q3^P?XE^"5_\ '?P/H/@G]L#_ (+
M_%C5U\'ZW!IGP\_;(^$?Q.\*_">YTVQT>W0WOBGQ3XY_9*^&*WOBS0;6:*/3
M;Z^^(4FM:CJ!E>]GUCS#YGZJ?M1:5X6U?]G_ .+&F>./!'Q7^)GA*X\&:R?$
M7P_^".M^/M&^+?C#3"]FU[H'P\U?X=^*O!GCRU\0WT+F#3H?#'BW0;S[48XK
M:1C@#\4/V1?@MX;L/VYO@+XU_9B_8^_X*+_ CP!X9\-?&2Z_:%\5_MK?&?\
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M:U@T?_A#-1\/S>&(/#RCP^FCII6ZSJ7PQ_P31_8W\(WGC&9?A]XH\6:5XO\
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M ,C?XI_[!GAG_P!'>(:ZVF(**** "BBB@ HHHH **** "BBB@ HHHH ****
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M&?\ T=XAKK:Y+2_^1O\ %/\ V#/#/_H[Q#76U0!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %(6 QUY]*6HI"05P2.&Z8R?
MN\5,I*$7)IM*VBWU:2_%H+.6D6DWU:NEWTTZ$H.1GUI"P!QSTS_/_"J\MP(\
M AG8*&=8QN< LJ;E7(+ .PW$<*.6X!!SI]7L;>XLK>6>WCN]2FGM]-M9+NW2
M;49K>&6Z:.QC>02W<@L(IK^1;9)C;VEM<3R[8[>1@)^\H[RE%SC3T4N6*3D]
M;Z)/5M)>8DU9MM**?)SZ<KF[J*7=MK9?(UC(H!.#QUP.>WO[T+*K $!N<]1Z
M?CC]<5F+?>8(&B@GEAN%D?SEB;R8Q&60K,'5'B<L.4ECC"!7W,&41M96X 4L
MT,RXB,F3&[*QW8$0V!R7)*X50VX$",R#< U)2;BHR4EKKKY6Z=?4A2DTHV]]
M.[=O=<-5HN][=7Z%QG"]<GZ#/IU_.G5FR7@0GS8)HAP5+A2'3<BL0%9CO7+-
MY8!9E4;-SNJF9;E\2%H)CL+E=J,3(BKN4H2JH6<!L+O^5@$8AG0$:DN7WM[Z
M.*UM;;7IUM?=7L:76RW6Y;+ =<_7M2]:I)=R-&TC6TT>',:JP.YV7Y7/(4)&
ML@=5E.8YD"R0LZ21ED6[F,HC>UDC5G*I)]]3MB1W9_E7RT64O I)S*RI)$&C
M?<J3<VXI.,DKJZ337?=>F^_<4FH1YW\-[?/^F7LC..^,_A13 V6"]BF[/3OC
MI3Z::=[=&T_5;C_577H]@HHHI@%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %121A@WRABP .3
MC(&>_;K[_3O4M%3.$:D7"<5.$DXSA)*4)Q::<)Q::E%IZKK9 G;5:,I?9WQP
MB YR &XY4*0<J=P./;K[9/Y/?MD?LI^*]#\6Q_M7_LU?\4U\5/#$\NK>-="T
M5EB?QE8VI)O=5TJW"F ZR;2:XT_Q!:2P/#KVE2W*1QQZE*\MY^MU9<BEQ(%&
M2)IAA_NYW@^9QU" <(?E8G+YKYSB3A_+N(,!1RO$5)8.O%SGD^+PCCA\7E6+
MHTE+Z[E^)5.<L+.A2C'V\8^[B<-S867+&:E#AS++Z>:8>5&2Y,0GS8?%1LJE
M"I:RG[2SE967NW2>J?2WR-^R5^U;X6_:;\ '5+-8]&\;:$;2S\:^$FF5KC2K
MJYWPV>IV<6^6Z.@:G+:W26MT\2"VGM[RTNMDEA=.GU\SA@?E<?(Q^967AACJ
M1C(ZL/O #..F?Q__ &M?V9_&GP8\>Q_M@_LO1G3/$WAZ66_^(W@G3+9Q;:[I
M%TD::U+;:;:*B7VC:P8;>?Q!H>T;)K6WU;3@NH:=IL^E?;O[+W[2_@_]IWP!
M%XM\-7,-EK=A(EEXN\)O>K/>:!J$I_=2+YFR2?2M20&;2[]46"YA(X2=70?/
M9#Q%CUCZW"'$TXT^),'@L5/+<1)0I8?C'+:%"I"GF>$G%RIX/$2?)#%4.>=1
MSDZB@O?2\S*,PK4<7_8.93_VRC0J2HXMQY:6)I*_---M*<U>'-&\>7?K)1_D
M3_X*<'_C/K]IXX(_XK7PP>< \?"[P,.F>^./4<\9KX5K[L_X*< ']OK]IO;N
M.?&7AMU)4A6C@^&G@6VD82'Y6(D ^4?-SZ@U\)U_M/P3*53@G@FI4I2P]:IP
M7PJZV%G)3J8>:R:A%1G.-E+VD%&M%I)*$XI75F_Y*XFE'_6;B"$4[TLSK0E.
M[Y:KU?/!65HV:5DWK?6X5&_4?[K?^A)4E1OU'^ZW_H25]9#^&O\ L/PW_J)B
M#PW\=#_L+PW_ *<B?WI?L#_\F7_LQ_\ 9&?!'_IIBKZZKY%_8'_Y,O\ V8_^
MR,^"/_33%7UU7^1G$G_)1\0_]CW.?_5ICC^Y,L_Y%N _[ L+_P"H]$****\4
M[@HHHH **** "BBB@ J-@Y?(QMVXZ\YR?TQC\>U,EG$3QH5),F[N!C:  !GA
MG9V1%0'<=Q8 JK$21R+(NY2",XR"""1UVL.& /&1QD&CMUL[Z^0=&NZ:\]=+
MKL^S$P^5QC !ZD\DY]NP^G6JHAG\PL=I7S"P&[^ QJN,;<9SGOZ'VJ]11'W7
M)[\SNU+5+1JT5I9:WMKJEV)E!2CRMR2M%73L_<G"HG>V[E!)OK%R76ZS1;W"
MJ%'EX"R9PQY9ON_PC@# )Z^QI3:RG!.P\,#\Y&<B#!R!D<QMZ$<?AHT45;5H
MN$DDI1J1;@N5VJ1Y):ZZ\NSZ/N)P3E.3<FYUXXAW>BG!P:4=-(7II\NN\M5?
M3\L/VL_^"9?PT_;0_:U^!_Q=^/GA[1_'/P9^$_P'^,G@)_!:>+/B#X*\4/\
M$;Q_XW^%FN^'?%-CKOP^U[PQJ+Z;I7A_PAXHT>\L[C6!%(^OJ[6=SC=%Z-\
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M/#<FM>/-5T^*7PGJP@BT3QA/;6U_;R>'M7O+.5";Q%;\U?\ @G3XK_9/U?\
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M#'[)W[6?A/0/@+XT\)_![]ESPI\9OV;/C-XX^(-KX8US]LOXY_%K2/VE-/\
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M5/\ D:?#O_8(\4_^A:%1W\VV_5N[_$!NE_\ (W^*?^P9X9_]'>(:ZVN2TO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW-EXLLO"RZ7<B<>?7O\ P5I^(GPQ^'UI\<?C]^SUX6\,_!OXD_L??M$_MA_
M/4?AK\8-:\=^-O$WA7]G_P *^%/'G_" ?$WPOXB^&?@G2/ WC7Q]X2\;:/J7
MANY\.>(O&NBPWB7&C:GJ4-PD"S4=:_X)L_%[6]3OOA1<:K\)V^&NN?M577[5
MFM?MAV_C'Q5:_MHW5KJ?Q$O/&UQ\!/\ A HOA,?"-QX?UG0]_P &[CXG7'[1
MFF0M\+[J^T%/@A)+:HU[PWB'_@F'^U+\>/A)H'[./QP\4_ #X>_"[X&?L/\
M[2W[)/P2\?\ PK\7_$7XC_$'XAZ]\</"'A+X;>"?BO\ %+P+XN^%/PN\-?#&
MT^'OA7P/IFIWW@3POXQ^*U]XC\7WUQ<V7CGP[8Z;%;ZCU..!TO.HJ:JPCF3B
MZWM896],;5P2DHUJF94Z'/++XXZG0OBHPI4?:X+EKO2\.>.B=Z<G12:4)8J*
M7U2%=TI3I4\%5Q7+#'SP4Z[6#E.IB'0QR5$_0SX"_M/?'#Q!\;O%/[.'[2OP
MG^'?PL^,&E_"/0OCAH$?PC^+6O\ Q9\"ZWX'U?7KKP==:5>:UXK^'/POUNR\
M8^&?$D"PZO;Z?X>N]!O+>]LYM.UW49@88_$==_X*%?%+2_B)XY\2V7P2\'W?
M[)'PR_:NT']C_P 8?$RZ^,.N6GQFF\=7L_@[0M>\?>'_ (5?\*\N/!=W\+_"
MOC3QM9>$KV6\^*EIX[U>_P!#\17]CX46Q327U*EIG@3]MWPQ\4?''[:/Q:^"
M_P"S[XE^,.G?!_X5?LU^!/@#^S_\;_BSXK\/^(-&USXPZ-JOQ*^*GB#XI^,_
MV9_!>N^''L1K4NL:+X"TKX3^)M*T71O"^I2Z[\5&;4'U+0.8\2?L2_M,R^+_
M (E_"+0;CX#3?LI?%[]M7PK^U]XD^(6L^.?B0OQX\*Z?%+\/O&GC3X+Z'\%K
M/X0ZMX*\2C7/B9X)U+5] ^*5S^T7X;C\.>%_%Z:++\++^3PEO\49V7M%+#*@
MZ3P-%?O)U%168+,L''%0>LYK"?V Y8B-57;SY^PO[-U(QX:_UI<]N5X?VC3?
M,_;?5G3ISA-R7*E56<.="G&,DY9=#"N:O.<7'HG_  5!^(=A9_"?XR_$3X'>
M%]%_90_:!USXT^'/@I\0/"_Q?UCQ1\6!>_"WX>?%;XH>&K[XM_#?4OAOX8\(
M^%]+^)_ACX.>+8/#K>$?B1XTN;#6]1\+Z5K1LI[V=(/:OV8OVY/BW\3OBK\*
M/AK\<_@MX%^%J_M'_LX^)?VH_@)JGP\^+^O_ !/^W> ?"FH_#6U\0^%OB9:>
M)/A=\.'\)_$;3;#XN^!M56P\+7?C/PM-;7&MPQ^('GTRW-Q\J:5_P3E_:-\1
M>%?@7^RIX_U7X$:#^RC^S1XC^-OB7P3\3_"?B?XC^+OCK\79/''P]^+WPT^%
M'AOQQ\)O$'PJ\%>!_A/8?#JU^-6K^*O%WC'1/CS\6IOB%K_P[\/6%AX7\-67
MCK4U\->[_LL?LE_M/:#\:?@%\0?VDE^ NB:/^R5^REXX_99^%Z_!/Q]\1?B%
MJGQ8N/'NI_!]?$/Q:^(,7CCX.?"6Q^%<\7AWX&^%;73?A=X>U3XOQ1:MXG\1
M7;?$"2VTBW&I5^Z<$XMW^LYG&FYZ5W@H9?BWEE2I"ZI_7:N;_5H9K#X*,G".
M&3I<T3IQ;J*=;V*IM<]1UO>=HU_[7RV-1)Z-6R=XZ481M%22<E";N?K?!,LP
MRI) !ZDG."!ZG\^^:L55MH5A! )/7]2#D^I/U['KFK580M[UOYM>JORPYDM]
M.;F\M[:%4^9TX.?QV?-Z\]2W_DGL_O84445984444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !5.3I_P !?_T&KE4WY''/ROTY_AK'$?PJG_7JO_ZCU C\;_Z]5#^&
M[_@IS_R?W^T]_P!CKX8_]5=X%KX4  S@8R"#CC(/4'V/<5]U_P#!3G_D_O\
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M?^*UOVC?_ILE(?AK_P %2@"?^&R/V S@$X'_  36_:-)..<#_C;)U]* /O\
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M4_-*T7P@_:1DCBB)*^;YJ_&PJ5$AC#>8L*)'Y\S2!+:3,31_\%355F_X3O\
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MPZQ>Z5I^GV%U>(US:Z=803QVL5?*SZ^O5E=EV22]%L?O'17Y[_V1_P %5_\
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M?Q1_9'_!5?\ Z*)_P3Y_\,O^TA_\_B@#]"**_/?^R/\ @JO_ -%$_P""?/\
MX9?]I#_Y_%(=+_X*JH5+_$/_ ()\["V"1\&?VD 1Z ?\7U<9)(QN*CKUQ2;2
M3=_A5W^?Y>@'Z#_Q_P# ?ZU\;?MU_$[]F#X/_LY?$+XC?MC6GA[5/@#X-G\
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MX]7^(%_X[A^'\EYI=[9:CJ]GPYXS_9)E\!_L&_LB_'SQ9\'?@C^WA9_LZ_\
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M&7_:0_\ G\?2M&K-Q>ZU?]?\#_@Y)J2NO/\  _0BBOSW_LC_ (*K_P#11/\
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M(_X*K_\ 11/^"?/_ (9?]I#_ .?Q2&?H))_!_P!=%_K7Y[? _P#Y21_MW_\
M9MW_  3\_P#3U^V=2R:5_P %55V;OB#_ ,$^WS(H4+\&/VDQ@C+%F,?QSFV@
M(KA2ZJAD*(7#,H;RS]BZ#XV6_P"WA^WA'^T%J_PGUGXB?\*+_809+GX,^&?&
MOA3P@/"QU/\ :^&C+<Z5X^\5>+M>7Q +]=<2_E34TT][!-)\BVCNQ?/( ?JO
M/"TIC*2>4R'(<*&90Q4.5SP&:/>@+;E&[<58@"J5II4-BSFT$5NKR74S10V\
M,41N+Z>6\OKEEC52]S>WL@N;N=RTMU,'FG>2>:65]6B@"OY#DDF5F/&%.0H
MC9 IV%&D7<[/B1G.X@YW(A6)[/S,B25W4+M0;Y$(+*R.S%) N\(P$3(J-&P+
MY9FR+M%%VM4FWY-+\P*3698+NE:3:X=?-!?8?.DE9D(96#G=&J[F:.)8E6.-
M4+*;@&  >P I:*2E)Z--+=7:?Y; %%%%, HHHH *Y35/^1I\._\ 8(\4_P#H
M6A5U=<IJG_(T^'?^P1XI_P#0M"H ;I?_ "-_BG_L&>&?_1WB&NIF4/%(A) 9
M2"1M)QW&&#*<],%2.>AKEM+_ .1O\4_]@SPS_P"CO$-=/<';!*W/$;'Y=N0
M.2-V%&.N6^48R>*$U%IM\J6KE_*EJY?*U_D3.[C)*/,W&5H_S.SM'_MY^[\S
M\^?B(I7_ (*C?L<B/("_L#?\%+-JDDC8O[2'_!)OY!G.U64%,* %R2H';^97
MXL^(/^"CT'Q<^*T/AKQ'^W_'H$'Q2^)EOX>A\.ZG^TQ!HG]@IXWUJ;25TA=
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MJWQ>^+6F^&/@/KFM_LT?%OXQ?&K3O"GQ5_9\\/2Z'\.K?PSX)NY/"$FM0?\
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M_P!!O+C_ .>:?]\K_A1Y<?\ SS3_ +Y7_"OSY_X:Q_:Z[?\ !+K]I YP,_\
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M](M_VD/_  __ .PI_P#1/4 ?H+Y<?_/-/^^5_P */+C_ .>:?]\K_A7Y]?\
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M>:-XS\-6OBWXB6FCVOB/6/L_QU^RC^SM\5M6\;^)/'7PG\->)?$'Q)\#:/\
M#;QQ?WO]M6=QKGA3PUJ4NM>%=-NH;>_TK[+?>&-7GFU3PYKUM'8^*=$$C/HV
ML6_F;Y-71_V9/@5X<^#5U^SKI/PN\-V_P7U*QO+76O!$XU6YT[6TU>]:_P!:
MOO$6I7L]YK7B;6M<U2274=:UC7==OM?U:]D>^U;4+J>1I*XJM!2P-7"TI<E6
M>#RS#TZ\ES>SKX.GET,77=FIRABWA,1*%/1TI8B,ISFX5.;HQ$H5:TZM*'L>
M=)2BN6UX4H4J;2A%)<L8)RT=[V75O\THOVV?VP-,\97W[.'B<_LX2_'KQS\;
M/V>OA]\*?B]HGPU^*]C\$/"'A/X]? GXK?'IM4^(7PIG^-&H^.O'&M>!8/@;
MX^\":0=&^+_PLTOXM>(M6\)W%W!\+;+^UK.#P?4_^"G?[;NMWG[0VG^"?"_[
M+6GM^QG^R_\ %/XY?&/4-:\*?%3Q5IOQT\6? 7XP?%?X>^+O#/P9O= ^,&@:
M?\-/!_Q5\/?#:74?"WB_Q3JGQ9OOA'XCEN--U_P_\5$M+V;2?V6\>_LJ_L[?
M$[2?'.D^-_A%H&N6OQ+M? ]MXNE<:UI^HZI_PJB"ZM_AS=P:Y87>DZQX=U'P
M9%?7R>'M4T;5-"U&U6]O#:7TAN97;#TS]CG]F/2- \2^'='^"?@VVT+QC\&I
M/V=O%EA;V-Q#;>(/@K/?^*M4U?X>ZT;F[-S>Z5J.L>,?%NJ:Q=:I.NMZA<>)
MM3N9M7OKEECDZJ3IPI2C.FI5)8O'8ASBE"/LL3B*=7#T5&\FOJU&$J3EM-R4
MDDH^]--QC"HIISE)KDELH)7O?K)M/]?(['X6_M >$_BIXR\3^ =*\,_&?3-=
M\%:7HVKZ[JOCC]G_ .-OP]^'-\VL107<%OX"^+GC?X;^&/A7\4VLFN(XIY/A
MGXQ\6BV2%I;S:BM<R^!_\$GE4_\ !+/_ ()IL54M_P ._P#]C<;B!G'_  SK
M\.3C/7&><=,U]Q:79QV LK2W1(+2VL(+.SMX"ZVJ6MI$D,+0@F9&41I''$AG
M,T-O'&TK2O*SCX>_X)._\HLO^":?_9@'[&__ *SK\.:4FF[I6_IF<8\J:O>[
M;U\[:?@??V!Z#\A1@>@_(4M%24)@>@_(48'H/R%+10 F!Z#\A1@>@_(4M% "
M8'H/R%&!Z#\A2T4 )@>@_(48'H/R%+10 F!Z#\A1@>@_(4M% "8'H/R%&!Z#
M\A2T4 )@>@_(48'H/R%+10!^>M['&O\ P55\,A44#_AWQXT7   VQ?M(?#XQ
M@ < (78J .,FOT)P/0?D*_/F_P#^4JWAG_M'UXW_ /6C_AY7Z#T )@>@_(48
M'H/R%+10 F!Z#\A1@>@_(4M% "8'H/R%&!Z#\A2T4 )@>@_(48'H/R%+10 F
M!Z#\A1@>@_(4M% "8'H/R%&!Z#\A2T4 )@>@_(48'H/R%+10 F!Z#\A7Y]_\
M%8P!_P $M_\ @I5C_I'_ /MD_AG]G3XDYQZ9VC.,9P,YK]!:_/O_ (*Q_P#*
M+?\ X*5?]H__ -LC_P!9T^)5 'W_  HBPQ*JJ%6*-5  P%50 ![   >U28'H
M/R%-C_U<?^XO_H(I] "8'H/R%&!Z#\A2T4 )@>@_(5#<2)!"\TCI%%&-\TKF
M-4BB7F25WE=(T2-069V)"*"Q5@,5)*<(Q'M^I%?)W[<NEZ+KG[)/QWT?Q./B
M4/#=_P"!+RV\03?"'1K;Q%\0;+16NK1]3U+0M O-3T>+6HM-LDFOM;TM;^.>
M]T"WU2WMHKF=TMI8J3=.'.HN6MK)V^=VFDO4TIP52I3IN7(JDU#FLY<MVKOE
M33E:]^5--VLG<^B=(\0:1K]B-4T36]+US3 UY&^HZ+J]IJ6GJ]M@30Q:A8F*
MQ>:#83.TT@^PRAH9&_?+5:7QAX6MI-!@N?%6AP7'BN7[+X9AN-;T.&7Q%*R[
M@=%B-_&VL2*A65DT9I':-QMC$H('\K?[)/C3Q7JO[ OQ?^%G['_[/,_Q-^&_
MB3XGVOAGXL?M#?L%7WPA^'&C^)?A-JOPMU'6O&&M>#+3X^?&_P""7PXN?CAI
MB:+X;^"/Q9U/X7>*;B/P7=^+[KQC#H$_CWP=>^#KG)\8^)_@9?\ _!,#]C8Z
MKH'@CX>?MC6'[+/PFUGX/?#_ .+_ (3EE_:D^-O@;X<:HVN6_P %O^"?7C?P
M[XJ\4>'K#]J3XLZ_HNDZ%X1N?AY<_$CXE^'Y/&/AG5OB3\,+ ZMH0L24I*&+
MFJ;;P]/#SA%2C>NZ].4W&.O[OV3BH2<UJY)J*BFR:J]ES6?.XU<=3LDXW^I4
MZ-3GN[I1K>VY8Z^XX-R<KI']8$7BC0)]=N/#,7B70Y/$=I8B^O\ 0X=2TUM:
MLK-SMBO)-%DOGU.TAE)0I/=V4UNW(69=V#;OM0ATX0M>WL5H]Y/#8VT=U<06
MZ7%Y<A([6S@N)Y8+9;^^D $$<:S;F2=+.W:9Y,_SE?!S6_@X_P"V5X/TJUN/
MA=IG[>.D?M]?M6^,_P!H;1+"\\+I\?O#O[+&IZ'XRUSPG?\ Q&-M<VFOV_P:
MMO!/B'X/P^'M5U2]UWP!_:NRV\#ZYKLT5Q>22_\ !1+XG_%KXE?M$?L,^-O#
MWP>^-'Q#_94\,?M5_L8^*_V??C)\%_B3^RKXD^ _QZ\1?$^[76M5\<O=WG[3
M'ASQ_J&G:3X;U>T\,_"]-2\ VW@S5;O_ (2[QK;^*;W2;[P?*_90P_ML;@L(
MZBIQQF/J8)UY1;C0A# 5L:L3.FFISISG2^K0A!\\JDN9.485(PFG[\L5&5XO
M#.HKVE)5'3P^*Q#L[)036%<;RO;VD9.+BFC^B.'Q/H5UJNI>'H/$F@3^(-%M
MK6\US0[35K*ZU31K"Y#&UN]3TN&]35M-@O'W1V]U=1O#<+&9-JAF2*;0O$>A
M^)K:6_\ #VOZ7KUG;W\]C-<Z#J>DZQ:O=VV%N;-KBPN[N**>T)8W%OFTNU9<
M&!6PK_ST?%SQU^Q1X7_;HTSQAHWB/X$VWPZ\+^%OVL_#W[?'@;P7HOB[P'^T
M_P##2QUOX6^//&GCGX]?MLWU_>1^/]:_9;CA\&:/X3^%EAXH\(^#K2^\7?%;
MX9_$'X2>-O''A:X\.Z*/IC_@EGXV_90^+?B3]H+XQ_LA^-OV<])\#>/3\*4T
M[]G/]G?XD?"WQ9<_#OP=X<TWQ /#'Q&^,O@GX2^)M9T+X7_&+XRRS:O)J&E:
MS)8ZK#H_AS2/#_BYKWQEH_B&WT[GBG*,9/W>:*=M[7UMTO;KHMR%/1-Q:NHM
MIZ-7C&6MTOYK:]MNA^TT8^1-VQFV+N900I.!DJ&+,%)Y&YF..K$\T[ ]!^0I
ML6?+CSG.Q,YVYSM&<[&=,YZ[&9<_=8C!+Z18F!Z#\A1@>@_(4M% $4JJ0H*J
M0SJ""H((.0001R".".XR#P:_/?X($G_@I)^W>3R?^&;?^"?@R>N/[;_;//\
M-F/U)]:_0F3^#_KHO]:_/;X'_P#*2/\ ;O\ ^S;O^"?G_IZ_;.H _0VBBB@
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M=G%J_C#Q%I/A+PSI[M'_ ,%*)9%N=9\2:YI&CVB&,9O-0MDD,:ON'5M\*O\
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M/_!43_H]?]BO_P 5O_%O_P"F84 ?H917YY_\*I_X*B?]'K_L5_\ BM_XM_\
MTS"C_A5/_!43_H]?]BO_ ,5O_%O_ .F84 ?H917YY_\ "J?^"HG_ $>O^Q7_
M .*W_BW_ /3,*/\ A5/_  5$_P"CU_V*_P#Q6_\ %O\ ^F84 ?H917YY_P#"
MJ?\ @J)_T>O^Q7_XK?\ BW_],PH_X53_ ,%1/^CU_P!BO_Q6_P#%O_Z9A0!^
MAE%?GG_PJG_@J)_T>O\ L5_^*W_BW_\ 3,*/^%4_\%1/^CU_V*__ !6_\6__
M *9A0!^AE%?GG_PJG_@J)_T>O^Q7_P"*W_BW_P#3,*/^%4_\%1/^CU_V*_\
MQ6_\6_\ Z9A0!^AE%?GG_P *I_X*B?\ 1Z_[%?\ XK?^+?\ ],PH_P"%4_\
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MV6O@&]^(OB/X&?%VP^-_PINO^"0<_P %-6EL_%6G^)?!S_#_ ,8_!J/]I0>
M;&66]TG3!_PB4GC+PW\:)=%\/V=OK7@V'7M"\6Z/J&EV^Y_8/%W[._[=.L:7
M^VY\,_!/@_QWX0T+]GJ2'X:?LD^,+O4-3U6W^,WP;^-7QW\+?'[XOW7A?3+7
MQAX-\2>)6\'_  JF\2_ *T\*Z5\7?!&N^(='L?\ A&-"\7^"-;U&PUW0OZ3/
MLD^YMODA"T9*AF!0AMK$ HRLR@(\>]2A56@=-TC7 E:T=EVED(+"3YC(RE@5
M&)!O#2'"JQ?>NZ52VU0PVZU<1.M4J5)QIKVM6M6=.,.6$95YY=4FH)\TDE+
MUG!N4G'^U<T?O.M0^K:XBH\14=2ZA>EA*,532Y80PF'J8:'*I<UG4C.,JR;:
MG.A0<5!0<9?R8:O^S#\5;C]FR#[1X9^*WB+X:6/Q^\1:_P#"'X$0?\$OOVA_
M#/[-^A2:E\'-,\*W.GWW[',_[='C']M;X9:%J?Q%T^X\4^ OC-I_BCX;:'\*
M?C)?^,OBC!X&U3P5XTM/&>J>[>'_ -D77O%7Q5^,FE?$+]D[Q;X+U;X\?MT?
M\$\?CC\7)--LO'/B3PEXL^#?A_\ 9!\$^%?&&@^(_CDBVMM\2M)\"?&_P?\
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M@U;!SGV./Y?Y_J:S;3G-1^&+23W?6]V*+ERPY[*<E=I:*]KNPM%%%!84444
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M"T/B_3=>L+G2[C1TNXS'7Y,?LP_ OXT?LQZ#XHN_@/\ L.?''X*_"/P_\%O
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M![AE(QZ'! !^?GC]BW_!4K]CD[2#_P ,!_\ !2YL<@'?^T7_ ,$G9!M9@I8
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M"C+?W?\ QX5\!?\ #M/]G7_HHW[?_P#XMB_X*F__ $9%'_#M/]G7_HHW[?\
M_P"+8O\ @J;_ /1D50'W[EO[O_CPHRW]W_QX5\!?\.T_V=?^BC?M_P#_ (MB
M_P""IO\ ]&11_P .T_V=?^BC?M__ /BV+_@J;_\ 1D4 ??I+8/RX_P"!"HBL
MA   X]QQZX_QKX'_ .':?[.O_11OV_\ _P 6Q?\ !4W_ .C(H_X=I_LZ_P#1
M1OV__P#Q;%_P5-_^C(IIM;?DA6]Y2ZI-+M9[Z;=#[Y <$9 X]_Y?7_.:DRW]
MW_QX5\!?\.T_V=?^BC?M_P#_ (MB_P""IO\ ]&11_P .T_V=?^BC?M__ /BV
M+_@J;_\ 1D4GJ[^5O+>^W?7<$DFWW=WZV2^6RT/OMMYQA<8.>H_S^%,VR9S@
M?GSGUSZ_Y]Z^!_\ AVG^SK_T4;]O_P#\6Q?\%3?_ *,BC_AVG^SK_P!%&_;_
M /\ Q;%_P5-_^C(IIM*WFWKKOKU_#MT&M&VMW:_7;1:=-S[\&X9^7.3GJ/:E
MRW]W_P >%? 7_#M/]G7_ **-^W__ .+8O^"IO_T9%'_#M/\ 9U_Z*-^W_P#^
M+8O^"IO_ -&12W$DHI);+Y];[_,^\I+=WE$G& [, 3V,4:8^N4+?CZ\U\[Q?
MLW:.GQU^.?QS?Q/K[:C\=?@C\$O@=K7ARUG;2K+P_HGP4UW]HG7M.U_0-8TV
M>#6+7Q%K]Q^T7KL6H7Z2QR6$7AK0FTUH97O9)?%?^':?[.O_ $4;]O\ _P#%
ML7_!4W_Z,BC_ (=I_LZ_]%&_;_\ _%L7_!4W_P"C(IW=Y/K.'LY><+-6\GJ]
M59^8U=144VHIQ=D^L<0L5&][W2KQ4[-6:7*_=T/,+[_@FOK?C PZ9\7_ -J3
MXD?%SPMX%^$WQD^$?P$MO$GA/PE:>,OAAI7QN^'U_P#"OQ5KOBKXAV1;7OC)
MK\'@*^?1;2?QA':VES=HGB'5[34O$=O8:I8_3&D_LH:1X<^,?PI^-GAGQGXA
MT+Q/X&^%D?P=\?V5HD#:+\;?!VEV&GQ^$Y/'&G/)]G@\1>#-7M+O5O#OB.QC
M;5K>VUC5/#\]S-HL\5O;^;?\.T_V=?\ HHW[?_\ XMB_X*F__1D4?\.T_P!G
M7_HHW[?_ /XMB_X*F_\ T9%%W[255R;G+F;;=TG*->$FHM<J<H8FM%I+V?O)
MJC&<(5(Y2HTYJTHMJZ=DVDU&I1JI.S3:53#TIW;]I>+7MN2<Z;^_<M_=_P#'
MA1EO[O\ X\*^ O\ AVG^SK_T4;]O_P#\6Q?\%3?_ *,BC_AVG^SK_P!%&_;_
M /\ Q;%_P5-_^C(I&I]^Y;^[_P"/"C+?W?\ QX5\!?\ #M/]G7_HHW[?_P#X
MMB_X*F__ $9%'_#M/]G7_HHW[?\ _P"+8O\ @J;_ /1D4 ??N6_N_P#CPHRW
M]W_QX5\!?\.T_P!G7_HHW[?_ /XMB_X*F_\ T9%'_#M/]G7_ **-^W__ .+8
MO^"IO_T9% 'W[EO[O_CPHRW]W_QX5\!?\.T_V=?^BC?M_P#_ (MB_P""IO\
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MC?M__P#BV+_@J;_]&11_P[3_ &=?^BC?M_\ _BV+_@J;_P#1D4 ??N6_N_\
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M[8REA(C+R)1ND\VOAG_AVG^SK_T4;]O_ /\ %L7_  5-_P#HR*/^':?[.O\
MT4;]O_\ \6Q?\%3?_HR*'",HU(N[C5BX35]XNUTM-+V3;5I-J,G*4X4IT3I!
M=*<G.'E)MMOSU;=GI]R/N1;"]50OVF,J0^]&5V5I)#$7D!,@.T[90L1^1 R%
M "I-/BL;R.1)'N%D*ON8X<%E#6^%4-(Z#Y(Y59]H=MZGCY\_#'_#M/\ 9U_Z
M*-^W_P#^+8O^"IO_ -&11_P[3_9U_P"BC?M__P#BV+_@J;_]&15MW<VU&]3E
M<O=6\>6S79IQCMORQOMK,HJ6K<G\7VFOB]JGMU7MI6?1QI-:TJ=OOW+?W?\
MQX49;^[_ ./"O@+_ (=I_LZ_]%&_;_\ _%L7_!4W_P"C(H_X=I_LZ_\ 11OV
M_P#_ ,6Q?\%3?_HR*11]^Y;^[_X\*,M_=_\ 'A7P%_P[3_9U_P"BC?M__P#B
MV+_@J;_]&11_P[3_ &=?^BC?M_\ _BV+_@J;_P#1D4 ??N6_N_\ CPK\_?\
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MO^"IO_T9% 'W[EO[O_CPHRW]W_QX5\!?\.T_V=?^BC?M_P#_ (MB_P""IO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<IJG_(T^'?\
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M*/\ OQH__P NJ .HKE-4_P"1I\._]@CQ3_Z%H5/_ .$DNO\ H5/%'_?C1_\
MY=5GK<7VJ^(M)N?["UC3[:QTW6X)I]1CL(X_-U!M,^SJGV:_NG;/V.;?\OR?
M)GAL@ Z6]_X][7_KK!_2K=%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5=_P#6M_U[M_Z$:**
#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm2323985d1_def14aimg003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2323985d1_def14aimg003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '' R # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^\.]-[=:Q
M9V46HZC80/H\UU,EF+ ?Z0U[91AR-0L;YLJUQ)P 0I&T_=-7?["U+_H:_$W_
M 'SX7_\ F<I3_P C5#_V KO_ -/-K73T <O_ &%J7_0U^)O^^?"__P SE']A
M:E_T-?B;_OGPO_\ ,Y7444 <O_86I?\ 0U^)O^^?"_\ \SE']A:E_P!#7XF_
M[Y\+_P#S.5U%% '+_P!A:E_T-?B;_OGPO_\ ,Y1_86I?]#7XF_[Y\+__ #.5
MU%% '+_V%J7_ $-?B;_OGPO_ /,Y1_86I?\ 0U^)O^^?"_\ \SE=110!R_\
M86I?]#7XF_[Y\+__ #.4?V%J7_0U^)O^^?"__P SE=110!R_]A:E_P!#7XF_
M[Y\+_P#S.4?V%J7_ $-?B;_OGPO_ /,Y7444 <O_ &%J7_0U^)O^^?"__P S
ME']A:E_T-?B;_OGPO_\ ,Y7444 <O_86I?\ 0U^)O^^?"_\ \SE']A:E_P!#
M7XF_[Y\+_P#S.5U%% '+_P!A:E_T-?B;_OGPO_\ ,Y1_86I?]#7XF_[Y\+__
M #.5U%% '+_V%J7_ $-?B;_OGPO_ /,Y1_86I?\ 0U^)O^^?"_\ \SE=110!
MR_\ 86I?]#7XF_[Y\+__ #.4?V%J7_0U^)O^^?"__P SE=110!R_]A:E_P!#
M7XF_[Y\+_P#S.4?V%J7_ $-?B;_OGPO_ /,Y7444 <O_ &%J7_0U^)O^^?"_
M_P SE']A:E_T-?B;_OGPO_\ ,Y7444 <O_86I?\ 0U^)O^^?"_\ \SE']A:E
M_P!#7XF_[Y\+_P#S.5U%% '+_P!A:E_T-?B;_OGPO_\ ,Y1_86I?]#7XF_[Y
M\+__ #.5U%% '+_V%J7_ $-?B;_OGPO_ /,Y1_86I?\ 0U^)O^^?"_\ \SE=
M110!R_\ 86I?]#7XF_[Y\+__ #.4?V%J7_0U^)O^^?"__P SE=110!R_]A:E
M_P!#7XF_[Y\+_P#S.4?V%J7_ $-?B;_OGPO_ /,Y7444 <O_ &%J7_0U^)O^
M^?"__P SE']A:E_T-?B;_OGPO_\ ,Y7444 <O_86I?\ 0U^)O^^?"_\ \SE'
M]A:E_P!#7XF_[Y\+_P#S.5U%% '+_P!A:E_T-?B;_OGPO_\ ,Y1_86I?]#7X
MF_[Y\+__ #.5U%% '+_V%J7_ $-?B;_OGPO_ /,Y1_86I?\ 0U^)O^^?"_\
M\SE=1TZU&TT2$*SJI968 \$JOWC]!0!S?]A:E_T-?B;_ +Y\+_\ S.4?V%J7
M_0U^)O\ OGPO_P#,Y72K)&Y(5U8C!(!!QN!(_,*3CK@4^@#E_P"PM2_Z&OQ-
M_P!\^%__ )G*/["U+_H:_$W_ 'SX7_\ F<KJ** .7_L+4O\ H:_$W_?/A?\
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MTVJSMGTPJLQSV!H YK^PM2_Z&OQ-_P!\^%__ )G*/["U+_H:_$W_ 'SX7_\
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M_P#S.5U%% '+_P!A:E_T-?B;_OGPO_\ ,Y1_86I?]#7XF_[Y\+__ #.5U%%
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MG4M/LHX%B\3>&K[2 EJUQ!)(62.0R6UP%J?\%Q/VB_%/P@_X(;?%&YT"XO\
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MSX8?M@?\%*?VE?#7AS]A_P#X*:_!+PU%\++G]K#]G_XX>.=0^%G[5_[%EGX
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MO%5GJ/AGQ-JW@KX>:GXKF\,)XIT674+!+<WVFS:/>W5E/=3V3^>1 T\1C/\
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M%_\ L7O$_P#Z4^':[.N,O?\ D=_"_P#V+WB?_P!*?#M %P_\C5#_ -@*[_\
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M5P0>/8@@C/&00,$@@<\>D<$"P*53 7"*J*H5(TC01HB*.BA%7(SC=N90H;:
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M/CC6O'.H_$OP-J]SI^A:;:8^'_CCPGIT%M!/9VVFP66J:M;WO7Z7_P $GO\
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M"FG>(;+P1K*K<^,?%-UIM_K_ (=U;5=#N]<O;C0[W399&=OK.B@#\S/VGO\
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MJA_[ 5W_ .GFUKIZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK2U%#T;_ 'V_I4M?-=O-)_>D_P!3ZAJS:[?Y+_,****!!1110 4444 %%%%
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M&[G=@[48#W=&\R,,BLRJ+R,J6"2G:S*ZA"SJ41&<[5R6"-(D;[<E9"P( 5B
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M_NG_ - %25&?]6_^Z?\ T 5$_A?R_-"^U'Y_H?%/_!0O_DTCXS>^AZ;U[?\
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M0>*;GXQ1GPM+X3T#P+XU^)7P\\<PZ+?>"KC5_$.@>&K/PW>76DW>H:G?:=I
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M10 4444 %%%% !1110 4444 %%%% !49_P!6_P#NG_T 5)49_P!6_P#NG_T
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MRG\"_P"WO_2Z@4445)84444 %%%% !1110 4444 %%%% !1110 R3[A^J_\
MH0K^/#XJ_P#)4?B-_P!CIXO_ /4FOZ_L/D^X?JO_ *$*_CP^*O\ R5'XC?\
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MG\/ZA\B_!W]C/XG_ +.MQJOPR^$OQ#3P_-\2/@UI5W'\<-'^&,5M\/\ P/\
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ML_AM\?/C?\+?CEH7_!)KP)XXU+Q!\-=-^ _BVT_9?\;?&SXI_"+P'J6A^&M
M\+6ES9:9^S1J_AB;Q@7AA?PIX=^(OB_1]/M+F_TS3[*:/PI%I=T?U5_X*/\
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M+_H'>(/_  FM8_\ C-'_  DL7_0.\0?^$UK'_P 9H Z:BN9_X26+_H'>(/\
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MPWU' 4H5Z-2,Z52.'H^T]G%Q;7+1KSE)*^E1RU>R_JOPCP.9Y3P=##9C@*F
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M=X@_\)K6/_C-'_"2Q?\ 0.\0?^$UK'_QF@#IJC+@.5) QCL>X!Y/09[5SO\
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MYM:Z>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M_G-_:5_9YD_:*_;2_:2M_A!\%OC=\1[/0](^$GP^_:"M$_:*^$GP8^%]UXB\
M6Z5X;\3>)5\$>'O$/P_^('C[5?$/B?X.:/X7\"_$[6[O5?!WAS4="N$T[P7<
MWOB&+5]1TG]<?VOM?T7P=^S1X_U'6?B%\:?@_!I6FZ/9Z)XS_9W\%>)/B/\
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M[Z;_ !H\M?0_]]-_C3Z* &>6OH?^^F_QI_2BB@ HHHH **** "BBB@ HHHH
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M;UFJ:=:2IJ5^94U+504E!/513U$V+W53[;$_HHJK>JOV.Z.U/]1/_ G]QO\
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M[^-?[%6K_&3X/^+1\4_"J:GX:\=>!/%WP>\%7/[3.D:]XF\ ?$NR?[-;^!?
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M^'5_[#<?_P"IE0_TEA_"H?\ 7FE_Z:IA11172,**** "BBB@ H/0]_;UHHH
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M:_&;5?BU+>^(YK6Q\";I_#EKX=FT_P"%NF2W^IP^!-*TX7^HV\O[E4 %%%%
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MI(#;[&!!'EB_10!CVVDI;WAOCY,ES*"ES,((DDG"F?[-++/)'<7\DUI%*]K
MAOTM$@N;DI;1DQJ-BBB@ HHHH K37*PNB%)&:0-M*+E00COB1L@1*5C;$DA6
M/(V[L\5\U_!3]LS]F+]HSQM\1_AU\$/C'X0^(_C/X37TFG^/-$\/7=Q--H\D
M&MZCX:NKFWN+BVM[36M-LO$FCZMX?OM3T.?4;"TUO3;S2YKA+V%H:W/VC=1_
M:*T[P;I4O[,?A#X(^,_'DGBK2+?Q#9?'KXA>-OAQX0TWX>RVNJR^)-7TW5O
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M \!^#]'TOP,3%KD]]>Z39)]#?"ZP\3^"/VO/A38^*=/^(_AV^_8I^*7_  5
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M/?WXL5ZD6WJXN*?PMM>_&WQ6TE'72TDI>1MKU37:_7S044450!1110 4444
M%%%% !1110 4444 %%%% !4,O6/_ 'F_] :IJAEZQ_[S?^@-43V7^.G_ .EQ
M&NO^&?\ Z1,_CK_:;_Y..^/_ /V63XE?^I;JU>(+T'T'\J]O_:;_ .3COC__
M -ED^)7_ *ENK5X@O0?0?RK_ $IX<_Y)KA/_ +)K+_\ TWAC_.G._P#D?<2_
M]E#C/RK"U4O?^/*[_P"N$_\ Z"]6SP"?2J=W_P >=T3@C[/-SW/R-GOGC&.1
M7J5YQC3<;N5><,0L-AXQ;J8JJL)B?W-*5O9QJ-/F7M91C9/70X</%3QF6KFC
M%QS;+ZEI7]Z,*OO)6ZZK?357/[B(.B?[L7_H(JY69 Y*QA3DGRU;'505)#'@
MX&  /KS@"K^2< O@GVQ[\'Z<]:_R\H*5.%1<O.GC,:[PE&27-BZCL];IQVDM
MT^A_I!2DIX?#23^*A2:5];>SIK5>J)**3TYR<?GTY_P_&EKI_KY]O4L****
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MVU_IU_\ %WXB7EG>VDBS6MU:W/BG4YH)[>:,LDT3QNICEC=HY5 >-V1E8^,
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M3]D;X/6/CZS\/:7XJ\4>*O&</P^\%:?XH\86O@3P<_BF]\(>-/&MK%XG\53
MKIEA>VG@2_T/1+>WM[O5]<\6ZKX;\-Z?!->:Y$C<T_[6/Q6?2+#3;3]F_P 6
MQ?&NT^$5K\0/'7P3N/%VA:EK7@[Q-K_Q#M/AIX7\)GQ1HLU]X:U/3M9UJ#Q3
MXUMO%<4<"77PY\.W.I6^E6]_/;:.EK_@H!\%OB[\<OV8OB#\.OA#I'PQ\:^(
MM0L-3&I?#/XXZ-8:Y\-/B[X;F\*>)])F\ :WJ]]X,\?3^%=6BU36-)\8^%O&
M>G^!]8U2#Q+X-T31M9N%T?6]4N(_AGP3^R;^U)^SC\-O'7[/_P"SYX@\":9\
M9/BE^RAH/AGX?^/I]3^(/@CX(_"&^\'_ !]^,?C+4/A3\+-=MO#?Q2\6>$?#
MOP]^&G[1VH>!/V>[B_TKQ9KNA>&/A=X)UGQ!HTO]D+H3@'LGBG_@IEXB\->
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MDVMYI?BSPM\9/AVM[=7>D62:+K[^)+!K6Z71C=7'R9XN_P""8_C?QYJGQR\
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M!Z#OCC&/7(Z\]@3C.0>YKW+]IO\ Y..^/_\ V63XE?\ J6ZM7B"]!]!_*O\
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M6X\.>&GN)GDGN99-%LI7FN)W:6XFDD>,R2/-.[R.[DN[,68DDDL'@[PK@?\
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MAEXIT3XD-/K"GQKK7Q=T_4D01>"=*1/NB_\ ^">O[.FK^#OASX-OK+QLVF^
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M_ 3XJVUO:QJ! D$'PZ\00QPJKEV2)5V[$1U"".) =J$-U/P,#/\ !OX0,9)
M&^%7P]PH=CPGA'1R=P8LC,S7!+2!$D8QH&=E 4 'RS_P]$_8I_Z*5XX_\1U_
M:8_^<]1_P]$_8I_Z*5XX_P#$=?VF/_G/5]_[#_??\Q_\31L/]]_S'_Q- 'P!
M_P /1/V*?^BE>./_ !'7]IC_ .<]1_P]$_8I_P"BE>./_$=?VF/_ )SU??\
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M+N?]G?\ :71=Q16\H,WP=VFX4LJ2VVX31/E)%656C$G_  ]$_8I_Z*5XX_\
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MCK^TQ_\ .>H_X>B?L4_]%*\<?^(Z_M,?_.>K[_V'^^_YC_XFC8?[[_F/_B:
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MOPAG62XCV[C;A@YBW2JQ5<-^@I4@$[WX&>H_^)K\S/VZ/BM^TK\*]8^$6H?
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MQ3%I*W\GP6\6:YI DDDDK)*R_KKZL?S;]6W;TOLO)'TNW_!4#]BM0"?B1XZ
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M+HO._;3])DE'E6[<5*]NCZ._7\]^U_MG_AYCX"_Z-2_X**_^(*?'[_YEZ/\
MAYCX"_Z-2_X**_\ B"GQ^_\ F7KX9T/_ (*Y?M-Z/\-_%7Q7^)O[,_P;?PM;
M?M)_$O\ 8;\!Z9\,/BS\3?&OB_Q7^U=X9\6+X"^'\][X8TKX*ZMK<'P4\<>,
M(;^SU6_\)Z7XV^+^@:+!!J'A[X5>._$M_I7@G4O2]/\ ^"D7[6XU33K;6/V7
M? NF:1X"U3PU#\;=4\5ZM\>_A!KOB;P]XK^+/@GX6Z1XJ_9\^'7QG^!'@7QK
MJFERGQ_8ZI+)\2;'PMICZWX0\9^%-#U_Q%8G0?&%^B3Z:;_@ICX"P<?LJ?\
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MJ^BVG[4&H>$_$_@'X@^&;"75A8:KXTT_[?HGBGX8WUEWOQ)_X*2^-?"'Q;\
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M0(;"#;(&8^&3R6#,K.D2A?E&\@L?.O$W[7O[2 ^$OQZ\$_$'PY\./@5^T?\
M";XL_L\?"W7/&7PK\8M\:/A1I7A/]HKQ+X$MM&^)GA34?B-\/O 6H)XFT;1_
M$7B?P^WA+Q]X"GM+#Q=H_ASQ'<Z?XC\)>);;3I?E7]HWQI\8_A?^W+\ OV5-
M._:C_;'^-'P_\3_!S]H;XI>)_ _P!L_A _[1'P]U/2KSX!Z-X.U+XC^)W_L>
M\U_X<:A>>*/&VK>$8M0\$Z7<Z3J^J:KIUIKOB/PYH>EZ!X) /O-O^"EW@1=I
M/[*O_!1$]V"_L*_'TM@Y4(R#PT9(7R5D'FH-\7S("K!@G_#S'P%_T:E_P45_
M\04^/W_S+U\2_"#]J[]HAOA-^QO^UMK'BSXC:Y??M'_ML>&?V5_&?[+?B6R\
M*?9?!?PS\5^./B+\)+-X;&/P]:^,]&^,GP8/AS3/C)\7-?U#Q1K,VIZ!X9^*
MVB:GI/\ 9K>'+SPG^^J.2SJP(^8B,'&710,R?+QM8G Z=,=: /SD_P"'F/@+
M_HU+_@HK_P"(*?'[_P"9>C_AYCX"_P"C4O\ @HK_ .(*?'[_ .9>OTAHH _-
M[_AYCX"_Z-2_X**_^(*?'[_YEZ:W_!2_P"V<_LI_\%%AG'3]A3X^C@=1G_A%
M<X/?G/8$"OTCHH _-U?^"F'@%1C_ (92_P""BQY)Y_84^/Q/))_Z%;H,X'M3
M?^'EW@#+'_AE/_@HL2QSD_L*?'T[?9<^%3@>W-?I)10!^;P_X*8^ 0,?\,I?
M\%%>/^K%/C]_3PL!^5'_  \Q\!?]&I?\%%?_ !!3X_?_ #+U^D-% 'X]_M$_
M\%'_  +K/[/OQUTB+]ES_@H)8RZK\&_B?IL5YJ_[$?QWTO2K6:^\$ZY:Q3ZE
MJ=UX86VT^QCDE5KJ]N66WM80\\S+$C,-?X.?\%'_  /I7PG^%=A-^R]_P4$N
M9-.^&_@C39I-._8>^/&H6EU<6_A/0U-S8WMIX<EAFLIHXUGM)B EU;R+<0R-
M&\6_[Y_:B&?V9_VB1Z_ OXN#@D'_ )$#Q!W'(^HYK6^!4:'X-_!I]H#1_"CP
M$B$<;8V\(>'BT8_Z9DA6V]-RJW49H ^//^'F/@+_ *-2_P""BO\ X@I\?O\
MYEZ/^'F/@+_HU+_@HK_X@I\?O_F7K](:* /S>_X>8^ O^C4O^"BO_B"GQ^_^
M9>C_ (>8^ O^C4O^"BO_ (@I\?O_ )EZ_2&B@#\WO^'F/@+_ *-2_P""BO\
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MULL&K7"W]E;;)-.>:?ZJ_P"'E_@)/D/[*?\ P44)3Y21^PG\?P"5&"0#X7)
MSTY..F3UKUWP. /VX_VDR  P_9Z_958.!\X\SQK^TPCKNZ[&6),IT+*&ZC-?
M82 !$ & %7 '0# X'L.U 'YP?\/,? 7_ $:E_P %%?\ Q!3X_?\ S+T?\/,?
M 7_1J7_!17_Q!3X_?_,O7Z0T4 ?F]_P\Q\!?]&I?\%%?_$%/C]_\R]'_  \Q
M\!?]&I?\%%?_ !!3X_?_ #+U^D-% 'YO?\/,? 7_ $:E_P %%?\ Q!3X_?\
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M4>6SIS_L.R_W6(YJ6@#\WO\ AYCX"_Z-2_X**_\ B"GQ^_\ F7H_X>8^ O\
MHU+_ (**_P#B"GQ^_P#F7K](:* /S>_X>8^ O^C4O^"BO_B"GQ^_^9>ODO\
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M_P#TI\.UV=<9>_\ ([^%_P#L7O$__I3X=H N'_D:H?\ L!7?_IYM:Z>N8/\
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MK^MV/Q*F/BQ==U?5;W6+B]BM+>[OI]/L;.S@]J?_ (*-7NA_MO?M!_L_^)M
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M_LC_ +=7@GX5?!+PUXXN/ ?@#2O^"5'[?#^+%^*_Q$\,^%_AWJGB_4O&-_\
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MV;/@M??$74;'Q!-+!/XQO/A+?:1JT_AR#58M)\06.HW,UREC<Z3=7?;^//\
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M_P#G/U^F=% 'YF?\/3/A3_T:Q_P4S_\ %:'[:'_SGZ/^'IGPI_Z-8_X*9_\
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M+B^+\3F="JJL7'DJ8.6;XE5+IN,KTI**FTW:>OR-H]O_ ,$;-!\0:%XXT_\
M:=_9UL?BQI'QJ^,'QQUWXP)X]^#$GQ9\=ZY\;O%OQ \5?$OP+\0?&T7AZUO_
M !!\)M7TWXA:Y\/SX86VTVZL?AGHWA+PG8^(=/MO#UI-/R&D>%/^"3_@WP+\
M'O"GPJ_X*(>'?A+XH^$,OQE>V^+OAWXP?LT^-_BEXZT7]HKQIX0^)/QLT7Q]
M/\<OA!\5?!.JCXA>.?AM\/=?O_$^@>!_"WC_ ,.R> ?#T'A#QEX:TZ;6;+5L
M#6OV\?V?_ASH_P :[WXR?LO_ +-?@O5/A%^VAK?PAT?3M/\ A_X2O+SXE_LJ
MR?M&?$#]F[0/C+X;T_6[70([?QLWQ8^&'C3X8^)-+37=2\,>'?$EAX?\5>)7
MT+PSX]T6#2_IG]FW]H7]F_\ :A^,FI_#;P#^QQH'A_0?#?P8\7^+_'>N^.?A
MA^SC%JGP[^,?A3XM7OPRU3X(^)++P1\0O&3:UJWV."T\9:7XJ\ :;XT^$'B'
MPCJ.DZ[HOQEU+^TK&QN/U%WDHU)J\^7DC-<S@Z2LTE)\R;NDVE-V_E2/GH4G
M2OSM5*DVYRK:)SO;2R:LMG91C%-6U:T^<?CKX!_X)*_M _#'PI\*M8_X*,Z9
MX0\/>%=&^/OAFTU3PK\:_P!F[Q#XBOO#W[2H4^.=)?4/BW\)OBC8^'M6LI&M
MO^$2\;_#VR\*?$K2;43Z9/XNU;1]8\16>M>-+9_L3?%GXX?$WQ'\7_VW?AGX
M'^&FD^(_B!XO_9[?1_VCOV8O&MA\*/BGXO\ VAM3^-MI\7?@%HFI_#;6U+>(
M;B^USQ%\0/"_[67AWXO1:/X[\3>)_AO\/+*;X'Z;I-O>_H[8_%'X&:/^SE\(
M/B]XC_8L\-_$GXD?%S5O$6A>%/@S\ /@S\(->\6^)-0\-P_$'5_$H\.6?Q'\
M0_#_ $FTLO"G@?X?:KXKUU_$GC#2KG6+N.P\#^#H/$/Q$\4^$O!&K>=^$/VT
M_P#@G=\1?"7Q2^)/PS_9RT_XB?![X9?#?P9\4(?C-HWP1^!NF> _'H^)'@_P
M'XS\*^$O#=EXFU[0/'/@?Q=J&A_%#P'(UY^T#X1^"_@"U%]K<5_\1$3P%\0I
M_#(:&_XL^-__  3R\4?"CX9_#-?^"C_A;PWXV^"NJV&L?#W]HOPW\8_@"GQR
M\/>,;+2[WPSJ_BZ9M=\#^(?@OJ>I>*]*\5>*=#\7^&]:^$;^ ]6TKQ#J^E6'
M@:#34LXH/F74/AW_ ,$MM9M/%V@:U_P5+US7?!OQ?UF#QY\<?!VH_M!?LW3Z
M)\>/VA;73TT?0OVC_'DT7P<_MS0OB5X2U+1_ 7B;PKX$^$NO_#']FZS\1_"_
MP#>3? 22TT+5(=;_ %G^#/@/X!?&/X<^$/B5;_LL>$_AR/%MA+??\(3\2O@[
M\)['QEX=$&H7>FW=IK$OA.;Q3X/U$&73IHM(UWP-XO\ &W@_Q'HESHWBKPWX
MDU_PSK>E:K<>M_\ #.GP#_Z(3\&O3_DF?@?ITQ_R+_IQ0!^&W[4Z_L$_&3QS
M\ /B'\-O^"COA;P!XU^'/[3.B?%_4O&'A']H7X%Z5XB\':;IOP&\5?"!=:\,
M6WB_X>^,='\3ZKITG_",:A+X5\:>'?%VB>+6N]>TGQCI7B+PC.V@P:EAX+_X
M)3Z+?:U>^&/^"E*>'=+\>^'-2LOC?H.E_&_]FN[LOCOXZN8_$T/B/XZ>.-7U
M7X/ZUXN\-?%7Q#J?B[4-?\7_ /"EO%/PD^'?B+44TBR\1> [WP_HUAHMO^VO
M_#.GP#_Z(3\&O_#9>!__ )GZ/^&=?@)_T0KX-?\ AL_ _;I_S .U 'XW_%:U
M_P""7?Q:U/7=0U;_ (*.Z5HVB>,/BEX?^)'COP!I'QL_9TU/PCXXC\._"WX
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MGA[PC-:^/H]"37]"\&^)O%OA7Q7J.F^))_%/[^?\,Z? /_HA/P:_\-GX'_\
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M/^)EUXJ\42_#;0M7O['6_B9KGP^T'7=7\07OA7P!X>;5/[/L?U]_X9T^ ?\
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M_ALO _\ \S] 'BO_  \<_8'_ .CR/V=/_#L^"_\ Y9T?\/'/V!_^CR/V=/\
MP[/@O_Y9U[5_PSI\ _\ HA/P:_\ #9>!_P#YGZ/^&=/@'_T0GX-?^&R\#_\
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MH?\ "K?B:U]X8L+"]\*17'PPO[5E@?A+I?B"X_9P^$>F_$73OC \'QMT%_\
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M'\8_#G_"4>%KKQ[XYLOAO\2/AUK%M=^$O$GPZT34?$O_  ENE1PSVEOI4]P
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M#J;3G/&U?H.E 'C'_#QS]@?_ */(_9T_\.SX+_\ EG1_P\<_8'_Z/(_9T_\
M#L^"_P#Y9U[5_P ,Z? /_HA/P:_\-EX'_P#F?H_X9T^ ?_1"?@U_X;+P/_\
M,_0!XK_P\<_8'_Z/(_9T_P##L^"__EG0/^"C?[!!X'[9'[.I/8#XL^"R3] -
M3R:]J_X9T^ ?_1"?@U_X;+P/_P#,_7F/QJ^%'PM^''PA^)GC_P #_LH_"_XF
M>,?!G@?Q+XE\,?#W0OAEX-;6?&NMZ-I5S?6'AK2X[;PO=W,]_J\\*V5I;6]O
M)<74\J6\.V6574 PQ_P4<_8'(##]LC]G0J1D$?%GP600#@D$:G@@'CZ\=:3_
M (>._L#8!_X;)_9SP1D$_%KP6,C .1_Q,^00RD'H0P/0BOST_9Z^*,'Q>^$7
MPRG\/? /]@OXG?''XH^"?VFOB#X9TWP+X&T_PQ\/_*^".GZ-X<\._#'QPMY:
M>)_$OPH^)'_"V_B3\-_#'C"+4G\6QZ+X8T;QHMQI6D^,7TO24YKQG\:6\ ^$
M_B;XPN_A'^P3XV\"_!;XR0_"C6_BIX-_9OUV7PO\5_%&K/X.73/A9X2TC2?&
MGC2R^%&N>&+C6]0T?XA_&7QYX\\4?"3P9K4%I:^)K;PZVF^)8M( /TP_X>._
ML##.?VR?V<Q@ G_B[7@K@$X!/_$SX!((!Z$B@_\ !1W]@8#<?VR?V<PO]X_%
MKP6%Z$CYO[3QR%8CGD*Q' ./+/C9IW@WX8_%O]F?P9X;_9 _9Z\3?#[XPZQ\
M3K/QYX[US2/AGHEWX2N/"7PE\6^/O!_A'PMHP\.QQZM=^)+_ $"\DU'Q7J-U
M%X=\->$]"U2:\-WJ6N:4]K^8G@O]MSPGXY\":1J<7P(_8:\'7/B7XHZMX6OO
MBQXV^"$^A?"/X96F@?LK>)OVDKGX?^)M/\0>)?#,_COQA?W&@)X&\*?%7PYX
M_P! ^#_C"PO?$WC#PC+KMUX OO!7B$ _8X?\%'?V!R0!^V3^SH2WW0/BSX+)
M;Y2_R@:F2?D!;C/R@MT!-*/^"CG[ YSC]LC]G0[=V['Q9\%G;LQOW8U/C9D;
MLXVY&<9%?"?Q@^,7@NR^$/A7XQ?"/]F']F&STC3OV)9/V]_B+H/Q)^$NDZSJ
M][\-[;0]+\4W7PV\"ZIHEIX0LM#\<1^'X_$D-GXJ\4:3JVD)J=KHL5]X9CM[
MB]D@\>M/VG;'6OBO\-_@[I/[,/[']CK?[4NFW_CK]F[Q9)\&(M4T?P;\/;/X
MV^(?A>&^,/AW^UM#U#QEK-_X8M?"WC%6\+:_\-[G3M1UN]\.W^@&3099]0 /
MU-_X>.?L#\_\9D?LZ\$*?^+L^"_O%48+_P A+[Q62-@.I62-@,.I)_P\<_8'
M_P"CR/V=/_#L^"__ )9U\M?L-_$OX._M5:393>*_V6O@5X(UK4?@A\*_C&]G
MI/PV\*WNGVFJ>(?&_P 9O@]\1/"NFWFH>'H)M6_X0CXC? :_U"+46MXII/#?
MCWPA%-$+FVDFG_0__AG3X!]?^%$_!H9[?\*S\#\>Q_XD!Y'?!(ST)'- 'BO_
M  \<_8'_ .CR/V=/_#L^"_\ Y9T?\/'/V!_^CR/V=/\ P[/@O_Y9U[5_PSI\
M _\ HA/P:_\ #9>!_P#YGZ/^&=/@'_T0GX-?^&R\#_\ S/T >*_\/'/V!_\
MH\C]G3_P[/@O_P"6=?(7[>__  4 _8=\2?L?_'31M#_:R_9YUO4[SPOIXM]-
MA^*7@VYDN/+\4:!))B%-3)8(BLY.#MV[AR!7Z3_\,Z? /_HA/P:_\-EX'_\
MF?KX[_;_ /@-\#](_8\^..H:?\$OA-:7=OH&AM%<6'@'P3IES&#XS\-"1DOE
M\/-]F41EB\C*4"!@^%)=0#UAO^"C/[!4=Q/%+^V/^SFKQ33P%%^+G@QMLEM+
MY%PC#^TMF^&9&B8JSC((SD&G?\/'/V!_^CR/V=/_  [/@O\ ^6=>UM^SQ\!)
M))3_ ,*,^#SYD9V:3X8^"1NDE=Y)G!;0&9W>1B\KLQ+NQ<G).4_X9T^ ?_1"
M?@U_X;+P/_\ ,_0!XK_P\<_8'_Z/(_9T_P##L^"__EG1_P /'/V!_P#H\C]G
M3_P[/@O_ .6=>U?\,Z? /_HA/P:_\-EX'_\ F?H_X9T^ ?\ T0GX-?\ ALO
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M"3?\,Z? /_HA/P:_\-EX'_\ F?H \5_X>.?L#_\ 1Y'[.G_AV?!?_P LZ/\
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M9DD%I,\MS\PFE9EE8 ^^**** "BBB@ HHHH **** "BBB@ KC+W_ )'?PO\
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M!7T!_P ,^? K_HA_P=_\-CX,_P#E71_PSY\"O^B'_!W_ ,-CX,_^5= 'S_\
M\//_ /@FE_TD/_89_P#$M?@%_P#/ H_X>?\ _!-+_I(?^PS_ .):_ +_ .>!
M7T!_PSY\"O\ HA_P=_\ #8^#/_E71_PSY\"O^B'_  =_\-CX,_\ E70!\_\
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M_P#X)I?])#_V&?\ Q+7X!?\ SP*/^'G_ /P32_Z2'_L,_P#B6OP"_P#G@5]
M?\,^? K_ *(?\'?_  V/@S_Y5T?\,^? K_HA_P '?_#8^#/_ )5T ?/_ /P\
M_P#^":7_ $D/_89_\2U^ 7_SP*/^'G__  32_P"DA_[#/_B6OP"_^>!7T!_P
MSY\"O^B'_!W_ ,-CX,_^5='_  SY\"O^B'_!W_PV/@S_ .5= 'S_ /\ #S__
M ()I?])#_P!AG_Q+7X!?_/ H_P"'G_\ P32_Z2'_ +#/_B6OP"_^>!7T!_PS
MY\"O^B'_  =_\-CX,_\ E71_PSY\"O\ HA_P=_\ #8^#/_E70!\__P##S_\
MX)I?])#_ -AG_P 2U^ 7_P \"C_AY_\ \$TO^DA_[#/_ (EK\ O_ )X%?0'_
M  SY\"O^B'_!W_PV/@S_ .5='_#/GP*_Z(?\'?\ PV/@S_Y5T ?/_P#P\_\
M^":7_20_]AG_ ,2U^ 7_ ,\"C_AY_P#\$TO^DA_[#/\ XEK\ O\ YX%?0'_#
M/GP*_P"B'_!W_P -CX,_^5='_#/GP*_Z(?\ !W_PV/@S_P"5= 'S_P#\//\
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M?\//_P#@FE_TD/\ V&?_ !+7X!?_ #P*/^'G_P#P32_Z2'_L,_\ B6OP"_\
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M/'@[1[FP'CO.A6N@R_$2^^'5_;6Y%S-#X0AU6S\G3M4M[6']9O\ AGSX%?\
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M?4(HR7M(M1L))@BWEN9/J-?^"GW_  33"@'_ (*'?L,Y  /_ !EK\ ^H&/\
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MQ+>226.GMIZ^J:?XZ_X)QV?P@T;X&6W_  6$_8Y\._#&S\ ^(?@AK/@7P/\
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M?\,^? K_ *(?\'?_  V/@S_Y5T ?/_\ P\__ .":7_20_P#89_\ $M?@%_\
M/ KY&_;Q_P""C?\ P3R\7_LB_&[PWX6_;U_8K\0:_JWAW2K73=(TC]JGX$W^
MH7MQ)XL\/*D<%M;^/7D8Y(+-@)&N7D9$5F'Z<_\ #/GP*_Z(?\'?_#8^#/\
MY5TJ_L^_ Q721?@A\'A)$PDB9?AIX,C9) "JNL@T>1D*AB=R ,.Q/*L ?/\
M_P /.O\ @FO&9/,_X*%_L.)MGDB;=^UG\!%VRQX62)L^/_EDC;AXSAT/# 4G
M_#S_ /X)I?\ 20_]AG_Q+7X!?_/ KWF']G/X"P ^7\"_@U&7R[K'\,/ X19'
M(>8Q^7H5NQ$LA:1WE9W9SD@9S4__  SY\"O^B'_!W_PV/@S_ .5= 'S_ /\
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M&?/@5_T0_P"#O_AL?!G_ ,JZ/^&?/@5_T0_X._\ AL?!G_RKH ^?_P#AY_\
M\$TO^DA_[#/_ (EK\ O_ )X%'_#S_P#X)I?])#_V&?\ Q+7X!?\ SP*^@/\
MAGSX%?\ 1#_@[_X;'P9_\JZ/^&?/@5_T0_X._P#AL?!G_P JZ /G_P#X>?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7&7O\ R._A?_L7O$__ *4^':[.N,O?^1W\+_\ 8O>)_P#TI\.T
M 7#_ ,C5#_V KO\ ]/-K73US!_Y&J'_L!7?_ *>;6NGH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *XR]_Y'?PO_ -B]XG_]*?#M=G7&7O\ R._A?_L7O$__ *4^': +A_Y&J'_L
M!7?_ *>;6NGKF"1_PE4//_,"NS^']LVG/ZC\QZUTV1ZC\Q0 M%)D>H_,49'J
M/S% "T4F1ZC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%)D>H_,49'J/S% "T4F1Z
MC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%)D>H_,49'J/S% "T4F1ZC\Q1D>H_,4
M +129'J/S%&1ZC\Q0 M%)D>H_,49'J/S% "T4F1ZC\Q1D>H_,4 +129'J/S%
M&1ZC\Q0 M%)D>H_,49'J/S% "T4F1ZC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%
M)D>H_,49'J/S% "T4F1ZC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%)D>H_,49'J
M/S% "T4F1ZC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%)D>H_,49'J/S% "T4F1Z
MC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%)D>H_,49'J/S% "T4F1ZC\Q1D>H_,4
M +129'J/S%&1ZC\Q0 M%)D>H_,49'J/S% "T4F1ZC\Q1D>H_,4 +129'J/S%
M&1ZC\Q0 M%)D>H_,49'J/S% "T4F1ZC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%
M)D>H_,49'J/S% "T4F1ZC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%)D>H_,49'J
M/S% "T4F1ZC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%)D>H_,49'J/S% "T4F1Z
MC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%)D>H_,49'J/S% "T4F1ZC\Q1D>H_,4
M +129'J/S%&1ZC\Q0 M%)D>H_,49'J/S% "T4F1ZC\Q1D>H_,4 +129'J/S%
M&1ZC\Q0 M<9>_P#([^%_^Q>\3_\ I3X=KLLCU'YBN-O?^1W\+_\ 8O>)_P#T
MI\.T 5?$GA2?7;^UO[3Q'K>@3VUG+IQ;2/L:BX@NY[:Z9Y_M*2,3&;10I7:P
MSD!CQ6)_PKS4/^BD^-O_  (LO_D*BB@ _P"%>:A_T4GQM_X$67_R%1_PKS4/
M^BD^-O\ P(LO_D*BB@ _X5YJ'_12?&W_ ($67_R%1_PKS4/^BD^-O_ BR_\
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M^BD^-O\ P(LO_D*BB@ _X5YJ'_12?&W_ ($67_R%1_PKS4/^BD^-O_ BR_\
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M^BD^-O\ P(LO_D*BB@ _X5YJ'_12?&W_ ($67_R%1_PKS4/^BD^-O_ BR_\
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5M#,5^S(B[E^PQD?>R.^20"B@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
